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Abstract 
Schistosoma mansoni is a parasitic helminth which gains access to the host’s 
vascular system by penetrating and migrating through the skin in search of a 
blood vessel. The aim of this thesis was to determine whether during this 
migration the schistosome cercariae induce blood vessel growth (angiogenesis). 
This was examined following both a single exposure to the parasite (1x) and four 
exposures (4x). After 4x infections it has been shown that the skin immune 
response is predominantly Th2 and may favour angiogenesis.  
Utilising both imaging and molecular techniques it was shown that the 
vasculature of the pinnae alters and pro-angiogenic growth factors are up –
regulated after infection.  This was exacerbated in the pinnae of 4x infected mice 
with a change in the predominant growth factors up regulated.  The difference in 
growth factors between 1x infected and 4x infected mice was in part due to the 
influx of haematopoietic cells into the dermis (DEC). In the 4x infected pinnae the 
DEC were predominately eosinophils (45%) which expressed hepatocyte growth 
factor (HGF) and matrix metalloproteinases (MMPs). Macrophages in the 4x 
infected mice were alternatively activated (up –regulating Arginase-1 and Ym1) 
and producing pro- vascular endothelial growth factor (VEGF) and placental 
growth factor (PlGF). These phenotypes were partially controlled by high levels 
of IL-10 in 4x pinnae, loss of which increased the expression of PlGF by 
macrophages. It was also shown that the cercarial secretions (0-3hrRP) have pro-
angiogenic properties. Culture of human umbilical vein endothelial cells 
(HUVECs) with 0-3hRP induced cell proliferation and the formation of primitive 
branches in vitro. Additionally using the Matrigel plug method it was shown that 
0-3hRP can induce the growth of new blood vessels in vivo. These results 
indicated that cercariae can directly induce blood vessel growth as well as 
altering the dermal innate immune response. This presents a potential 
therapeutic benefit in the treatment of non-healing wounds. 
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Overview of the Introduction 
 
This thesis aims to examine the complex process of angiogenesis during infection 
with Schistosomiasis mansoni (S.mansoni). S.mansoni is a parasitic helminth, 
which utilises blood vessels in order to infect its mammal host (Pearce 2002). The 
results presented here will examine changes in both the dermal vessels and the 
immune system in relation to angiogenesis.   
The first part of this introduction will introduce schistosomiasis and the 
parasite’s interactions with the skin during infection. The second part will give an 
overview of the processes involved in angiogenesis and wound healing, with 
particular focus on key growth factors. The final section will cover the immune 
response to schistosomiasis, including a description of the multiple infection 
model used in this study, and the influence of the immune system on 
angiogenesis in disease. 
 
1.1 Schistosomiasis 
1.1.1 The disease and life cycle 
 
Schistosomiasis is a caused by a parasitic helminth that utilises two hosts and 
several morphologically distinct life cycle stages (Pearce 2002).  Infection is 
prevalent across Africa, Asia and South America (Chitsulo 2000). Schistosomiasis 
is a major cause of morbidity among infected populations (van der Werf 2003). 
There are five main species of helminth which cause schistosomiasis; one of the 
most prevalent and widely studied is S.mansoni which causes intestinal 
schistosomiasis in humans and is the focus of this study (Kabatereine et al 2002. 
Pearce 2002). 
S.mansoni has a two host life cycle; snails and mammals, consisting of several 
morphologically distinct stages. The snail host for S.mansoni is the water snail 
Biomphalaria glabrata (Files 1949). Within the snails the parasite undergoes 
successive replication within the hepatopancreas producing thousands of the 
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human infective stage; the cercariae. These are shed into the water daily from 
the snail host dependant on temperature and light. They are composed of a head 
and tail and vigorously move to maintain their position in the water awaiting a 
permissive host.  Infection of the human host occurs when bare skin comes into 
contact with infected water (Pearce 2002). The cercariae attach and directly 
penetrate the skin. During this process the tail detaches (although this is 
disputed and the cercariae release their gland contents. The parasite must 
migrate through the epidermis into the dermis in search of a blood vessel, or on 
occasion a lymphatic vessel (McKerrow 2002).  
Upon entry into the circulatory system the schistosomula migrate to the lungs 
where they push through the capillaries, elongating and maturing to allow 
subsequent migration of the worm (Wilson 1986). The mature worms continue 
around the circulation to the hepatic portal system where the males and females 
pair up and migrate along the length of the major vessels, to as close to the 
intestines as possible (Miller 1980, Dean 1984). The females lay eggs which 
transit through the vessel wall into the lumen of the intestine and are passed out 
of the body in faeces. Whilst many eggs exit the body some can get backwashed 
into the liver or remain lodged in the intestinal wall (Doenhoff 1985). Eggs which 
do exit the body can hatch into the snail infective stage; miracidia upon contact 
with fresh water and complete the life cycle. 
At several points during the schistosome life cycle the parasite is in close 
association with the vasculature of the host. During elongation in the lungs and 
egg passage through into the intestinal lumen the parasite is in direct interaction 
with the vessels. It has been previously shown that the eggs of schistosoma 
mansoni secrete factors aiding their escape from the tissue (Loeffler2002). 
Among these is a factor which has been shown in vitro to induce processes 
associated with angiogenesis, including endothelial cell proliferation and 
assembly into primitive vessels (Kanse 2005). 
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 During the skin stage the parasite needs to find and enter a blood vessel to 
continue the infection process. Therefore it is possible that the cercariae as well 
as the eggs may induce angiogenesis or vascular remodelling. 
 
1.1.2 Migration of cercariae through the skin 
 
Many previous studies of S.mansoni have concentrated on the chronic egg stage 
of infection; this work will focus on the early skin interactions to the cercariae. 
The cercariae are approximately 250µm long consisting of a large head section 
(100µm) containing  pre- and post- acetabular glands and a forked tail (150µm 
long) which allows it to move within the water (Doresy et al 2002). Invasion of 
the host skin requires the cercariae to attach and penetrate through the skin 
layers, triggered by host chemical stimuli (Haas 1994, Haas 1997).  
The skin is composed of two main layers, the epidermis and dermis (Menon 
2002). It is within the dermis that the blood vessels are located, and the 
cercariae must force through multiple epidermal layers to reach this. The 
outermost of these is flattened dead and dying cells whilst the lower layers are 
more structurally integral, composed of primarily keratinocytes which are 
anchored with adherent junctions to each other and the basement membrane 
(Menon 2002). The parasite forces its way through these epidermal layers until 
reaching the basement membrane which separates the epidermis and dermis 
(Cozzani 2001). Skin migration can be stalled here as the basement membrane 
which contains a thin but strong layer of collagen fibres and microfibrils (Smith 
1982). Penetration and entry through the epidermis can take around 30 minutes 
in mice but the majority of the larvae can still be found in the dermis up to 40 
hours after infection (He 2005). This timing is contentious and seems to be highly 
dependent on the host species and method of detection (Wilson 1987, 
McKerrow 2002, Curwen 2003, Whitfield 2003). During this time however the 
cercariae are in close contact with the keratinocytes and can cause significant 
damage to the epidermal layer eliciting wound healing responses.  
 
 
16 
 
Once through the basement membrane the cercariae move through the dermis 
and locate a blood vessel. In murine studies it can take the parasite 10hrs to 
locate a vessels and a further 8hrs to penetrate through the endothelial cell layer 
into the blood stream (Crabtree 1980). The dermis is composed primarily of 
fibroblasts which produce the extracellular matrix (ECM) the structural scaffold 
of the skin (Chiquet 2003). ECM is composed primarily of proteoglycans, heparin 
sulphate and elastin and collagen fibres (Pflieger 2006). Throughout the dermis is 
a well ordered network of both blood and lymphatic vessels (Menon 2002).  
Migration through the dermis is associated with the release of proteolytic 
enzymes from the glands of the cercariae (Keene 1983, McKerrow 2002).  These 
contain a mix of proteases, including a large amount of cercarial elastases, which 
can degrade the proteins that compose the extracellular matrix. (Newport 1988, 
Curwen 2006). Studies using models of extracellular matrix have shown cercarial 
secretions will degrade elastin, collagen and glycoproteins (McKerrow 1983).  
The timing of parasite secretion release is controversial. Some studies have 
shown that the acetabular glands are emptied before reaching the dermis 
(Curwen 2003) while others believe it is used for dermal migration (Crabtree 
1985, McKerrow 2003).  
After cercarial penetration of a vessel, de-granulating platelets can be found. 
Platelets contain a number of inflammatory mediators which could influence 
both activation of the immune response and inflammation driven angiogenesis 
(Mannaioni 2004).  The movement and the release of extracellular matrix (ECM) 
degrading enzymes by the cercariae suggests that they have the potential to 
induce wound healing and angiogenesis in the skin. 
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1.2 Wound healing and Angiogenesis 
1.2.1 Overview of wounding and angiogenesis  
 
Wound healing comprises of a series of closely regulated steps. The process can 
be broken down into three phases, inflammation, proliferation and remodelling, 
although these are not distinct steps and in vivo wound healing will overlap 
spatially and temporally (Witte 1997).  
The inflammatory phase is characterised by an influx of leukocytes and the 
production of pro-inflammatory cytokines e.g. Interluekin-1β (IL-1β), 
Transforming growth factor-α (TNF-α) and Interferon –γ (IFNγ). These cytokines 
and the release of histamines, primarily by resident immune cells and the 
fibroblasts of the skin,  cause vasodilatation of surrounding blood vessels aiding 
the extravasation of leukocytes into the surrounding tissue (Neufeld 2006). There 
is an initial rapid neutrophil influx immediately following wounding before 
macrophages and then lymphocytes are recruited (Gimstad 2011). Platelets 
rapidly enter the site of damage and are an important source of chemokines and 
Platelet derived growth factor (PDGF), which is pro angiogenic (Mannaioni 2004, 
Gleissner 2008).  In healing wounds new blood vessels sprout from the existing 
vasculature to supply oxygen to the new tissue (Tonnesen 2000). The damage to 
the skin layers releases growth factors which are sequestered in the extracellular 
matrix (ECM) and further growth factors are released by the cells in the skin; 
keratinocytes, fibroblasts and endothelial cells as well as by the haematopoietic 
cells recruited (Frantz 2005). After revascularisation of the wound the fibroblasts 
grow across the wound and deposit a provisional extracellular matrix. During this 
process re-epithelialisation of the epidermis occurs with epithelial cells crawling 
over the wound site proving cover for the new tissue to remodel and contract 
(Witte 1997). 
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1.2.2 The physiological process of angiogenesis 
 
In a developing embryo the formation of a fully functioning vascular network is 
essential to survival. This process, termed vasculogenesis, utilises endothelial 
progenitors – angioblasts, which migrate and form networks of vessels under the 
guidance of several growth factors including vascular endothelial growth factor 
(VEGF) (Carmeliet 1996). The primitive vascular networks undergo remodelling 
and maturation into the quiescent functioning vasculature of an adult (Patan 
2000). The term angiogenesis is used to encompass this process and the process 
of new blood vessel formation in the adult. 
As well as being a physiological process in embryonic development, angiogenesis 
is important in the maintenance of the adult tissues. Local changes in the levels 
of pro and anti angiogenic growth factors control this process. Angiogenesis can 
be initiated by hypoxia, release of angiogenic growth factors by cells and from 
damaged tissues (Brogi 1994). It is also induced in several diseases, including 
cancer (Carmeliet 2000). 
The process of angiogenesis itself involves a series of steps (Figure 1.1). Firstly 
the vessels, which are usually quiescent in the fully developed adults, undergo 
vasodilation. This can be initiated by nitric oxide and VEGF (Fukumura 2001). In 
order to allow endothelial cell proliferation and eventual migration, the junctions 
between endothelial cells need to loosen. The adhesion molecules, platelet 
endothelial cell adhesion molecule 1 (PECAM-1) and vascular endothelial 
cadherin (VE-cadherin), are both redistributed on the cell surface weakening the 
cell-cell connections (Eliceiri 1999). Excessive vasodilation is detrimental and can 
lead to circulatory collapse, and hypertension among others (Schermuly 2011). 
The angiopoietin family of genes controls the balance of vascular leakage 
(1.2.3.1). Angiopoietin 1 (Ang1) is constitutively expressed and maintains 
vascular stability whilst angiopoietin 2 (Ang 2) promotes leakage and loosening 
of endothelial cells and the basement membrane of vessels (Roviezzo 2005).  In 
order to clear a path for new vessel migration the existing ECM and basement 
membrane of the vessels must be remodelled. This is accomplished primarily by 
the Matrix metalloproteinases (MMPs) (1.2.3.2). MMPs act in a cascade 
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promoting ECM degradation, pericyte detachment from vessels and growth 
factor release (Rundhaug 2005).  
Proliferation and migration of the endothelial cells is then induced by pro-
angiogenic growth factors. Many of these are sequestered in the ECM and 
released by MMPs whilst others are produced by platelets (Nagase 1999). 
Several distinct families of growth factors can stimulate angiogenesis some with 
overlapping functions whilst others have a distinct role. The VEGF family of 
growth factors is central to angiogenesis controlling endothelial proliferation, 
directional migration and lumen formation (1.2.3.3). One member of the VEGF 
family – Placental growth factor (PlGF) is particularly associated with pathogenic 
angiogenesis (1.2.3.3). It and platelet-derived growth factor (PDGF) are 
redundant during development but induced in adult angiogenesis where they 
Figure 1.1: Overview of angiogenesis 
 
Quiescent vessels are stabilised with smooth muscle cells and pericytes. When pro-
angiogenic stimuli are released the endothelial cells rearrange their cell-cell 
adhesion molecules and become activated. MMPs degrade the basement 
membrane around the vessels and surrounding ECM. Growth factors released by 
neighbouring cells  direct the proliferation and migration of endothelial . The cells 
of the immune system can also be a source of growth factors (1.3). After the signals 
are resolved the endothelial cells stabilise and up-regulate cell-cell contacts 
maturing with a layer of smooth muscle cells and pericytes to become quiescent 
again. 
 (HGF- hepatocyte growth factor, PlGF – Placental growth factor, FGF – fibroblast growth factors, 
VEGF – vascular endothelial cell growth factor ) 
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often function to promote the recruitment of inflammatory cells to sites of 
remodelling (Mannaioni 2004). Hepatocyte growth factor is another factor 
expressed primarily in pathological angiogenesis, controlling endothelial cell 
mobilisation and invasiveness (1.2.3.5). Whilst the Fibroblast growth factors 
(FGFs) (1.2.3.4) are essential in both developmental and physiological 
angiogenesis. After cells have proliferated and mobilised angiogenic inhibitors 
suppress further proliferation and stimulate the maturation of endothelial cells 
into mature vessels (Moses 1991). Endothelial cells assemble as tubes which 
eventually form a lumen which fuses to the pre-existing vessels; the new 
vasculature eventually becomes quiescent. 
 
1.2.3 Factors involved in angiogenesis 
 
1.2.3.1 The angiopoietins 
 
The up-regulation of pro-inflammatory cytokines and histamines can induce 
vessel permeability but it is also tightly controlled by the angiopoietin family . Of 
these there are two main genes, Ang1 and Ang2, which work antagonistically 
though their mutual receptor Tyrosine-protein kinase receptor (Tie 2) (Stoeltzing 
2003, Maisonpierre 1997). 
Ang1 is expressed constitutively in the adult and helps maintain vessel 
quiescence (Brindle 2006). Ang1 signalling suppresses vascular permeability by 
up-regulation of cell to cell adhesion molecules on the endothelial cells of the 
vessels, including both PECAM 1and VE-Cadherin (Gamble 2000). Transgenic over 
expression of Ang1 can cause blood vessels to become leakage resistant even in 
the presence of VEGF (Thurston 1999).  
Ang2 is expressed at sites of angiogenic sprouting and remodelling (Maisonpierre 
1997). It induces vascular leakage by binding to Tie 2 and preventing Ang1 
signalling. Ang2 signalling induces dissociation of the endothelial cells and 
inflammation of the vessels. Ang-2 must be produced constantly at high 
concentrations to overcome the constituent expression of Ang-1 (Kim 2000, 
Roviezzo 2005).  
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1.2.3.2 Matrix metalloproteinases   
 
To allow new blood vessels to form the existing ECM must be degraded, this is 
achieved in part by a family of zinc containing proteases called the matrix 
metalloproteinases (MMP). They are synthesized as inactive zymogens with a pro 
peptide domain which must be cleaved for the enzyme to become active 
(Rundhaug 2005). MMPs have various effects on the ECM including degradation 
to clear areas, releasing bound angiogenic factors and exposing integrin binding 
sites essential for the movement of growing blood vessels (Xu 2001, LeBrasseur 
2002).   
Among the MMPs, matrix metalloproteinase 9 (MMP-9) has been instigated as 
essential in the angiogenic process. Genetically modified mice lacking MMP-9 
have impaired angiogenesis and impaired vascular remodelling. (Itoh 1998, Van 
Hinsbergh 2006). MMP-9 and MMP-2, both members of the gelatinase family, 
cleave type IV collagen to expose αvβ3 integrins which are critical for 
pathological angiogenesis (Mahabeleshwar 2006). MMP-19 is expressed in 
wounded and repairing tissue and is associated with hyper proliferation of 
keratinocytes. MMP-19 is particularly expressed in granulation tissue by 
endothelial cells, fibroblasts and also the infiltrating cells (Sadowski 2003, Raza 
2000).MMPs also aid in the final stage of wound repair; remodelling. Fibroblasts 
accumulate at the wound and deposit an array of ECM components.  This 
provisional ECM is degraded by MMPs and replaced with an ECM of a 
composition more like that found in un- injured tissue. (Nagase 1999)  
 
1.2.3.3 The VEGF family  
 
VEGF is one of the most documented pro-angiogenic growth factors, and is 
widely regarded as an essential mediator in angiogenesis (Frelin 2000, Ferrara 
2002, McColl 2004, Carmeliet 2005, Otrock 2007). Its activity is largely restricted 
to cells of the vascular endothelium although it has been shown to stimulate 
macrophage migration. (Barleon 1996) VEGF stimulates endothelial cell 
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mitogenesis and migration as well as enhancing vascular permeability (Carmeliet 
2000).  
The VEGF gene family consists of seven proteins with varying and overlapping 
activities; VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, VEGF-F and PlGF. These 
each signal through one or more of the VEGF receptors; VEGFR1 (Flt-1), VEGFR2 
(Flk-1), VEGFR3 (Flt-4) and Neuropilins 1 and 2.VEGF-A and PlGF are the main 
angiogenic mediators (see below), VEGF-B is poorly mitogenic for endothelial 
cells and VEGF-C and D are primarily lymphangiogenic (Otrock 2007). 
 
VEGF-A 
The primary VEGF family member is VEGF-A, also referred to as just VEGF. The 
gene encoding VEGF-A comprises of 8 exons, which through alternative splicing 
produce 4 predominant isoforms in mice: VEGF120, VEGF164, VEGF188, VEGF205  and 
2 less abundant isoforms VEGF 144  and VEGF 182 (Tischer 1991) . These isoforms 
have varying heparin binding affinity which alters their angiogenic function. The 
most predominant of these isoforms is VEGF164  which partially binds heparin and 
is partially soluble. VEGF120 is completely soluble whilst VEGF188 is entirely matrix 
bound and sequestered in the ECM (Poltorak 1997, Krilleke 2007). 
VEGF production is regulated primarily by hypoxia through activation of the 
Hypoxia inducible factor (HIF) -1 (Liu 1995, Detmar 1997).  In addition several 
growth factors including TGFα, TGFβ and PDGF up-regulate VEGF expression, 
along with pro inflammatory cytokines including IL-6 and IL-1α (Salgado 1999, 
Goumans 2003, Nagineni 2003). VEGF-A signals through Flt-1 and Flk-1 which are 
both trans-membrane receptor tyrosine kinases (Shibuya 2001) Flt-1 undergoes 
phosphorylation upon VEGFA binding but does not appear to transduce a signal 
and was proposed to be a dummy receptor preventing binding to Flk-1 and 
regulating growth. However recently binding to the receptor has been associated 
with matrix metalloproteinase release and haematopoiesis (Wang 1998). Flk-1 is 
essential in developmental angiogenesis and is the main mediator of the 
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mitogenic effects of VEGF. Binding induces proliferation, migration and survival 
responses in the endothelial cells (Gerber 1998). In pathogenic conditions, VEGF 
up-regulation has been identified in tumour angiogenesis and associated with a 
high risk of subsequent metastasis. Anti VEGF treatments are currently being 
used to reduce vascularisation and development of tumours (Dirix 2010, Willet 
2004).  
 
PlGF 
PlGF, which was originally identified in the placenta, is not essential in 
developmental angiogenesis but is expressed during pathological angiogenesis. 
(Hiratsuka 2001, Seaman 2007). PlGF signals through Flt-1 and it is theorised that 
it can displace bound VEGF which is then free to signal through Flk-1 and induce 
angiogenic responses. (Carmeliet 2001). PlGF stimulates the growth of 
endothelial cells (ECs) and smooth muscle cells (SMCs) (Wang 1998). 
Overexpression of the gene in the skin results in a significant increase in number, 
branching and diameter of the blood vessels (Odorisio 2002). As well as acting on 
endothelial cells PlGF can recruit bone marrow derived cells to neo-angiogenic 
sites (Carmeliet 2003). This places a central role on PlGF in many inflammatory 
diseases including arthritis and cancers (Yoo 2009, Taylor 2010) 
 
VEGF-D (FIGF) 
VEGF-D, also known as c-fos inducible growth factor (FIGF), activates Flk-1 and 
Flt-4 and has both angiogenic and lymphangiogenic properties (Byzova 2002, 
Saharinen 2004). FIGF is translated as an inactive precursor protein and must be 
proteolytically cleaved before it is active. Only fully processed forms will activate 
Flk-1 and induce angiogenesis (Stacker 1999). FIGF has potent angiogenic effects 
in vivo and in vitro. Endothelial cells stimulated with FIGF alter their morphology 
and proliferate, whilst overexpression of FIGF in rabbit corneas induces 
significant neo vascularisation (Marconcini 1999) 
 
 
24 
 
1.2.3.4 FGF family 
 
The fibroblast growth factors like the VEGFs induce a wide range of responses in 
both developing embryos and adults. In humans 22 structurally related FGFs 
have been identified (Ornitz 2001). FGFs are required during development and 
the timing and pattern of expression varies between tissues (Maruoka 1998, Liu 
2005).  
The main FGF involved in angiogenesis is FGF2, mice lacking this gene have 
cardiovascular defects and delayed wound healing (Ortega 1998). FGF2 induces 
endothelial cells to organise into tubules and induces sprouting from mature 
vessels (Montesano 1986, Fulgham 1999, Cross 2001). As FGF2 is sequestered in 
the ECM through its heparin binding affinity, it can be released following 
wounding through proteolytic cleavage (Emoto 1998).  
 
1.2.3.5 HGF 
 
Hepatocyte growth factor (HGF) as its name suggests is primarily expressed in 
the liver, but is also found throughout several tissues in the body including the 
skin (Zarnegar 1995). It has supposed functions in liver regeneration but can also 
enhance motility and growth of endothelial cells marking it early on as a 
potential pro-angiogenic molecule (Matsumoto 1992, Morishita 1999). HGF is 
derived from a single chain glycoprotein which is proteolytically cleaved to 
produce a heterodimer of two subunits (Nakamura 1989). Signalling by HGF 
occurs through the receptor Met (Bottaro 1991, Dong 2001). This is a 
heterodimer which transduces multiple biological effects including mitogenesis, 
morphogenesis and motogenesis (Weidner 1993). HGF and VEGF work in concert 
to promote vessel formation from activated endothelial cells (Xin 2001). 
Activation of the Met receptor by HGF stimulates high levels of EC proliferation 
and motility, and HGF is particularly up-regulated in EC monolayers following 
wounding (Bussolino 1992, Camussi 1997). 
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1.3 The Immune response and angiogenesis 
 
1.3.1 Pathological angiogenesis  
 
Angiogenesis is an essential mechanism in the development and maintenance of 
adult vasculature during several physiological processes, including wound repair 
and menstruation (Smith 2001). However it can also play a distinctly pathological 
role. Many diseases have an angiogenic component, usually either excess new 
vessel growth, deformations to existing vessels or inhibition of growth (Carmeliet 
2003).  
One of the main differences between physiological and pathological angiogenesis 
is the involvement of the immune system. Platelets, monocytes/macrophages 
and other leukocytes are recruited to wound sites of inflammation or damage 
and can direct the expression of angiogenic factors (Frantz 2005). The cells 
themselves can also release pro-angiogenic growth factors.  Several 
inflammatory pathological conditions show exacerbated / exaggerated 
angiogenesis including asthma, arthritis and psoriasis (Jackson 1997, Bos 2005, 
Rudolph 2005, Holt 2010).   
In rheumatoid arthritis an unknown factor causes the influx of large numbers of 
inflammatory cells into a joint and the release of pro-inflammatory cytokines 
(Kinne 2007). This leads to the formation of a pannus and up-regulation of MMPs 
and pro angiogenic growth factors (Clavel 2003).  The outer synovial layer of a 
normal joint is predominantly avascular and under a quiescent state. Aberrant 
pathological angiogenesis allows vascularisation and inflammation of the joint 
progressing the disease (Walsh 2001). Two predominant factors are VEGF and 
PlGF, which drive vessel growth and vascularisation of the joint lining and 
allowing more leukocytes to be recruited perpetuating the swelling and 
destruction in the joint (Luttun 2002). PlGF in particular is up-regulated 
significantly in rheumatoid arthritis and causes excessive fine vessel branching 
(1.2.3.3). Blocking the PlGF receptor, Flt-1, has been shown as an effective way to 
 
 
26 
 
reduce disease in mouse models of arthritis, by restricting revascularisation and 
halting disease progression (Yoo 2009).  
Another disease which exhibits excess inflammation driven angiogenesis is 
psoriasis. This is an inflammatory disorder of the skin, characterised by excessive 
growth of keratinocytes, inflammatory cell accumulation in the epidermis and 
excessive dermal angiogenesis (Creamer 2002). Importantly it is the change in 
vessel morphology which characterises this disease. Capillaries of the skin 
become dilated and torturous elongating throughout the dermis. VEGF and 
Hypoxia inducible factor (HIF) are strongly up-regulated in the skin of psoriasis 
patients along with Ang2 which promotes vascular leakage (Simonetti 2006). 
Vessels in psoriasis, unlike in mature disease free skin, are thin and numerous 
pushing up through the dermis to the usually avascular epidermis. The change in 
morphology of these vessels from their native state aids in the progression of the 
disease (Heidenreich 2009). 
In addition to a direct immune cell mediated initiation of angiogenesis, tumour 
cells secrete factors to promote their own growth and survival which can drive 
angiogenic processes (Chung 2010). As tumours grow they increase demand on 
nutrients and oxygen in the surrounding tissue and the centre of the tumour 
becomes hypoxic. The hypoxia pathway is initiated causing up regulation of VEGF 
and FGF-2 among other factors, and inducing angiogenesis. New vessel growth is 
essential for reoxygenation but is also an important step in the final stages of 
tumour maturation and the ability of a tumour to metastasise (Vaupel 2004). The 
vessels which grow into and around a tumour are morphologically different to 
those of normal vasculature. The vessels are often thin and densely packed and 
are not stabilised with pericytes and smooth muscle cells. The basement 
membrane is disorganised and as such the tumour vasculature is frequently leaky 
(Carmeliet 2000). Tumour vessels often express specific markers including CD105 
(also known as Endoglin) which is a surface component of the TGF-beta receptor 
complex. CD105 is expressed at high density on tumour vasculature and can be 
used to distinguish between tumour vessels and pre-existing vessels (Seaman 
2007).   
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S.mansoni is in close association with blood vessels throughout its life cycle, as 
such there it is possible that the parasite either directly or through the immune 
response it is inducing is causing aberrant pathological angiogenesis within the 
host.  
 
1.3.2 The immune response to schistosomes 
 
During infection with schistosomes the immune system undergoes a switch. Eggs 
which become lodged in the tissue elicit a vigorous immune response. This 
response is down regulated from a pro inflammatory Th1 driven phenotype to a 
regulatory Th2. The Th2 driven response encapsulates the eggs encasing them in 
granulomas of collagen fibres and immune cells, predominantly eosinophils and 
macrophages (Hoffmann et al 2000). The majority of research into 
schistosomiasis has concentrated on the chronic immune response to the eggs.  
At the onset of egg production the body mounts a strong inflammatory response 
with high levels of IFNγ detectable. However as infection progresses and egg 
laying increases this response shows a switch to a predominantly Th2 associated 
response with increases in IL-10, IL-4 and IL-13 (Pearce et al 1991). This is 
associated with the presence of dendritic cells and macrophages around the eggs 
driving the Th2 phenotype. (MacDonald et al 2001) Experimental models in mice 
have shown that these Th2 responses are protective and beneficial for the host, 
mice lacking IL-4 or T cells die shortly after infection (Fallon and Dunne 1999). IL-
10 dependant effects are likely to control much of the Th1 to Th2 switch as IL-10 
deficient mice (IL-10KO) develop an unchecked Th1 response and exacerbated 
pathology and mortality (Sadler et al 2003). 
There are fewer papers focusing on the skin response to infection and those 
which do often look in conjunction with monitoring downstream pathologies. 
There are few that have focused on the immune response in relation to the skin’s 
ability to recover and the angiogenic effects in the skin. The passage of the 
cercariae through the skin will cause both damage and also invoke an innate 
immune response which may impact on downstream immune regulation.  
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Invasion of the skin by cercariae causes an inflammatory cytokine release and 
localised oedema, vasodilation and inflammatory cell influx. The epidermis of the 
skin thickens early (~6hours post infection) and remains thickened for several 
days after infection (Icani 1984, Hogg 2003). Granulocytes can be seen infiltrating 
into the epidermis, these are primarily neutrophils but eosinophils are also 
present (Incani 1984, Ward 1988).  After infection the dermis shows considerable 
oedema, leukocyte infiltration and vasodilation (Mastin 1983, Wheater 1979). 
The cell influx contains initially neutrophils accompanied later by macrophages, 
dendritic cells and eosinophils which peak at day 4 (Hogg 2003). The phagocytic 
cells of this influx (macrophages and dendritic cells) can capture the parasite 
antigen and migrate to skin draining lymph nodes which will lead to initiation of 
the adaptive immune response and alter the phenotype of the cells (Paveley 
2011).  
After infection many inflammatory mediators are found in the dermis including 
IL-6, IL-1β, MIP1α and eotaxin (He 2002, Wolowczuk 1997).  This is an immediate 
innate response to the parasite induced wounding of the skin. This initial 
response develops and other cytokines including IL-12 and IL-10 are expressed 
(Angeli 2001). IL-10 has known regulatory functions and as discussed previously 
has been implicated as beneficial in the modulation of the host immune 
response to schistosomes (Dewals 2010). Skin resident cells including 
keratinocytes and fibroblasts are both potential sources of the IL-10 
(Ramaswamy 2000). The in fluxing leukocytes may also make and respond to the 
IL-10 regulating the immune response in the skin.  
 
 
1.3.3 The dermal immune response to multiple infections with S.mansoni 
 
 
Just prior to beginning this project the laboratory showed that the immune 
response in the skin after multiple infections showed a similar switch to that 
seen after egg deposition. Individuals living in infected regions are likely to be 
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repeatedly exposed to schistosomes, as they come into contact with 
contaminated water sources through daily tasks e.g. collecting water and 
washing. Human studies document increasing resistance to reinfection and lower 
infection intensities in high risk areas, potentially as a result of re infection. 
(Caldas et al 2000). Infected children in these areas show elevated IL-10 levels 
perhaps indicative of an immune switch from multiple infections (Van der 
Biggelaar 2000).  
Unfortunately the murine host, used predominantly in experimental models, 
cannot survive multiple infections due to the pathology caused by egg 
accumulation. Several studies have used non-human primates to determine 
whether multiple infections can alter the host responsiveness to infection and 
subsequently confer protection (Sturrock 1984, Farah 1997). These studies 
showed that the multiple infected animals had delayed pathology and re 
stimulated peripheral blood mononuclear cells (PBMC) induced increased levels 
of IL-4, IL-5 and IL-10 compared to a single infection (Farah 2000, Nyindo 1999). 
However these studies have not focused on whether multiple infections affect 
the initial immune response at the skin infection site.  
Two infection regimes have been utilised in the mouse model in order to 
examine multiple infections in the skin; infection with radiation attenuated (RA) 
cercariae or the bird schistosome Trichobilharzia regenti (T.regenti).    
RA cercariae have severely reduced migration through the skin (Mastin 1983, 
Mountford 1988). Vaccination with RA cercariae induces immune-mediated 
protection against challenge infection (Hewitson 2005). Exposure of the skin to 
RA cercariae induces rapid inflammation as seen with infection of un-attenuated 
cercariae (Riengrojpitak 1998, Elsaghier 1989). Infection with a single dose of RA 
cercariae induces a Th-1 dependant response with high levels of IFNy and IL-2, 
whereas multiple infections induced increased levels of IL-5, IL-4 and IgG1 which 
are associated with a Th2 response (Caulada-Benedetti 1991). Dense foci of 
eosinophils and mononuclear cells were detected in multiply exposed pinnae 
suggesting a hypersensitivity reaction (Chang 1986, McLaren 1990) 
 
 
30 
 
Infection with the bird schistosome T.regenti causes cercarial dermatitis in 
humans. The skin pathology after infection is similar to that seen in murine skin. 
(Horak 2002). The skin thickens and the acute phase cytokines, IL-6 and IL-1β, are 
expressed followed by increasing amounts of IL-12 (Kouřilová 2004). In 
comparison, re-exposure of the skin to T.regenti induces the release of IL-4 and 
IL-10 alongside a sudden release of histamine from mast cells in the skin 
(Kouřilová 2004). This suggests that the re-exposure results in and allergic type 
response in the skin. 
Previous experiments in the laboratory, just prior to the start of this work, have 
used a multiple infection model exposing the pinnae of mice to ~150 cercariae 
once a week for four weeks (2.2.2). The immune response in the pinnae and skin 
draining lymph nodes has been shown to change after this regime (Cook 2011). 
After multiple exposure to S. mansoni cercariae both IL-4 and IL-13 were up-
regulated in the skin alongside an increase in IL-10 and significant influx of cells, 
particularly eosinophils, into the skin site. 
The cytokines and cell types up-regulated following multiple exposure in all three 
of these models are all heavily associated with angiogenesis and altered wound 
healing in both skin and other tissue sites in diseases including psoriasis, asthma 
and arthritis. The cytokine levels and cell types recruited to the skin after these 
multiple infections causes change in the immune response but may also affect 
the wound healing and angiogenic potential of the skin. 
 
1.3.4 Cytokines in angiogenesis 
 
As well as modulating immune responses, cytokines and chemokines can have 
direct and indirect angiogenic properties. A number of cytokines released during 
inflammatory conditions can be involved in the angiogenic process, these 
include, IL-1, IL-8, IL-6 and TNFα. Both IL-1 and IL-6 can induce angiogenesis 
through the activation of VEGF, and have been implicated as essential in the 
production of an angiogenic response in some tumours (Kim 2003, Margetts 
2002). In rheumatoid arthritis inflammatory cytokines activate macrophages 
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contributing to the unbalanced inflammatory response by releasing growth 
factors, matrix metalloproteinase, cytokine and chemokines. There is matrix 
destruction and angiogenesis which disrupts the natural structure and integrity 
of the joint (Smeets 2003, Felsmann 1996, Wakisaka 1998, Firestein 2003).  
IL-8, which was originally described as a macrophage derived pro-angiogenic 
factor, is up regulated in hypoxia and can lead to changes in the cytoskeletal 
organisation of cells controlling cell retraction (Tamm 1998). It also increases the 
production of matrix metalloproteinases 2 and 9 by endothelial cells. (Hirani 
2001, Aihua 2003). 
TNF-α stimulates the synthesis of platelet-activating factor (PAF) by monocytes 
and endothelial cells.  This factor causes vasodilatation and recruitment of 
platelets which are important in angiogenesis. (Mannanioni 2004, Nurden 2011). 
The inflammatory response in the skin following schistosome infection may 
influence the delicate balance between pro and anti angiogenic factors which 
maintains the quiescence of the vessels. 
Th2 cytokines can also affect the pro/anti- angiogenic balance. IL-4 is often found 
up-regulated alongside IL-13 in diseases which have high levels of angiogenic 
induction (Munitz 2008). IL-4’s angiogenic properties are conflicting with several 
studies categorising it as anti-angiogenic whilst others show it is pro-angiogenic. 
Indeed IL-4 can induce a pro-angiogenic phenotype in macrophages (Mantovani 
2002).  With regards to wound healing IL-4 levels increase the first 4 days after 
wounding stimulating collagen production by fibroblasts (Salmon-Her 2000). 
Culture of aortic endothelial cells with IL-4 significantly stimulates the formation 
of tube-like structures which could be inhibited by blocking the IL-4 receptor 
(Fukushi 2000).  Administration of IL-4 to the cornea of rats induces neo 
vascularisation in vivo (Fukushi 1998). These studies used concentrations of 
250ng of IL-4 injected directly into the cornea. An alternative study injected 
10ng/ml IL-4 alongside FGF2 into rat corneas and blocked the neo vascularisation 
(Volpert 1998). This work also showed that endothelial cell migration was only 
induced when stimulated with small amounts of IL-4(0.01ng/ml). Both IL-4 and 
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IL-13 induce up-regulation of mRNA for VCAM -1 in vascular endothelial cells. 
Soluble VCAM-1 can induce angiogenesis and is correlated with increased 
metastasis in tumours (Ding 2003). IL-13, like IL-4, is instigated as anti-angiogenic 
but is a major inducer of fibrosis and tissue remodelling particularly following 
wounding (Kaviratne 2004, Fichtner-Feigl 2005). IL-13 addition in capillary tube 
assays leads to inhibition of tube formation (Nishimura 2008). IL-13 stimulates 
eosiniophillic inflammation and remodelling in lungs and induces up-regulation 
of MMP-9 and resulted in alveolar remodelling in asthma (Lanone 2002).  In 
S.mansoni infections, IL-13 drives liver fibrosis and remodelling independent of 
MMP-9 and TGFβ (Kaviratne 2004)  
IL-10 is directly associated with both wound healing and angiogenesis. It is 
expressed following wounding and associated with wound viability (Peranteau 
2008, Werner 2003). However, in relation of angiogenesis, IL-10 also has anti- 
and pro-angiogenic properties. IL-10 inhibits blood vessel growth in ischemic 
conditions which show high levels of pro inflammatory cytokines (Silvestre 2000). 
It appears to function primarily in the resolution of inflammation and thereby 
probably acts primarily to reduce angiogenesis. However IL-10 stimulated 
macrophages produce VEGF and nitric oxide and can induce retinal angiogenesis 
(Dace 2008). 
 
1.3.5 Immune cells and angiogenesis  
 
The skin is the first barrier to schistosome infection and the innate immune 
response mounted here will impact later in the regulation of the infection and 
development of an adaptive immune response. The immune cells recruited in 
this response may not only function to prime the adaptive immune response and 
defend against the parasite infection but influence also the angiogenic/ wound 
healing response (Frantz 2005, Yu 2003). Increased VEGF expression will cause 
increased vascular permeability in addition to stimulating endothelial cell 
proliferation and migration (1.2.3.3). This increased permeability will enable 
immune effecter cells to egress from vessels into the surrounding tissue 
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(Aghajanian 2008). The cells which influx into the site will determine the 
response produced. Innate immune responses to infection have been shown to 
affect the angiogenic response in a tissue. Following schistosome infection a 
large influx of cells is present in the dermis. These include eosinophils, mast cells, 
dendritic cells, and macrophages all of which have angiogenic properties (1.3.1). 
1.3.5.1 Neutrophils 
 
Neutrophils primarily function as the first responders to injury or infection 
(Weiss 1989, Dovi 2004). Within the skin they respond immediately following 
wounding, whether by an infectious agent or penetration of the skin with a 
needle, and can produce inflammatory cytokines which will increase vascular 
permeability and the recruitment of further immune effecter cells (Ng, 2011). 
Neutrophils play an important role in physiological angiogenesis. During the 
menstrual cycle they are a potent source of VEGF supporting growth and 
proliferation of the endometrial tissue (Lathbury 2000). In addition, in 
pathological conditions, neutrophils are thought to provide an early angiogenic 
switch in the tissue site (Nozawa 2006). Neutrophils cultured with combinations 
of LPS, TNFα and IL-1β are stimulated to release VEGF (McCourt 1999). In 
addition to growth factors, neutrophils also represent a source of pro-angiogenic 
proteases. MMP-9 expressing neutrophils are found in and around tumours and 
provide the initial switch to a pro-angiogenic tumour in the early stages of gastric 
carcinogenesis (Nozawa 2006).   
 
1.3.5.2 Macrophages 
 
Macrophages are present in virtually all tissues and have a diverse range of 
functions, primarily repair and protection (Lucas 2010).  Following wounding, 
macrophages will scavenge and phagocytose cellular debris during tissue 
remodelling. Macrophages have been found in close association with vessels in 
pro-inflammatory conditions when the level of VEGF present is high 
(Sunderkötter 1994, Ausprunk 1977). Within tumour studies the depletion of 
monocytes leads to reduced vascularisation of the tumour (Lewis 2006). 
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Macrophage secretions alone can induce angiogenesis indicating a molecule 
produced by macrophages is the angiogenic mediator and activation of the 
macrophages is essential for this release (Sunderkötter 1991, Crowther 2001). 
Proliferation of endothelial cells following wounding is up-regulated briefly and 
quickly down-regulated. Thus to allow continued neo-vascularisations e.g in 
tumours, the endothelial cells must be activated for longer, macrophages are 
potential activators of this (Delavary 2011). Macrophages release several 
proteases which can cleave the ECM into pro-angiogenic components e.g fibrin 
and releasing ECM stored growth factors (Russell 2002, Skjøt-Arkil 2010). They 
can also induce vascular permeability due to the release of vasoactive substances 
including prostaglandins (Coussens 2002).  Growth factor expression by 
macrophages can directly induce the endothelial cell growth and vessel 
formation releasing, PDGF, VEGF, TNF-α and TGFβ among others (Assoian 1987, 
Bottomely 1999, Ligresti 2011).  
Macrophage activation is currently a widely researched topic. The activation 
status of macrophages is influenced strongly by the cytokine milleu they are 
subjected to (Mantovani 2004, Nathan 1984, Mosser 2003). Macrophages were 
originally thought to be solely pro-inflammatory activated by IFNγ and producing 
nitric oxide, among other radicals, to remove pathogens after infection and 
present antigen to T cells (Zhang 2008). However several ‘alternative’ 
macrophages have been phenotyped including the alternatively activated 
macrophages (AAMΦ) which are induced by the Th2 associated cytokines IL-4 
and/or IL-13 and heavily associated with helminth infections. (Gordon 2003, Noël 
2004, Rodriguez-Sosa 2002).  
AAMΦs process arginine with the enzyme arginase as opposed to inducible nitric 
oxide synthase and produce anti-inflammatory agents such as Transforming 
TGFβ, IL-10, Ym-1 and RELMα (Edwards 2006).This leads to the production of 
polyamines and proline which are components of the extracellular matrix and 
required for remodelling. Polyamines also affect fibroblast differentiation 
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promoting wound healing. It is thought that these macrophages can also express 
growth factors promoting angiogenesis (Sunderkotter 1994).   
AAMΦ are particularly associated in helminth infections (Anthony 2006, Noël 
2004, Gordon 2003).In schistosome infections AAMΦ and are essential in the 
down-regulation of the pro inflammatory response and host survival as the 
infection progresses to a chronic phase (Herbert 2004). Recently it has been 
suggested that they are in fact an innate and rapid response to tissue injury, 
which most parasites cause (Loke 2007, Allen 2011). 
In addition to IL-4/IL-13 stimulated ‘alternative’ macrophages a ‘regulatory’ 
phenotype has been described. (Mosser 2008). These can be stimulated by IL-10, 
immune complexes, prostaglandins and apoptotic cells (Kono 2008, Erwig 2007). 
These regulatory macrophages express large amounts of IL-10 and down regulate 
IL-12 production instigating them as potent down regulators of inflammation. 
Unlike the AAMΦ, regulatory macrophages do not contribute to ECM production 
but do produce TGFβ which has a functional role in angiogenesis (Edwards 2006, 
Martinez 2008). Large scale gene expression studies comparing IL-10 stimulated 
and IL-4 stimulated macrophages revealed that only 18% of the genes overlap 
between the two suggesting significant difference in the phenotype of IL-10 
activated macrophages (Stumpo 2003). Of these genes several have angiogenic 
roles including hypoxia inducible elements and platelet activating factors 
(Stumpo 2003).   IL-10 stimulated macrophages have been implicated in cancer 
progression and express VEGF (Riboldi 2005, Nardin 2008).  Schistosome 
infection of IL-4Rα-/- mice prevents AAMΦ development and induced 
exacerbated iNOS production around granulomas. IL-10 could not compensate 
for this loss of IL-4/IL-13 signalling and it is unclear whether in schistosome 
infection IL-10 can cause alternative activation of macrophages (Herbert 2004, 
Dewals 2010).  
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1.3.5.3 Dendritic cells 
 
The main function of dendritic cells is to process antigens and present them to 
the cells of the immune system perpetuating an adaptive immune response 
(Cella 1997, Igyártó 2011). Dendritic cells can be distinctly pro or anti angiogenic 
depending on their activation status (Sozzani 2007). Activation in the presence of 
pro inflammatory conditions (e.g. LPS and TNF-α) producs an anti-angiogenic 
phenotype whilst, culture with prostaglandins will induce VEGF expression 
(Jonuleit 2005, Riboldi 2005, Banchereau 2000, Wollenberg 2002). Dendritic cells 
can also produce cytokines which increase endothelial sensitivity to angiogenic 
factors promoting angiogenesis (Dong 2009). In tumours, pro-angiogenic 
dendritic cells appear to accumulate in and around tumours expressing TNFα and 
IL-8 (Curiel 2004).  
 
1.3.5.4 Eosinophils 
 
Eosinophils control mechanisms associated with allergy (Efraim 2008) and are a 
hallmark of helminth infections (Ovington 2000, Behm 2000, Klion 2004). 
Eosinophils have also long been associated with allergy and also closely 
associated with fibrosis and tissue repair (Levi-Schaffer 2004, Williams 2004, 
Gharaee-Kermani 1998). Eosinophils can directly affect fibroblast properties 
increasing their production of ECM components modulating the process of tissue 
repair. This is suggested to be primarily through eosinophil expression of IL-4 and 
IL-13, and perhaps through release of stored TGF-β (Doucet 1998). Eosinophils 
also release MMPs, particularly MMP-9 (Schwingshacki 1999).  These functions 
are all intrinsically wound healing linked but eosinophils may also have a role in 
angiogenesis. The major basic protein (MBP) of eosinophils can induce 
endothelial sprouting in a dose dependant manner and amplifies endothelial cell 
responses to VEGF (Puxeddu 2008)  The granules of eosinophils also contain 
VEGF and PDGF which are bioactive when released. (Puxeddu 2005). Rat aorta 
sprouting models revealed that eosinophil sonicates can enhanced endothelial 
sprouting (Puxeddu 2003).  
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One disease in which eosinophils are unequivocally linked is asthma (Busse 1992, 
Jacobsen 2007, Wardlaw 2000, Humbles 2004). Characterised by tissue damage 
and remodelling, the eosinophil contributes by the production of destructive 
enzymes and the release of TGFβ and MMP-9. However there is also 
considerable vascular remodelling in asthma and eosinophils are one of the main 
contributors of VEGF in asthma as well as producing FGF2 and IL-8 (Hoshino 
2001). Schistosome infections show increased levels of eosinophils in granulomas 
and in the skin (Sabin 1996, Reiman 2006, Cook 2011). They can also drive 
recruitment of alternatively activated macrophages to tissue sites (Voehringer 
2007). 
1.3.5.5 Mast cells 
 
Mast cells are resident in the tissue, and although mostly known for their role in 
allergic responses, they are also involved in wound healing and angiogenesis 
(Prussin 2003, Theoharades 2006). Mast cells produce inflammatory mediators 
and histamines which drive vessel dilation and promote the early stages of 
angiogenesis. They are also the source of significant levels of angiogenic growth 
factors, VEGF, FGF2, TGFβ and IL-8 (Norrby 2002, Levi-Schaffer 2002, ). Mast cells 
can also indirectly induce angiogenesis through protease degradation of the ECM 
releasing bound growth factors and through the recruitment of monocytes and 
lymphocytes which perpetuate the angiogenic response (Puxeddu 2005). 
Epithelial cancers can exploit the inflammatory mast cell response. De-
granulating mast cells adjacent to the tumours inadvertently stimulate 
angiogenesis mainly through MMP induction, and the tumour cells then 
perpetuate this leading to highly vascularised tumours (Coussens 1999, Yano 
1999, Tomita 2000).  
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1.4 Aim of this study 
 
Previous studies in schistosomiasis have focused on the immune response in the 
skin to cercarial infection but little work has been done on the angiogenic 
response. It is known that the eggs of S.mansoni can induce angiogenesis but no 
evidence exits of cercarial induction of blood vessel growth. It is also known that 
multiple infections of mice with S.mansoni causes an up-regulation of Th2 
cytokines in the skin and several factors closely linked to angiogenesis. 
 
The main objective of this study is; 
‘To determine whether infection with S.mansoni induces angiogenesis in the skin 
and whether this is altered after multiple infections.’  
 
If angiogenesis is induced following infection this could be by a combination of 
three different mechanisms; growth factor release in the skin, innate immune 
response or direct parasite antigen induction. The work presented here will 
address each of these mechanisms in turn: 
Chapter 2:  focuses on characterising the angiogenic response following single 
and multiple infections. 
Chapter 3: attempts to determine whether the haematopoietic cells recruited to 
the dermis after infection contribute to angiogenesis. 
Chapter 4:  investigates the effect loss of IL-10 has on the innate immune cell 
response and the release of pro-angiogenic growth factors. 
Chapter 5:  aims to determine whether the cercarial secretions can directly 
induce angiogenesis. 
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Chapter 2:  General Materials and Methods 
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2.1 General Materials and Methods 
 
2.1.1   Parasite Maintenance 
 
The schistosome parasite life cycle is maintained in house by routine passage of a 
Puerto Rican strain of S. mansoni through Biomphalaria glabrata snails and NMRI 
mice housed under specific pathogen free conditions. Parasites for infection 
were shed from snails by placing the snails in ~10ml of water and incubating 
under a bright light for 2 hours.   Cercariae were then diluted in ‘aged tap water’ 
to the required concentration. 
 
2.1.2 Infection Scheme 
 
Female C57BL/6 mice weighing between 18 and 25 grams were used for all 
experiments unless otherwise stated.  Mice were anaesthetised with 10% Sagatal 
in 10% ethanol (May & Baker, Dagenham UK) at a dose of 0.01ml/kg of body 
weight, and were then exposed to S. mansoni cercariae via each pinna.  As 
described previously (Mountford et al 2001), pinnae were immersed in 1.3ml of 
water containing 150 cercariae and left submerged for 20 minutes before the 
mice were turned and the contralateral pinna infected in the same manner. The 
mice were then sacrificed at various time points post the final infection; days 1, 
2, 4 and 8 were all used in this work (Figure 2.1). Multiply infected mice (4x) 
received one dose on the same day each week for four weeks in total (Cook et al. 
2011). Single infection mice (1x) received just a single dose coinciding with the 
final dose for the 4x mice 
 
 
 
 
 
Figure 2.1 Timeline of infection 
 
Mice were infected with 150 
cercariae per pinnae (300 in total) 
on the same day for four weeks 
(4x) and once on the final day of 
the 4x infection (1x). Mice were 
sacrificed at one of four time 
points after the final infection 
 
300 cercs 
300 cercs 300 cercs 300 cercs 300 cercs 300 cercs 
 
 
300 cercs 
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2.1.3 RNA Extraction 
 
To analyse levels of mRNA transcript in the skin, pinnae were removed and 
immediately frozen in liquid nitrogen.   Frozen whole pinnae were crushed using 
a micro dismembrator (B.Braun Biotech International), and the resulting 
powdered tissue re-suspended in 1ml Trizol (Invitrogen). RNA was extracted 
following the manufacturer’s protocol using a phenol, chloroform extraction 
isopropanol precipitation. Pellets were washed in 70% ethanol and re-suspended 
in DEPC-treated water (Ambion). RNA concentrations were measured (Nano 
Drop 1000 Thermo Scientific) and adjusted to 0.5μg/10μl. 
 
2.1.4  Reverse Transcription 
 
RNA Samples were reverse transcribed following the manufacturer’s protocol for 
Superscript II Reverse transcriptase (Invitrogen). Total RNA (10µl) at 0.5μg/10μl 
was added to 2µl of mix containing 1µl of OligodT (Invitrogen) and 1µl of 10mM 
dNTPs (Promega). The mix was heated for 5 minutes at 65°C then quickly chilled 
on ice before the addition of  7 µl of master mix (containing 4µl of 5x First strand 
buffer, 2 µl 0.1M DTT and 1 µl RNase OUT (Invitrogen). The complete sample was 
heated at 42°C for 2 minutes prior to the addition of  1 µl Superscript II reverse 
transcriptase which was followed by incubation at 42°C for 50 minutes and at 
70°C for a final 15minutes to yield cDNA. 
 
2.1.5 Semi-quantitative Polymerase chain reaction (SQ-PCR) 
 
The cDNA samples were each diluted with 30µl of DEPC water to produce cDNA 
at a concentration of between 5 and 20ng/ml.  Each PCR reaction totalled 25 µl: 
5 µl of cDNA and 20 µl of master mix. The mix contains 2 µl  10x Buffer, 1.5 µl  
MgCl2, 0.5 µl 10mM dNTPS, 0.5 µl forward primer, 0.5 µl reverse primer, 0.2 µl 
Taq Polymerase and 14.9 µl DEPC water. The reaction followed the same cycle 
regime for each gene with alterations to the annealing temperature dependent 
on previous optimisation (Annealing temperatures, cycle numbers and primer 
sequences are provided in Appendix 1)  
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PCR Cycle:  
1- 95°C for 3 Minutes 
2- 95°C for 30 seconds 
3- 60°C (or alternative) for 30 seconds 
4- 72°C for 30 seconds 
5- Repeat from 2-4 for the required number of cycles 
6- 72°C for 5 minutes 
7- End 
 
PCR products were visualised on 2% agarose (Melford) gels in 250ml of 0.5% TAE 
buffer containing 5 μl of ethidium bromide. To each well, 5 μl of PCR product 
mixed with 1µl of 6x Green/orange loading dye (Fermentas) was loaded 
alongside 2µl of 100bp ladder (New England Biolabs) and run for ~20 minutes at 
100V. The intensity of the bands was compared to the intensity of the house 
keeping gene GAPDH for each sample using (Alpha Imager, Alpha Innotech 
Corporation). 
 
2.1.6 Real time Quantitative PCR (Q-PCR) of DEC 
 
Real time PCR was used to detect expression levels of Arginase-1, Ym1, RELMα 
and iNOS. 5µl of diluted gene standard was added alongside 5µl of test cDNA, 
produced as described (3.2.9) and 20µl of PCR reaction mix (2.5µl 10x PCR Buffer, 
2µl MgCl2 [50mM], 0.25µl ROX reference dye, 0.1µl Platinum Taq DNA 
polymerase, 0.5µl dNTP, 1µl of both forward and reverse primers [10mM], 1.25µl 
TaqMan probe [0.5µM-0.05µM] and 11.4µl DEPC treated water) to each well of a 
96-well optical reaction plate (Applied Biosystems). Samples were then run using 
the standard protocol;  
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PCR Cycle:  
1- 95°C for 5 Minutes 
2- 95°C for 30 seconds 
3- 60°C for 1 minute 
4- 72°C for 30 seconds 
5- Repeat from 2-4 for 50 cycles 
6- 72°C for 5 minutes 
7- End 
Results were analysed using ABI PRISM 7000, the cycle number at which the 
sample crossed the threshold was compared for each sample to the standard 
curve and from there the concentration of template calculated. For each sample 
the gene of interested was divided by GAPDH to normalise the expression and 
the ratio presented in arbitrary units. 
 
 
2.1.7 In vitro cultured pinnae biopsies 
 
To isolate the growth factors within the skin site of infection, whole pinnae were 
removed, dipped in 70% ethanol (to ensure sterility of the skin surface) and then 
split using forceps exposing the dermal surfaces. Each half was laid onto 500µl of 
complete media (RPMI1640, 10% Foetal Calf Serum, 1% Glutamine, 1% penicillin-
Streptomycin) dermis side down and incubated at 37°C overnight. The culture 
supernatant was recovered and centrifuged to remove cells which had exuded 
from the pinnae overnight, and frozen at -80°C until analysis. 
 
2.1.8 Enzyme linked immunosorbent assay (ELISA) 
 
Culture supernatants obtained as above (2.2.12) were analysed for expression of 
VEGF using DuoSet ELISA kit (R&D Systems; VEGF – DY493, all concentrations 
were pre-determined by the manufacturer). Plates were coated with the 
required concentration of capture antibody diluted in PBS and left overnight at 
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4°C. Wells were aspirated twice with 400µl of PBS plus Tween (PBST = 0.05% 
Tween 20 in PBS) before blocking by the addition of 400µl of 1%BSA in PBS for 
2hrs at room temperature.  Standards were prepared as doubling dilutions in 
1%BSA PBS to produce a standard curve of 11 points (Top standard was 
1000pg/ml) Samples were incubated alongside the standard curve for 2hrs at 
room temperature.  After washing 5x in PBST, the detection antibody was added 
for 2hrs at room temperature.  Plates were washed again 5x in PBST and 
Streptavidin horseradish peroxidase added for 45 minutes at room temperature.  
Following 5x final washes,  Sure Blue TMB Substrate ( KPL, Gaithersburg MD, 
USA)was added  and the plates left to develop at room temperature. Readings 
were taken at 650nm using a MRX II plate reader (Dynex Technologies Ltd, 
Worthing UK). 
 
2.1.8 Statistical Analysis 
 
Throughout the thesis the data is compared statistically using the students t-test. 
For each graph unless otherwise stated the groups being compared are the 1x 
with the 4x for each time point which is shown as stars on the graphs over the 4x 
time point. For most of the figures each of the infection time points is also 
compared to the naive and the results described in the text. The graphs show the 
mean value with the error bars representing the + standard error of the mean. 
*p<0.05, **p<0.01 and ***p<0.001. 
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Chapter 3:  Characterising the angiogenic response 
following single (1x) and multiple (4x) infections. 
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3.1 Introduction 
 
The association between schistosomiasis and angiogenesis is not a new concept 
in respect to the interaction between the egg and the intestinal vessels (Loeffler 
2002). However there is little evidence at present as to whether the cercariae 
also induce vessel growth and remodelling. The cercarial passage through the 
skin is likely to cause considerable damage to the skin and an intrinsic part of the 
wound healing response is the growth of new vessels to aid repair and 
production of new mature tissue (Tonnesen 2000). In addition to the eggs, the 
cercariae produce secretions thought to aid their passage through the skin and 
may be directly inducing angiogenesis.  
Angiogenesis is a complex process involving several discrete steps which overlap 
temporally and spatially. As described (1.2.2) new vessel growth requires 
activation of the mature quiescent endothelium and signals to induce 
proliferation and migration of the endothelial cells. Initial loosening of the 
vessels is induced primarily by the balance of the angiopoietins (1.2.3.1) 
alongside a remodelling of the ECM by the MMPs (ref). The rate and manner of 
blood vessel growth following this depends on the type and level of the growth 
factors produced. VEGF has long been considered as essential in angiogenesis, 
indeed VEGF knockout mice die at embryonic day 11-12 (Carmeliet 1996). 
Alongside VEGF, PlGF is also widely described and considered to be primarily 
induced in pathological angiogenesis (1.2.3.3). Many additional growth factors 
including the fibroblast growth factor family and HGF have all been well 
documented as up regulated in angiogenesis and associated with several disease 
states (1.2.3.3).  
Using both molecular and imaging techniques this chapter aims to determine 
whether after penetration of the skin the presence of the cercariae induces a 
change in the vasculature. Markers and features of angiogenesis will be 
monitored between days 1 and 8 after infection and will also compare between a 
single and a multiple infection with the cercariae using the model described in 
section 1.3.2 and method 2.2.2. 
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3.2 Materials and Methods 
3.2.1 External imaging on the pinnae and vessel quantification 
 
Mice were anesthetised and the pinnae observed using a stereomicroscope (Carl 
Zeiss) at 18x magnification with down lighting. Multiple images were taken of the 
pinnae both loose and pressed between glass slides to produce a flat area to 
visualise. The vessel network and images were then analysed using Adobe 
Photoshop Cs3. In order to quantify the vascular network, a macro was devised 
to distinguish red vessels from the background tissue of the skin; naïve pinnae 
were used to set the baseline values and which was then applied to all images 
taken. Output is given as the density of the pixels identified by the software in 
the entire pinnae. (This method was devised and optimised by C.K. Saleh, 
University of York, Department of Biology). 
 
3.2.2 Skin Histology 
 
Groups of mice were infected either 1x or 4x via the pinnae as described in 
section 2.1.2.  Pinnae thickness were measured at various  times after the final 
infection  using a dial gauge micrometer (Mitutoyo, Japan) and were then 
removed and fixed in 4% neutral-buffered formal saline (Sigma, UK).  Tissues 
were wax-embedded, sectioned at 5µm and stained with Haematoxylin & Eosin 
(service provided by the Veterinary Pathology Department, University of 
Liverpool, UK.) 
 
3.2.3 αCD31 and αCD105 vessel labelling 
 
Pinnae from infected mice (2.1.2) were removed at selected time points post-
infection (Days 1, 2, 4 & 8).  In order to remove hair from the pinna surface, a 
depilating agent (SoftSheen-Carson, Magic shaving powder) was placed onto the 
pinnae and left for 2 minutes. Pinnae were then washed in PBS and spilt in two 
thereby exposing the internal dermal surfaces before fixing in 2% 
paraformaldehyde (Agar Scientific) for 10 minutes on ice. Pinnae were then 
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rinsed and placed in 0.5% saponin (Sigma Aldrich) containing 5% sheep serum 
(Sigma Aldrich) for 30 minutes at room temperature. Antibodies used to stain the 
vasculature were diluted to the required concentration (Rat anti Mouse 
CD31/PECAM conjugated to FITC – 1:100 (ebioscience clone # 390), rat anti 
Mouse CD105/Endoglin conjugated to pacific blue– 1:50 (ebioscience clone # 
MJ7/18) in the permeabilising mix. The pinnae were incubated with the 
antibodies at room temperature for one hour, and then washed thoroughly in 
PBS before being mounted in Vector shield (Vector Laboratories).  
 
3.2.4 Visualisation and quantification of CD31+ and CD105+ vessels 
 
Pinnae were imaged whole using a Zeiss LSM 510 meta (Carl Zeiss Ltd). All images 
were captured using identical laser settings at 488nm and 410nm excitation 
wavelengths and 520nm, or 455nm emission wavelengths. Levels of CD105 
expression, as judged by staining with anti-CD105 antibody across pinnae 
samples, were quantified using Velocity software (Improvision®,UK), and 
determined as % expression within the fluorescent channel. The intensity was set 
to exclude the background and include only stained vessels. The total viewed 
area was then calculated for CD31 and CD105 separately. To normalise CD105 
expression to the number of vessels present in an image, the area of the CD105 
was divided by the area of CD31 expression and the ratio plotted. 
 
3.2.5 Measurement of vascular leakage using the Modified Miles assay 
 
Mice were placed at 40°C for 10minutes to dilate blood vessels, and then 
injected intravenously via the tail vein with 200μl of Evans blue 
dye(George.T.Gurr, London UK) (60mg/kg).  Mice were left for 90 minutes to 
allow the dye to circulate around the body and then sacrificed. Pinnae were 
removed and weighed before imaging using a stereomicroscope under bright 
light.  
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After gross measurements, pinnae were split in half and placed in 600μl of 
formamide (Sigma Aldrich) and left rotating at 60˚C for 18 hours.  After 
incubation, the tissue extract was recovered leaving the tissue and plated in 
duplicate (50μl) into a 96 well tissue culture plate. A standard curve of Evans 
Blue diluted in formamide was prepared on the same plate (Top standard 
1000μg/ml). The plate was read at 570nm using a MRXII plate reader (Dynex 
Technologies Ltd, Worthing UK) and the standard curve used to determine the 
concentration of dye within the test samples 
 
3.2.6 Detection of active MMPs 
 
The DQ-Gelatin Assay (Molecular Probes) was used to quantify active MMP 
expression in tissue samples.  A vial of desiccated substrate was reconstituted in 
1ml of dH2O to prepare a 1.0mg/mL stock solution.   Aliquots (20μl) of diluted 
substrate were added to wells of a black 96 well plate, supplemented by 80 μl of 
1x reaction buffer (kit component) to produce a total volume of 100ul. Test 
samples (100 μl) were then added and incubated for 1hr at room temperature.  
Samples were the overnight culture supernatants obtained from skin biopsies 
(2.1.7) diluted 1:2 before addition. Resulting fluorescence of the substrate was 
measured using a fluorescent plate reader (BMG Labtech POLARstar OPTIMA).  
To localise the MMP activation 50µl of reconstituted DQ-Gelatin substrate was 
mixed with 200µl of Cygel (Biostatus) which is a thermo reversible gel. The Cygel 
and substrate mix was placed onto 10µm thick unfixed sections of pinnae and 
left to set and incubate at room temperature for 1hour. The sections were 
imaged using the Zeiss LSM 510 meta (Carl Zeiss Ltd). All images were captured 
using identical laser settings at 488nm excitation wavelengths and 520nm 
emission wavelengths. 
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3.3 Results 
3.3.1 Vessels become more visible following infection 
 
In un- infected pinnae, large central vessels were clearly visible from the exterior 
(Figure 3.1 A panel 1) and from these vessels there were commonly 2 to 3 visible 
branch points which lead to the smaller vessels throughout the dermis.  After a 
single infection (1x), the skin became noticeably redder and the central vessels 
more visible (Figure 3.1 A panel 2). The vessels appeared wider and there was an 
increase in the number of branch points visible by eye: ~5 to 6 from the central 
vessel.  After multiple infections (4x) this branching number increased again to 
approximately 7 to 8 branch points from the single source vessel (Figure 3.1 A 
panel 3). In addition, the vessels appeared wider than either naïve, or 1x infected 
pinnae, and pairs of vessels were clearly visible along the centre of the pinnae. 
Smaller vessels originating from the main trunk branches were also visible and 
can be identified at the terminal edge of the skin. In addition to an increase in 
the number of visible vessels, several have taken on an alternative structure, 
with deviations from the linear pattern to convoluted wavy vessels (Figure 3.1 A 
*). 
 The number of visible vessels was quantified to give a numerical readout for the 
area covered (Figure 3.1B). The vessels were identified using Photoshop® utilising 
a macro designed to identify the areas of ‘red’ in each image (3.2.1). By altering 
the higher and lower intensity parameters, this allowed the vessels to be 
identified from the background tissue. The number of red pixels in these layers 
equates to the area of vessels visible by eye in the image. Following both 1x and 
4x infections, there was a significant increase in the area of visible vessels when 
compared with the naïve pinnae (p<0.001 for all time points compared to naïve).  
At days 1, 2 and 4 post-infection there was an additional significant increase in 
the 4x pinnae compared to the 1x group (P<0.05 and P<0.01). Over the time 
course of infection, the vessels remained visible and the quantified increase did 
not return to naïve levels. 
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A  1      2           3 
B 
Figure 3.1 Imaging and quantification of blood vessels following infection 
 
A: Images from naive and day 2 infected pinnae taken under 12x magnification from 
several orientations (panel 1 = Naïve, panel 2= 1x, panel 3 = 4x) Several branches can 
be seen from the central vessels in all pinnae. * indicates vessels in the 4x which are 
no longer linear. B: Quantification of the visible vessels. Using Photoshop the visible 
vessels were identified based upon the intensity of the red. The number of individual 
pixels is proportional to the amount of vessels identified.  All infected values versus 
the naïve p<0.001. Significant differences shown are 1x versus 4x *p<0.05, **p<0.01, 
(n=10 pinnae from 5 mice) 
* 
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3.3.2 The epidermis and dermis are disrupted and thicken following infection 
 
The thickness of infected pinnae was measured at days 1,2,4 and 8 post-infection 
and compared to naïve samples (Figure 3.2). The thickness of the pinnae did not 
increase significantly in the 1x mice compared to the naïve sample, although 
there was a slight increase in the average thickness at day 8.  However, 4x pinnae 
increased in thickness significantly compared with both the naïve and 1x pinnae 
(all p<0.001). This increase in thickness remained over the time course of 
infection and was still elevated at day 8 post infection. 
 Sections through the pinnae show that this increase in thickness occurs both in 
the dermis and epidermis (Figure 3.2 B). Within naïve skin, the dermis is 
organised and well-structured and the epidermis is thin consisting of 1-2 layers of 
cells. After 1x infection, the thickness of the epidermis appeared to increase to 2-
3 cells particularly above areas where the dermis appears disturbed. Within the 
dermis there are several patches where haematopoietic cells have in fluxed 
though these are sparsely distributed throughout the dermis. 
 In 4x pinnae, the dermis is considerably thicker, predominantly to one side of 
the cartilage. The epidermis has thickened to 4-5 cells deep. The increased 
thickness in epidermis occurred throughout the pinna section. The structure of 
the dermis appeared damaged with pools of red blood cells detected along the 
section, perhaps indicative of vessel haemorrhaging. Blood vessels were also 
larger supporting the observations made in section 3.3.1, whilst immune cells 
were also visible within the vessels. Haematopoietic cells were apparent 
throughout the dermis and large groups were present under the epidermis 
particularly around areas of haemorrhaging.  The H&E staining revealed that 
many of the cells within the focal influx have the morphology of eosinophils. 
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A 
B 
Figure 3.2 Thickness and histology of pinnae 
 
A: Measurement of the thickness of pinnae over the time course. Significance 
shown are the 4x time point compared with the equivalent 1x time point. All 4x 
groups were significantly increased compared with the naïve p<0.001 however 
none of the 1x time points were significantly increased compared to the naïve.  
(n=40 pinnae measured form several experiments, Mean +SEM) 
 
B1-B3:  H&E stained sections of pinnae (panel 1 = Naïve, panel 2 = 1x day 2, panel 
3 = 4xday2). Sections show the cartilage central to the pinnae (C) with the 
epidermis stained darkly purple (E) and the dermis in pink (D). Hair follicles (H) 
and blood vessels (B) are also visible. After infection infiltrates of cells are visible 
in the dermis and blood vessels (arrowed). Sections were imaged under 10x - left 
panel and 20x – right panel, magnification. Images are shown of selected pinnae 
from 5 stained. 
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3.3.3 The vessels of 4x pinnae are thicker and more numerous than 1x and 
naïve 
 
The vessels visible by eye on the surface of the pinnae are only a small 
proportion of the entire vasculature of the skin, a network of smaller capillaries 
and minor tributaries of the major vessels thread throughout the dermal layer of 
the skin. To visualise the entire vascular network, fluorescent microscopy was 
utilised (3.2.3) to detect vessels expressing platelet endothelial cell adhesion 
molecule 1 (PECAM1), otherwise known as CD31. This adhesion molecule is 
constitutively expressed on the vascular endothelium (Newman 1997). An 
antibody against CD31 (conjugated to FITC) was used to identify the vessels and 
images were taken throughout the entire depth of the skin to show that both the 
large arteries and veins, and the smaller vessels, have been stained throughout 
the dermis (Figure 3.3 A). 
Images were taken over the entire area of several pinnae. Vessels in naïve pinnae 
appeared linear with regular branch points and become thinner as they branch 
towards the terminal ends (Figure 3.3 B Panel 1).  Within 1x pinnae, there was an 
increase in the brightness of staining, and there were a greater number of 
vessels branching out from the large trunk vessels (Figure 3.3 B Panel 2 Δ). There 
was a similar density of small vessels at the terminal edge compared to naïve 
pinnae. In 4x pinnae, the vessels were also bright, with several branches and 
sprouts from the main vessels, as well as dense webs visible at the terminal ends 
(Figure 3.3 B Panel 3 Ο). Several of the main vessels exhibited a more convoluted 
construction, perhaps as a result of disruption to the integrity of the junctions 
between endothelial cells (Figure 3.3 B Panel 3 ◊).   
Whole vessels were imaged in 1x and 4x pinnae by moving from the base of the 
pinna towards the very edge along a single vessel (Figure 3.3 C). In the 4x pinna, 
the main vessel is more convoluted than in the 1x pinna, and has small webs of 
vessels extending off. Some of the vessels do not appear properly formed, and at 
the edge of the 1x pinna the vessels form a neat network of fine capillaries, 
whilst in the 4x pinna they are more diffuse. 
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A 
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Ο 
◊ 
Δ 
Figure 3.3 The vessels of the dermis in labelled with FITC conjugated anti CD31 
mAb 
 
A: Representative series of three images taken at different depths through similar 
zones of the pinnae. Left panel : main vessels at the base of the dermis. Middle 
panel; smaller vessels sprouting up along the larger main vessels.  Right panel: fine 
capillaries near the epidermis of the skin. Images from naïve pinnae.  Initial 
optimisation was completed on three naïve pinnae 
 
B: Top panels show vessels at the edges of the pinnae. Bottom panels show vessels 
taken several frames in from the edge but do not include the large vessels visible 
by eye. Ο – Marks dense webs of vessels at the edge of 4x pinnae. Δ – Indicates 
multiple branches from the central vessels of 1x pinnae. ◊– Disruption of the linear 
structure of the 4x vessels. All infected images are day 2 post infection and are 
representative images form a group of 6 pinnae. 
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C 
Figure 3.3 C Composites of the entire vessel network of 1x and 4x pinnae. 
Images follow one main vessel from the base of the pinnae to the very edge of 
the skin. 
C 
C 
1x 
4x 
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Expression of CD31 was quantified using Velocity imaging software 
(Improvision®, UK), and the total area of CD31+ vessels in each image calculated. 
Whilst CD31 is a widely used marker for blood vessels it is also expressed on 
lymphatic vessels, but to a lesser degree. In several of the images lymph vessels 
may be visible but the staining was fainter, and these faint vessels were excluded 
in the analysis. The average area of each 10x image taken at intervals over the 
entire area of several pinnae.  This  showed that both 1x and 4x infected pinnae 
had a significantly increased vessel area (Figure 3.4A) and this further increased 
in 4x compared to 1x pinnae (P<0.001).   The vessels in infected mice were also 
wider, as the mean diameter increased significantly in both 1x and 4x compared 
to naïve pinnae (P<0.001; Figure 3.4B)  
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Figure 3.4 Quantification of CD31 positive vessels. 
 
A: Total area in 920µmx920µm zones of the pinnae. 40 images were taken of each 
pinna; the mean values are areas from n = 5 mice ± SEM in 1x vs naive  p<0.05, and 
4x vs naïve p<0.001.  
B: Diameters of CD31+ vessels measured from images chosen at random from all 
over the pinnae. 1x vs naive p<0.001, 4x vs naïve p<0.001. 
 
Significance shown in the figure are for 1x compared to 4x pinnae  ***p<0.001. 
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3.3.4 Vessel remodelling identified by labelling with αCD105 
 
To better quantify the extent of vascular remodelling within the skin, pinnae 
were stained with anti-CD105 mAb, alongside anti-CD31 mAb. A member of the 
TGFβ receptor family CD105 is up-regulated on remodelling vasculature and is 
expressed across metastatic vessels in tumours (Fonsatti 2003). 
Whole pinnae were stained with both anti-CD105 and anti-CD31 mAbs and 
visualised by fluorescent microscopy (3.2.4).  Images were taken from several 
regions of the pinnae: the trunk vessels at the base, the edges of the pinnae and 
vessels several frames from the edge. The three regions allow analysis of a range 
of different sized and shaped vessels throughout the pinnae.  
CD105, in red, was present along the large trunk vessels of the pinnae, with 
similar expression in both naïve and 1x samples (Figure 3.5A).  However in the 4x 
sample, the trunk vessels showed greater levels of red staining, than in the 1x 
and naïve pinnae, particularly at junctions (Figure 3.5B).  At the edges of the 
naïve pinnae, CD105 expression was absent. CD105 was also not detected at the 
day 1 and 2 time points after 1x infection, although the small vessels at the edge 
and in the middle of the pinnae had up regulated CD105 expression by days 4 
and 8.   In contrast, the small edge vessels of the  4x group show elevated 
expression of CD105,compared with the naïve and 1x groups, immediately after 
the fourth infection (i.e. day 1) vessels express CD105 at all subsequent time 
points (Figure 3.5B).  In the 4x group, consistently high expression of CD105 on 
the mid branches was detected, whilst naïve and 1x pinnae only expressed 
CD105 in small patches on the mid vessels (Figure 3.5A). Several of the vessels in 
4x pinnae were predominantly red, and these might be entirely new vessels 
sprouting from the original CD31+ vessels. Intense CD105 staining is also seen 
around the junctions of vessels in several of the 4x pinnae. 
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A: Naïve and 1x infection samples 
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Figure 3.5 Identification of CD105 expression on pinnae vessels 
 
A: Representative images of five naïve and five 1x pinnae. The 1st panel shows 
the vessels at the very edges of the pinna. The middle panel is a representative 
image several images from the edge and the final panel is the largest vessels 
found at the base. CD31 is shown in green and CD105 in red. 
B: Same panels for 4x pinnae, images taken from five pinnae for each time 
point. 
B: 4x infection samples 
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3.3.5 CD105 expression is up regulated on vessels in infected pinnae 
 
In order to quantify the levels of CD105, the ratio of CD105 to CD31 in each 
image was calculated in many images taken from five biological replicates (3.2.4).  
Expression of CD105 on the vessels in both infection groups was detected at all 
of the time points (except 1x day 1 Figure 3.6A). The ratio of CD105 to CD31 in 4x 
pinnae was significantly higher compared with the equivalent 1x pinnae, apart 
from day 8 where expression in the 4x group is near 1x levels.  
There was a slight increase in expression of CD105 mRNA in 1x pinnae but this 
was not significant compared to naïve levels (Figure 3.6 B).   However, there was 
a significant increase in 4x pinnae on day 1, although the levels declined over the 
time course to resemble those in 1x and naïve pinnae. As CD105 expression was 
clearly detected by microscopy on days 4 and 8 in 4x mice, this could indicate 
that transcription occurs early after infection but that the receptor is maintained 
on the vessel surface until much later time points in the 4x infection group. 
 
 
 
 
 
 
 
Figure 3.6  Analysis of CD105 expression 
 
A: Ratio of CD105 to CD31 expression averaged across 5 pinnae. Sample size is 20-45 
images per group taken from random fields of view over the total area of the 5 pinnae. 
Values are mean + SEM. Significance shown is each 1x and 4x time point compared, 
*p<0.05, ** p<0.01. 
 
B: Transcript levels of CD105 quantified by SQ-PCR, expressed relative to the house 
keeping gene GAPDH; values are mean ± SEM; sample size is 5 biological replicates per 
time point. 
A: CD105 expression ratio B: SQ-PCR of CD105 expression 
* 
 
 
62 
 
3.3.6 Increased vascular permeability following infection 
 
In order to allow new vessels to sprout and existing ones to remodel, the 
junctions between endothelial cells must loosen (Aplin 2006). As such, one 
indicator of the induction of angiogenesis is increased permeability of the 
vasculature. The modified Miles assay (3.2.5) was used to determine vascular 
leakage by injecting Evans Blue dye into the vascular system of infected mice. 
The circulating dye extravasates into and is trapped in the tissue surrounding 
permeable vessels. This can then be extracted from the tissue and quantified. As 
an internal control for differences in the individual mouse, vasculature, and the 
administration of the dye, only one pinna from each mouse was infected.  
External imaging of pinnae revealed that the dye was not detected in un infected 
pinnae, whilst both 1x and 4x pinnae had regions of blue radiating predominantly 
from the midline of the pinna (Figure 3.7A). The dye was visible by eye in 1x 
pinnae on day 1, and faintly at day 2. In 4x pinnae, the dye was seen in the tissue 
on days 1, 2 and 4. The dye was extracted from the pinnae and the concentration 
analysed (Figure 3.7B). After infection there was an immediate increase in the 
levels of dye leaking into the tissue (day1) this was seen in both the 1x and 4x 
pinnae (Figure 3.7 B). However, the concentration within 4x pinnae was 
significantly higher at the early time points compared with 1x pinnae (d1 & 2). 
Furthermore, the levels of dye within the tissue remained greater for longer in 4x 
than 1x pinnae. Levels did not decrease to naive levels by day 8.  
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Figure 3.7 Vascular permeability following infection 
 
A: Representative images of 1x (left) and 4x (right) pinnae 90minutes after Evans blue 
injection. In each image the un-infected pinnae is to the right and the infected pinnae from 
the same mouse on the left.  Experiment completed once on three mice per timepoint. 
B: Quantification of Evan’s blue in the pinna extracts. Values are mean ± SEM, n=3 All 4x 
values are significantly increased compared to naïve. Only day 8 of the 1x is significantly 
increased compared to the naïve p=0.05. Statistics shown are the 1x and 4x time points 
compared *p<0.05 
4x 
A: 
Infected                 un-infected Infected                 un-infected 
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3.3.7 Angiopoietin 2 is strongly induced in 4x pinnae 
 
Vascular stability can be influenced by the levels of Angiopoietins 1 and 2 
(Thurston 2000) and increased levels of Ang2 can compete with Ang1 to promote 
vessel permeability (Maisonpierre 1997). Transcript levels of Ang1 were analysed 
in whole pinnae between days 1 and 4 post infection (when the dye is still visible 
in the skin) and in 1x pinnae were observed to decrease between days 1 and 2 
but increase again at day 4 (Figure 3.8).  Ang 2 was detected at the same level as 
Ang 1 on day 1 but remained elevated over the time course.  In 4x pinnae, levels 
of Ang1 remained relatively low, whereas Ang2 was significantly elevated 
(p<0.01) compared to the equivalent 1x time points and remained elevated over 
the time course.  
 
 
 
 
 
 
 
 
 
 
 
 
 
d1 d2 d4 d1 d2 d4
0.00
0.25
0.50
0.75
1.00
1.25
1.50
1.75
2.00
2.25
Ang1
Ang2
1x 4x
E
x
p
re
s
s
io
n
 r
e
la
ti
v
e
 t
o
G
A
P
D
H
Figure 3.8 Angiopoietin 1 and 2 gene expression  
 
Transcript levels of Ang 1 and Ang 2 were analysed at days 1,2 and 4 
after either 1x or 4x infection. Expression is shown relative to GAPDH. 
Values are mean ± SEM; n=5.  Statistics shown are Ang2 levels 
compared between the 1x and 4x for each time point , ***p<0.001. 
Ang2 is also significantly increased in the 4x compared to Ang1 
(p<0.001) 
*** 
*** 
*** 
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3.3.8 4x pinnae show increased levels of active MMPs compared to 1x and 
naïve  
 
Sprouting of new vessels requires the remodelling of areas of the ECM and the 
degradation of the vessel basement membrane. This is performed by the matrix 
metalloproteinases (Raza 2000). To analyse levels of active MMPs the DQ gelatin 
assay was used (3.2.6). This utilises a substrate which when cleaved, by MMPs of 
the collagenase and gelatinase families, becomes fluorescent. The levels of 
fluorescence are therefore proportional to the concentration of the MMPs 
within the sample. The levels of active MMP protein in the sample did not 
change between the naïve and 1x samples, however levels were significantly 
increased at days 2 and 4 in the 4x pinnae (P<0.05 days 2 and 4; Figure 3.9A). 
Incorporating the DQ Gelatin into cygel (3.2.6) allows layering of the substrate 
over pinnae sections. The MMPs digest the substrate which remains trapped in 
the gel over the enzyme. Figure 3.9B shows that the MMP activation was within 
the dermis with the activation clustered around the cartilage in the middle of the 
pinnae where the larger vessels of the skin are located. Fluorescent patches are 
widespread in the 4x pinnae, whilst there are only a few in the 1x and absent in 
the naïve.  
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Figure 3.9 Levels of Collagenase 
and gelatinase MMPs in the skin. 
A: Mean levels ± SEM  of 
fluorescence in supernatants 
collected from in vitro cultured skin 
biopsies; n = 5.  
B: Representative overlays of 
substrate on pinnae sections; 
arrows in 4x pinnae indicate areas 
of high MMP activity. Infected 
pinnae are day 2 post infection. 
A: 
B:  
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3.3.9 Transcript levels of MMP-9 and MMP-19 increased after infection 
 
The DQ Gelatin assay identified increased levels of collagenase and gelatinase 
MMPs but does not quantify levels of each specific MMP. RNA from whole 
pinnae was reverse transcribed (2.1.4) and analysed by SQ-PCR (2.1.5) for 
expression of three MMPs commonly expressed in pathological angiogenesis 
particularly in the skin; namely MMP-2, 9 and 19 (Rundhaug 2005).  
In both the 1x and 4x infection groups, transcripts for MMP-2 and 9 were 
identified (Figure 3.10 A & B).  Analysis of MMP-2 identified an increase in 
transcript levels between days 1 and 8 in 1x pinnae, but a decrease over the 
same period in 4x pinnae.  However, naïve levels of MMP-2 transcript were also 
high and at none of the time points in the infected samples was the expression 
significantly increased compared to the naïve.  
MMP-9 was significantly induced in 4x pinnae compared to the naïve and 1x 
groups at the earliest time points after infection (P<0.01).  After day 2, the 
expression of MMP-9 declined, though still remained greater than in naïve 
pinnae at day 8.   1x pinnae had a significant increase at day 1 compared to naïve 
(p<0.05), although this returned to naïve levels by day 2 over the remainder of 
the time course. 
 MMP-19 was also up-regulated after infection and, similar to MMP-2, showed a 
late induction in 1x pinnae with a significant increase at day 8; in 4x pinnae there 
was a gradual decline in MMP expression. However, in contrast to MMP-2 there 
were still significantly higher levels of transcript at day 2 in the 4x 
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Figure 3.10 Transcript analysis of MMPs. 
  
For all graphs the expression is shown 
relative to levels of GAPDH in the sample. 
Significance shown is student’s t test on 
the corresponding time points for 1x versus 
4x pinnae; n= 5. *p<0.05, **p<0.01, 
***p<0.001 
A: MMP-2, B: MMP-9 and C: MMP-19. 
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3.3.10 Two isoforms of VEGF are significantly up regulated after 4x infection 
 
As discussed (1.2.3.3), VEGF is widely regarded as central to the angiogenic 
process (Ferrara 2003). Several isoforms of VEGF exist which have different 
phenotypic roles in the angiogenic process; VEGF120 and VEGF 164 are soluble and 
partially soluble respectively, whilst VEGF188 is membrane bound (Neufeld 1999). 
These three isoforms were identified during analysis of whole pinnae transcript 
following infection (Figure 3.11) and while expression of VEGF120 was not 
significantly different between the infected and naïve groups, and did not alter 
over the time course of the infection (Figure 3.11 A), VEGF164 was significantly 
up-regulated in the 4x groups compared to the naïve (P<0.05), although no 
significant difference was observed between 1x and 4x pinnae (Figure 3.11 B). 
VEGF188 was also significantly up regulated in 4x compared to 1x and naive 
pinnae. There was no significant difference in the expression of VEGF188 over the 
time course with levels remaining elevated until day 8 (Figure 3.11 C).  The 
concentration of VEGF protein was also measured by ELISA. This measures only 
the concentration of the soluble isoforms VEGF120 and VEGF164 (Figure  3.11. D). 
There was a significant increase in the concentration of VEGF at 4x days 2-8 
compared to the 1x time points but no significant difference at day 1 or between 
the naïve and 1x time points. 4x days 2 to 8 were also significantly increased 
compared to the naïve (p<0.001 for all) 
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Figure 3.11 Transcript and protein levels of VEGF 
 
A-C : Transcript analysis of the three individual isoforms of VEGF identified in 
the pinnae.  A : VEGF120 , B: VEGF164 , C: VEGF188.  Values are means ± S.E.M. 
Significance values are for 4x versus the 1x pinnae at respective time points 
(n = 5).  *p<0.05, **p<0.01, ***p<0.001.  
D: Protein levels of VEGF measured by ELISA.  None of the single infection 
time points were significantly different to the naïve whilst days 2-8 of the 4x 
were significantly increased compared to naïve (day 2 p<0.05, day 4 and 8 
p<0.01) n=10 supernatants from two experiments 
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3.3.11 Array analysis of angiogenic factors 
 
To identify further angiogenic factors which may be induced by schistosome 
infection, a Q-PCR based array was utilised containing 84 genes for both pro and 
anti angiogenic factors.  Five biological replicates were pooled for the 1x and 4x 
samples for each time point analysed. 
Many of the genes showed little or no change in expression when infected time 
points were compared to the naïve as shown in Table 2.1.  Several showed a 
small increase compared to the naïve which is likely not to be significant, as such 
genes which are up regulated at least two fold are identified in bold, and it is 
these genes that were selected for subsequent verification. 
The majority of the genes on the array were growth factors and their receptors. 
Several of the genes were up regulated in both the 1x and 4x compared to naïve 
samples; Endothelial cell growth factor 1 (ECGF 1), Epidermal growth factor 
(EGF), fibroblast growth factors 1 and 6 (FGF1 & FGF6), all peaked in their 
expression on day 1 post infection in both the 1x and 4x groups. PDGF was 
expressed in both the naïve and infected pinnae but had an early peak of 
expression (day 1) in the 1x group, and a late peak in the 4x (day 4) group.  Of 
note, the angiopoietin genes previously analysed (Figure 2.9) were up-regulated 
after infection.   Ang2 in particular was up-regulated to a greater extent in 4x 
than in naive or 1x pinnae. In addition, transcription of the angiopoietin receptor 
Tie2 was also up regulated in both infection groups.  
Whilst many of the factors were present in both the 1x and 4x infection groups, 
several genes were up regulated only after 4x infection. FIGF and PlGF, and it’s 
receptor FMS-like tyrosine kinase 1 (Flt1), were all up regulated only in the 4x 
compared with naïve samples,  but expression did not change in 1x compared 
with naïve pinnae.  In addition to pro-angiogenic growth factors, the array 
analyses several anti angiogenic associated genes. Pro-collagen type 18α1, 
whose C terminal domain is cleaved to produce Endostatin (a potent 
angiogenesis inhibitor), was expressed in the 1x group at low levels and was 
absent in the 4x samples.  In addition, the thrombospondins (1 and 2) which 
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inhibit the migration and proliferation of endothelial cells were down regulated 
in both the 1x and 4x groups compared to naïve. Transcription factors controlling 
growth and development of vessels were up regulated after infection; Heart and 
neural crest derivatives expressed transcript 2 (Hand2) and Hypoxia inducible 
factor 1 alpha (Hif1α) were both up regulated in the 1x group after compared to 
the naïve but were further up regulated (over 2 fold) in the 4x compared to 
naïve. The T-box factors 1 and 4 were expressed only in the 4x group, although 
the increase was less than two fold compared to naïve.  
Proteases and their inhibitors were detected in both the infection groups.  The 
matrix metalloproteinases MMP-19 and 9 were up-regulated in both groups, 
although MMP-19 was expressed at higher levels in 4x compared to naïve 
pinnae. Tissue inhibitor of metalloproteinase 2 was down regulated in both 
infection groups whilst Tissue inhibitor of metalloproteinase 1 was up regulated.  
In addition to the growth factors and signalling molecules associated primarily 
with angiogenesis, the levels of several angiogenesis associated chemokines and 
cytokines were analysed.  All of the genes analysed were up regulated in both 1x 
and 4x infections compared to naïve. Many of the chemokines peaked at day 2 
post infection in both 1x and 4x groups.  However CCL2 was expressed more than 
10 fold in 4x compared to 1x pinnae and peaked early at day 1 post infection. 
TNF and it’s associated factors were up regulated to a greater extent in 4x 
compared to both naïve and 1x pinnae, and peaked late at day 4 post infection. 
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Growth Factors and Receptors 1x 4x Adhesion molecules and matrix 
proteins 
1x 4x 
Angiopoietin 1 ↑ 1 ↑ 2 Cadherin 5  ↑ 1 ↑ 1 
Angiopoietin 2  ↑ 1 ↑ 1 Pro collagen type IV alpha 3 ↓ ↑ 2 
Connective tissue growth factor x ↓ Coagulation factor 2 ↑ 1 ↑ 1 
Endothelial cell growth factor 1 ↑ 2 ↑ 2 Integrin alpha V  ↑ 1 x 
Endothelial differentiation gene 1 x ↓ Integrin beta 3 ↑ 4 ↑ 1 
Epidermal Growth factor ↑ 1 ↑ 1 Laminin alpha 5 ↓ x 
Endoglin ↑ 1 ↑ 1 Platelet/ Endothelial cell adhesion 
molecule 1  
↑ 2 ↑ 2 
Eph receptor B4 ↓ ↓ Thrombospondin 1 x ↓ 
Epiregulin x ↓ Thrombospondin 2 ↓ ↑ 2 
Fibroblast growth factor 1  ↑ 1 ↑ 1 Transcription factors 
Fibroblast growth factor 2 x ↓ Ephrin A1  ↑ 1 ↑ 1 
Fibroblast growth factor 6  ↑ 2 ↑ 2 Ephrin B2 x ↓ 
Firboblast growth factor receptor 3 ↑ 1 ↓ Endothelial PAS domain protein 1 x x 
C-fos induced growth factor x ↑ 2 Heart and neural crest derivatives 
expressed transcript 2  
↑ 4 ↑ 2 
FMS-like tyrosine kinase 1  x ↑ 2 Hypoxia inducible factor 1α  ↑ 2 ↑ 2 
Fizzled homolog 5 x ↑ 2 Mitogen activated protein kinase 14  ↑ 4 ↑ 1 
Guanine nucleotide binding protein 
α13 
↑ 2 ↑ 2 Prostoglandin - endoperoxide synthase 
1 
↓ ↓ 
Hepatocyte growth factor ↑ 2 ↑ 2 MAD homolog 5 ↑ 2 x 
Insulin-like growth factor 1 ↑ 4 x Sphingosine kinase 1 ↓ ↓ 
Jagged 1 ↓ ↓ T-box 1 x ↑ 2 
Kinase insert domain receptor x x T-box 4 x ↑ 2 
Leptin ↓ ↓ Proteases and enzymes 
Midkine  ↑ 4 ↑ 1 Alanyl (membrane) aminopeptidase  ↑ 1 ↑ 1 
Natriuretic peptide receptor 1  x ↑ 1 Matrix metalloproteinase 19 ↑ 2 ↑ 1 
Neuropilin 1 ↓ ↑ 2 Matrix metalloproteinase 2 x x 
Neuropilin 2  x ↑ 2 Matrix metalloproteinase 9  ↑ 2 ↑ 2 
Platlet derived growth factor alpha  ↑ 1 ↑ 4 Plasminogen activator urokinase  ↑ 2 ↑ 2 
Placental Growth factor  x ↑ 1 Tissue inhibitor of metalloproteinase 1 ↑ 4 ↑ 4 
Plexin domain containing 1 ↑ 1 ↑ 1 Tissue inhibitor of metalloproteinase 2  ↓ ↓ 
Tyrosine-protein kinase receptor ↑ 2 ↑ 2 Trans-membrane serine protease 6 x ↑ 2 
Transforming growth factor alpha  ↑ 1 ↑ 1 Serine (or cysteine) peptidase 
inhibitor, Clade F, member 1 
↓ x 
Transforming growth factor β1  x ↑ 2 Plasminogen  x ↑ 2 
Transforming growth factor β2 ↓ ↓ Cytokines and Chemokines 
Transforming growth factor β3 ↓ ↓ CCL11 ↑ 1 ↑ 1 
Transforming growth factorβr1 ↓ x CCL2 ↑ 2 ↑ 1 
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Table 3.1: Analysis of gene expression  
 
Genes are grouped dependant on function and expression of the genes is identified as 
either up-regulated, up-regulated more than 2 fold (in bold), down-regulated or no 
change by comparing the infected time points to the naive. For each gene where up-
regulation is identified the peak day of expression is noted to the right of the symbol. 
 
 
 
 
 
 
 
 
 
 
 
 
Vascular growth factor A  x x Colony stimulating factor 3 ↑ 2 ↑ 2 
Vascular growth factor B x x CXCL1 ↑ 2 ↑ 2 
Vascular growth factor C x ↑ 2 CXCL2 ↑ 2 ↑ 2 
Angiogenesis Inhibitors CXCL5  ↑ 2 ↑ 2 
Brain specific angiogenesis inhibitor 1  ↑ 1 ↑ 1 Interferon gamma ↑ 2 ↑ 1 
Pro-collagen type XVIII alpha 1  ↑ 1 x Interleukin 1 beta ↑ 2 ↑ 2 
Stabilin 1  ↑ 2 ↑ 2 Interleukin 6  ↑ 2 ↑ 2 
Leukocyte cell derived chemotaxin 1 x ↓ Tumour necrosis factor α ↑ 2 ↑ 4 
Key 
↑ - Up-regulated        ↑ - Up-regulated  > 2 fold 
↓ - Down-regulated    x  -  No change         
Numbers indicate peak day of expression post infection 
Tumour necrosis factor α- induced 
protein 2 
x ↑ 4 
Tumour necrosis factor (ligand) 
superfamily member 12 
↑ 2 ↑ 4 
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3.3.12 Several pro-angiogenic growth factors were up regulated after infection 
 
In addition to VEGF, five further growth factors were selected for verification 
based upon the results angiogenic growth factor array (Table 2.1).  For PlGF 
there was no significant difference between 1x compared to naïve pinnae. 
However, in 4x pinnae there is a significant induction of PlGF at day 1 which 
decreased rapidly to naïve levels by day 2 (Figure 3.12 A). 
In contrast, ECGF was up-regulated in 1x and 4x pinnae compared to naïve 
samples but was not significantly different between the two infection groups.  It 
was expressed from the earliest time point and remained elevated until day 8 
when expression in 4x pinnae was significantly greater than in 1x pinnae (P<0.05; 
Figure 3.12 B).   
FGF1 was expressed in a similar profile to PlGF, peaking in 4x pinnae on day 1 
and declining thereafter (Figure 3.12 C). However, in contrast to PlGF, FGF1 was 
still significantly up regulated at day 2 compared to the naïve levels.  In 1x 
pinnae, the only value that was significantly greater than naïve levels was on day 
4.  
Expression of HGF was only significantly increased in 4x pinnae, whereas there 
was no difference between 1x and naïve pinnae (Figure 3.12 D).  The mean level 
of expression fell slightly between days 1 and 8 but still remained elevated 
compared to either 1x or naïve values.  
FIGF was also induced early in 4x pinnae but it was not significantly changed in 1x 
infected pinnae compared to naïve (Figure 3.12 E). Unlike the gradual decrease 
seen in FGF1, expression of FIGF in 4x pinnae dropped rapidly to naïve levels by 
day 4.   
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Figure 3.12 Levels of pro-angiogenic growth factor transcript from pinnae at days 1-8 
after infection 
 
Transcript levels of the growth factors were analysed from pinnae samples collected on 
days 1,2,4 and 8 after infection and compared to naïve. Values are mean ± SEM; n=5  
Significance is shown for 1x compared with 4x samples, at the corresponding time points. 
*p<0.05, **p<0.01. 
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3.4 Discussion 
3.4.1 Overview 
 
The aim of this chapter was to determine whether angiogenesis is induced 
following schistosome infection and whether the process is enhanced following 
exposure to multiple infections. Utilising both visual and molecular techniques it 
was shown that the vasculature of the skin changes and levels of pro-angiogenic 
growth factors are significantly increased following infection. This was further 
amplified in 4x pinnae. 
 
3.4.2 Pinnae vasculature changes after infection 
 
Visible changes in the pinnae were monitored over the course of infection. 
Observations made many years previous to this research noted that the skin 
following S.mansoni infection becomes reddened and the vasculature more 
apparent (Pearce 1986). Within this study the skin infection site became 
markedly redder and the vessels more pronounced after cercarial exposure.  
Vessels also showed an alteration in structure with many no longer linear and a 
significant increase in their number in 4x compared to the naïve and 1x pinnae.  
This could be due to new vessels sprouting, or it could be dilation of existing 
vessels allowing smaller ones to be visible externally.   
 
In order to determine the extent of vessel dilation which would lead to vascular 
leakage, the modified Miles assay was used to quantify plasma leakage into the 
surrounding tissues. Dye was only observed in infected pinnae (and not the 
contralateral uninfected control pinnae) indicating that the vascular dilation was 
not a systemic response. The early peak (day 1) of dye extravasation, is indicative 
of inflammatory vascular leakage which is likely to be controlled, at least in part 
by the increased levels of Ang2 expression (Roviezzo  2005), as observed after 
infection particularly in  4x pinnae. Ang 2 is only expressed at sites of remodelling 
and promotes destabilisation of the vessels and loosening of the connections 
between endothelial cells by signalling through Tie2 (Thurston 2000). Taken in 
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conjunction with evidence of dye leakage, the elevated expression of Ang2 
transcript is strong evidence for remodelling of the endothelial cells in 
preparation for sprouting of new vessels. 
Although external imaging of vessels and quantification of vascular leakage do 
not provide conclusive evidence of new vessel growth, expression of high levels 
of CD105 on new vessels or ones undergoing remodelling, provides additional 
evidence of angiogenesis.  It was observed from images taken over a large area 
of the pinnae, that there are more vessels present after infection. Within each 
image there was a significant increase in the number of branches and area 
covered by the vessels; this was greater in 1x compared to naïve pinnae and was 
further increased in 4x mice. The diameter of the vessels also increased 
significantly thus corroborating data from the modified Miles assay.  As the 
labelling procedure for CD31 and CD105 takes place on fixed tissue which is no 
longer under vascular pressure,  the increase in vessel diameter is therefore a 
permanent change and not due to increased blood flow and pressure in the 
vascular circulation. Diameter increases were observed in 1x compared to naïve 
mice, and was further increased after multiple infections. The increased 
diameter of the vessels was sustained to day 8 when vasculature leakage had 
reduced indicating that this increase was a permanent feature of the vessels.  
The shape of the vessels was also observed to change after multiple infections. 
Typically, vessels are linear and have several branch points along their length.  
The vessels in the 4x pinnae more closely resembled that of tumour vasculature. 
They were highly permeable and took on a convoluted appearance, are likely to 
be undergoing continuous remodelling and inflammation as seen around 
tumours (Seaman 2007). In 4x pinnae, there are several regions where the 
vessels are convoluted and small bundles of fine vessels have sprouted from 
larger vessels. This could be in regions where parasites have penetrated the skin. 
The parasites in the skin are approximately 50µm wide and as such will not 
penetrate through these small vessels (Crabtree 1980). However, the induction 
of high levels of pro-angiogenic growth factors in the skin around the parasite’s 
point of entry may be inducing these bundles of neo vascular growth. 
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CD105 expression was up-regulated in 1x pinnae, although this was only 
detectable from day 2 while expression in 4x pinnae was increased from day 1. 
The ratio of CD105 to CD31 in the 4x skin is also significantly higher than in 1x 
pinnae and intense areas of labelling are apparent at junctions of vessels. This 
appearance and increase of CD105 staining after infection is, further evidence 
that the vessels are responding to cercariae and are remodelling and branching 
out to produce new vasculature. 
 
3.4.3 MMPs are up-regulated in 4x pinnae 
 
Essential to the process of angiogenesis is the clearance of the ECM around 
mature vessels. This allows the endothelial cells of mature vessels to proliferate 
and migrate and is controlled in part by MMPs (Stetler-Stevenson 1999).  
Degradation of the ECM also facilitates the influx of further inflammatory cells 
and perpetuates inflammation. Analysis of total active MMP levels in the pinnae 
using the DQ-gelatin assay indicated that a significant increase in activation was 
only present in 4x pinnae.  However, the mechanical process of splitting the 
pinnae to obtain the supernatants may have activated latent MMPs in the skin, 
thus accounting for the high levels of fluorescence in naïve pinnae which may 
mask subtle differences in expression in 1x pinnae.  
Whilst this assay measures active MMPs, it does not discriminate between the 
collagenases and gelatinases, of which there are two and four recognised 
members respectively (Nagase 1999). Analysis of selected skin and tumour 
angiogenesis associated MMP transcripts in the whole skin (i.e. MMP2, 9 and 19) 
revealed elevated levels of all three MMPs in 4x compared to 1x and naïve 
pinnae, and re-enforces the observation that MMPs were not greatly elevated 
after a single infection.  
Up regulation of MMP-19 after multiple infections is indicative of significant re-
modelling in the epidermis of the skin. MMP-19 is not expressed in normal skin 
but is significantly produced by keratinocytes in inflammatory skin ulcers and 
psoriasis (Suomela 2003). High levels of MMP-19 in the 4x group could implicate 
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an exacerbated keratinocyte response which would correlate with the increase in 
epidermal thickness observed.  MMP-9 has been identified in studies of 
angiogenesis in a wide range of models as essential for vascular production, and 
elevated levels of MMP-9 transcript were found in both infection groups. MMP-9 
exposes the alpha 5 beta 3 integrin as it cleaves collagen, a process which is 
essential in pathological angiogenesis (Mahabeleshwar 2006). Higher levels of 
MMP-9 would expose more of the integrin and increase angiogenic potential in 
the skin. Observations of early skin wounds have identified that MMP-9 and 
MMP-2 levels can fluctuate significantly (Salo 1994). Additionally, knockout of 
MMP-2 does not affect the speed at which wounds heal (Frossing 2010).  
Combined, the results presented suggest that it is the Gelatinase B enzyme 
MMP-9, rather than the Geltinase A MMP-2, which is responsible for the 
remodelling observed following both single and multiple infections, consistent 
with data from other skin wound healing models.  One of the likely sources of 
increased MMP-9 transcript is the fibroblasts (Ravanti 2000), additionally the 
immune cells recruited to the skin following infection may also be a significant 
source (Chapter 4).  
Transcript analysis of MMPs is only suggestive of the levels as MMPs must be 
proteolytically cleaved to become active. Therefore zymography would be a 
much better method to analyse the levels of specific MMPs. This technique 
utilises substrate specific gels to analyse levels of both pro and active MMPs 
based on their size. In addition to the three MMPs analysed there are many 
others which have been linked with pathological angiogenesis and more recently 
with schistosome infection. MMP-12 in particular is expressed at high levels in 
the liver and lung after infection with S.mansoni (Madala 2010). MMP-12, which 
is an elastase, is induced by IL-13 signalling and could potentially be driving and 
exacerbating the inflammation in the skin following 4x infection. 
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3.4.4 Infection induces the release of pro-angiogenic growth factors 
 
Production of VEGF in schistosome infections has previously been studied in 
relation to the formation of granulomas to eggs in the intestines and liver 
(Baptisa 2005). The data described in this chapter shows that VEGF expression is 
also induced in the skin in response to infective larvae.   
Three isoforms of VEGF were identified in the 1x and 4x infections. The soluble 
isoform VEGF120 is expressed at similar levels in all three groups of mice, whilst 
VEGF164 was up regulated only after infection. This isoform is regarded as the 
isoform associated with pathological angiogenesis and is expressed at high levels 
in inflammatory conditions (Ishida 2003, Detmar 1998). However, the largest 
difference in VEGF expression was in VEGF 188. This isoform is matrix bound and 
promotes migration of endothelial cells by binding to the ECM to provide 
guidance cues (Robinson 2001). It is reportedly important in modulating the 
sprouting of new vessels. Several studies with single isoform expressing mice 
have suggested a model where different isoforms act as a gradient along which 
blood vessels elongate or branch (Poltorak 1997). The VEGF188 isoform induces 
the endothelial cell branching. Over expression of the isoform produces thin 
highly branched vascular networks which may explain the pattern of branching 
seen in the 4x pinnae but absent in the 1x (Carmeliet 2000). The differential 
expression of the various isoforms in the skin after multiple infection, suggests 
that an amplified angiogenic response, or a more rapid response is occurring in 
the 4x pinnae. 
To identify further angiogenic factors which may be acting following schistosome 
infection a gene array was utilised. This array identified several additional pro-
angiogenic growth factors which were expressed after 1x or 4x infection and also 
several genes which were up regulated in only the 4x infected groups.  Genes 
which were expressed either over the 2 fold limit in 1x and 4x pinnae, or 
expressed in 4x pinnae alone, were selected for verification by SQ-PCR. 
Unfortunately some of the results appeared un-reliable and several of the genes 
selected for verification by SQ- and Q-PCR showed remarkably different patterns 
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of expression to the array.  This discrepancy in the array could have been due to 
some or all of the cDNA having been contaminated or degraded during the 
processing from RNA. DNA contamination would give false high readings whilst 
degradation of the samples would reduce the amount of transcript hypothesised 
to be seen.  This may have been resolved by using biological replicates, 
unfortunately the cost of the arrays meant that pooled replicates had to be used. 
However the array did identify several genes which were up-regulated and 
identified HGF, PlGF, FIGF and VEGF as up-regulated only in the 4x group. PlGF is 
expressed only in pathological angiogenesis whilst HGF expression is primarily 
associated with invasive angiogenesis (Autiero 2003 and Rosen 1997).  HGF 
stimulates cell migration, proliferation, and protease production to allow 
invasiveness of the endothelial cells through the ECM and formation into 
capillary-like tubes (Bussolino 1992) and it is overexpressed in several invasive 
cancers correlating with increased tumour angiogenesis. PlGF is associated with 
inflammatory lesions and neo vascularisation (Carmeliet 2001). Expression of 
both PlGF and HGF correlates with excessive inflammatory angiogenesis. The 
patterns of PlGF and HGF expression observed here, suggest that following 
multiple infections there is a significant increase in angiogenesis.  In addition to 
HGF and PlGF, FIGF is also significantly expressed in 4x pinnae. Known as 
‘vascular endothelial growth factor D’, this growth factor is active in both 
angiogenesis and lymphangiogensis (Marconcini 1999). High levels in the present 
study could suggest that the lymphatics of the skin are also affected following 
multiple schistosome infection. Schistosome cercariae can reportedly 
extravasate from the skin through a lymphatic vessel (Curwen 2003) in addition 
to utilising blood vessels. FIGF activates VEGFR2, and can stimulate similar 
phenotypic changes as VEGFA by stimulating endothelial proliferation, branching 
of endothelial cells in vitro, and causing neovascularisation.  
In addition to growth factors, the array identified the levels of several 
chemokines and cytokines which were all highly up-regulated after infection. In 
particular CCL11 (Eotaxin) , which recruits eosinophils, and CXCL1, a neutrophil 
chemo attractant, were both up-regulated more than 10 fold in the infected 
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groups compared to the naïve. Whilst both chemokines have immune functions 
they are also shown to have a direct effect on endothelial cells inducing micro 
vascularisation and migration of endothelial cells. (Salcedo 2001, Wang 2006) 
 The results from the array suggest an increase of pro-angiogenic factors 
following infection, and in addition different families of factors were up-
regulated in the 4x compared to the 1x pinnae. However, several expression 
patterns of factors up regulated on the array were not replicated in the SQ-PCR 
verification. Hand2 and IFNγ which were both found on the array were 
undetectable by SQ-PCR. Therefore, verification of any of the genes is essential 
to be confident in the observed expression pattern, although the array was a 
useful indicator of which genes to study further. 
Together, my data indicate an alternative, or amplified, series of angiogenic 
stimuli and pathways which are induced following multiple infections but are not 
induced by a single infection. This could be due to ‘priming’ of the ECM after a 
single infection with growth factors being sequestered which can then be 
released quickly after re-infection. However, as the growth factors induced differ 
between single and multiple infections, this appears unlikely.  Instead, 
differences could be due to the cell types present and the cytokine environment 
of the skin after multiple infections. Cellular composition of the skin following 
infection is examined and discussed in the next chapter. 
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3.4.5 Summary 
 
The results in this chapter show that angiogenesis is induced in the skin following 
exposure to infective schistosome larvae. The vessels of the skin become 
permeable and show increased levels of markers of remodelling. CD31 imaging 
reveals both an increase in the number and diameter of the vessels in the skin. 
High levels of matrix metalloproteinases following infection indicate the 
induction of the remodelling cascade preparing the ECM for the growth of new 
vessels. However, only total active collagenase and gelatinase levels were 
analysed, although individual MMPs were identified by transcript. Further work 
could utilise zymograms to determine the active levels of each MMP. Pro-
angiogenic growth factors are induced by both single and multiple infections, 
however there is a difference in the predominant factors between the groups. 
This difference could be due to the immune response induced in the skin 
following infection. The next chapter will attempt to characterise the 
predominant immune response in the skin including characterisation of the 
phenotype of leukocytes recruited. In particular cells will be analysed for pro-
angiogenic phenotypes. 
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Chapter 4:  Determining the angiogenic phenotype of 
the dermal innate immune response to infection 
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4.1 Introduction 
 
The previous chapter has identified up regulation of pro-angiogenic growth 
factors following infection with schistosome cercariae. The entry of the cercariae 
into the skin involves penetration and transit through the epidermis to reach the 
blood vessel rich dermis (Haas 1997).  This penetration will cause several 
reactions in the skin. Initially penetration will cause damage to the skin which 
would initiate the skin’s wound healing mechanisms. This includes induction of 
the innate immune response (1.3.1).  In addition during penetration the 
cercariae release secretions (termed 0-3hrRP) whose antigens are likely to be 
recognised by innate immune receptors such as TLRs which trigger innate 
immune responses. Activation of the immune system is highly interdependent 
with angiogenesis and therefore analysis of the dermal immune response and 
cell types recruited is essential in understanding the angiogenic process observed 
following infection. 
Within mature resting tissue there are small numbers of residing leukocytes, 
however following tissue injury there is a significant influx of leukocytes to 
augment these residing cells (Neufeld 2006). These are essential in forming the 
granulation tissue and clearing both infectious agents and the debris produced 
from damage (Tsirogianni 2006). During this process blood vessels grow into the 
site to provide the cells and nutrients required for repair. Nearly all lineages of 
the immune system are involved in response to tissue damage and infection. 
Neutrophils followed later by macrophages are two of the main responders. 
Macrophages in particular are an important source of growth factors and 
cytokines and have long been known to play an important role in the regulation 
of wound repair and angiogenesis (Rappolee 1988) 
Multiple infections with schistosome cercariae can alter the cytokine balance in 
the skin from predominantly Th1 to Th2. The cytokine production in a tissue site 
can have both a direct and indirect effect on angiogenesis. Many pro 
inflammatory cytokines including IL-6, IL-1β and TNFα induce angiogenesis 
through release of growth factors or direct interaction with endothelial cells (Kim 
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2003, Margetts 2002). Additionally the release of cytokines determines the 
phenotype of cells recruited to the site of infection. The cytokine balance in the 
skin after 4x infections becomes predominately Th2 and as such may activate the 
leukocytes differently to the 1x and stimulate release of additional growth 
factors. 
As described earlier in 1.3.4.2 & 1.3.4.3 cells are plastic in their phenotype, 
macrophages in particular are known to change significantly dependant on the 
cytokines produced at the site of infections. The broad classifications of classical 
and alternatively activated macrophages produce very different components and 
whilst classical macrophages have long been thought to be responsible for the 
clearance and microbial killing in wounds alternatively activated macrophages 
secrete components of the extracellular matrix and growth factors. Alternatively 
activated macrophages were initially described in helminth infections. They have 
been described in the intestinal granulomas of schistosome infected mice 
(Herbert 2004). More recently it has been suggested that AAMacs are in fact an 
innate and rapid response to tissue injury, macrophages are found in close 
association with vessels and produce VEGF (Allen 2011, Ausprunk 1977). Various 
phenotypes of macrophage are also found in and around vascularised tumours 
and depletion of monocytes leads to reduced vascularisation of the tumour (Sica 
2002).  The phenotype of the macrophages following multiple infection may 
change and contribute to the elevated levels of pro-angiogenic cytokines within 
the 4x pinnae.  
In addition, helminth infections also lead to recruitment of mast cells, basophils 
and eosinophils. Eosinophils in particular are recruited to S.mansoni granulomas 
and are associated with several diseases which exhibit high levels of fibrosis and 
angiogenesis (Levi-Schaffer 1997). Eosinophils can directly affect fibroblast 
properties and modulate the process of tissue repair (Doucet 1998). They also 
store several pro –angiogenic growth factors within their granules; VEGF and 
FGF2 (Puxeddu 2005). Eosinophils have been shown to promote endothelial cell 
proliferation in vitro and induce new vessel formation in chick membrane model. 
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The type and phenotype of the cells recruited to the skin following cercarial 
infection could highly alter the angiogenic response. This chapter will determine 
the cytokine balance in the skin following both 1x and 4x infections and identify 
the types of cells recruited and their angiogenic phenotype. The difference in 
growth factor expression between 1x and 4x mice may be due to differing 
phenotypes in the immune cells.  
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4.2 Materials and Methods 
4.2.1 Dermal Exudate Cell (DEC) retrieval and counts 
 
In order to recover dermal exudate cells (DEC), pinnae were prepared as in 
section 2.2.12. During this overnight incubation, cells migrate out into the culture 
media and are then termed DEC comprising adherent and non-adherent cells.  
After recovery of the culture supernatants, they were spun (300 x g for 7 
minutes) to pellet the non-adherent cells. To recover adherent cells, 500µl of ice 
cold PBS was added to the empty wells and incubated for 20 minutes at 37°C; the 
cells were re-suspended and added to the non-adherent cells previously 
collected. The total cell sample was then washed in PBS and either used for flow 
cytometric analysis (4.2.2), or frozen in Trizol for RNA extraction (2.1.3) 
 
4.2.2 Labelling DEC with antibodies for flow cytometric analysis 
 
DEC were re-suspended in PBS supplemented with 1% foetal calf serum (Biosera, 
UK), counted and aliquoted at 105 cells per tube in 100µl total volume. To each 
tube, 10µl of normal goat serum (Sigma-Aldrich) and 1µl of anti-CD16/32 mAb 
(BD Pharmingen) was added to block Fc receptors and incubated at 4°C for 
30minutes.   The following conjugated antibodies were added to the required 
tubes (Table 4.1).  
Tubes were incubated with the required antibodies (as above) for 1hour at 4°C in 
the dark before being washed with 2ml of 1%FCS/PBS. Cells were then re-
suspended in 500µl of 1%FCS/PBS and kept on ice until analysis using a CyAn ADP 
flow cytometer (DakoCytomation, Ely, UK) with 405nm, 485nm and 633nm 
lasers. The forward and side scatter properties of the cells were measured and 
the proportion of dead cells calculated using propidium iodide staining (PI) to 
gate out non-viable cells. 
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Antibody Clone Supplier Isotype Supplier 
F4/80 FITC BM8 eBioscience Rat IgG2a eBioscience 
CD45 APC 30-F11 eBioscience Rat IgG2bκ eBioscience 
Ly6G PE RB6-8C5 eBioscience Rat IgG2bκ eBioscience 
CD11b APC M1/70 eBioscience Rat IgG2bκ eBioscience 
IA/IE Biotin M5/114.15.2 eBioscience Rat IgG2bκ eBioscience 
CD11c FITC N418 eBioscience Armenian 
Hamster IgG 
eBioscience 
SiglecF PE E50-2440 BD 
Pharmingen 
Rat IgG2aκ BD 
Pharmingen 
Streptavidin 
Pacific blue 
Goat IgG Invitrogen - - 
 
 
4.2.3 Cell sorting of DEC 
 
DEC were obtained and labelled with antibodies to F4/80 (FITC conjugated) and 
MHCII (APC conjugated) (4.2.2). Cells were then separated using a MoFlo cell 
sorter (DakoCytomation) by Karen Hodgkinson of the Imaging and Cytometry 
Labs (University of York). Three populations were sorted; F4/80+MHCII - , 
F4/80+MHCII mid, and MHCII hi. Cells were collected into RPMI medium containing 
10% FCS. After sorting, cells were washed, prepared for cytospining, or re-
suspended in 250µl of TRIZOL ™ for RNA extraction. 
 
4.2.4 Cytospins and DiffQuick staining 
 
Cytospins of the sorted cell population were prepared to confirm cellular 
identity. Briefly, 2x104 cells of each sample were spun for 3 minutes at 400g onto 
glass slides in a cytospin (Cytospin 2, Shandon, UK) which were left to air dry 
before being stained with DiffQuick  as per the manufacturer’s protocol. Slides 
were then washed in pure water until all excess stain was removed; slides were 
then air dried and coverslips applied using DPX (BDH, UK).  
Table 4.1 Antibodies used for DEC labelling 
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4.2.5 Pinnae digest  
 
The skin remaining after overnight culture for DEC was removed and placed into 
a solution of 50µg/ml Liberase. The pinnae sheets were incubated at 
37°C/5%CO2 for 30 minutes before being torn into smaller pieces. These were 
then incubated for a further 40minutes at 37°C shaking gently. After incubation 
the cell suspensions were strained and the cells pelleted. These were re-
suspended in 1%FCS/PBS and labelled for flow cytometry using the same 
markers as the DEC (4.2.2) 
 
4.2.6 Cytokine array kit 
 
Skin biopsy culture supernatants from naïve, 1x day2 and 4x day 2 infected mice 
were collected (2.1.7) and analysed using the R&D Systems Proteome Profiler ™ 
Array (Mouse Cytokine array panel A; ARY006 R&D Systems Europe, UK). The kit 
comprises a membrane spotted with 40 different cytokine antibodies in 
duplicate. The assay was performed following manufacturer’s protocol. The final 
blot was detected using chemiluminescence kit (Promega). X-ray films were 
exposed for 20 sec. Results were analysed by densitometry of the spots (Alpha 
Imager) 
 
3.2.7 Cytokine ELISAs 
 
Skin biopsy culture supernatants (2.1.7) were analysed for levels of 7 different 
cytokines (Table 4.2): 
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Cytokine Capture 
Antibody 
Detection 
Antibody 
Supplier Standard top 
concentration 
Supplier 
IFNγ R46A2 XMG1.2 BD Pharmingen 10ng/ml Recombinant 
cell line 211A 
IL-1β mAb-4a BAF-401 BD Pharmingen 25ng/ml R&D Systems 
IL- 4 BVD4-
1D11 
BVD6-24G2 BD Pharmingen 10ng/ml R&D Systems 
IL-5 TRFK-5 TRFK-4 BD Pharmingen 25ng/ml R&D Systems 
IL-10 Kit – DY417 R&D Systems 2ng/ml R&D Systems 
IL-12 Kit – DY499 R&D Systems 1ng/ml R&D Systems 
IL-13 Kit – DY413 R&D Systems 4ng/ml R&D Systems 
TNFα Kit –CMC3013 Invitrogen 5ng/ml Invitrogen 
 
 
 
4.2.7.1 IFNγ, IL-1β, IL-4, IL-5 (in house using paired antibodies from BD 
Pharmingen) 
 
Plates were coated with the required concentration of antibody diluted in PBS 
(50μl per well) and left overnight at 4˚C. After incubation, the plates were 
washed 2x in PBST (PBS and 0.05% Tween20) before blocking with 400μl of 
10%FCS in PBS and incubated for a minimum of two hours at room temperature. 
The block was then expelled and the standards and samples added (50μl per well 
in duplicate); recombinant cytokine standards were prepared in doubling 
dilutions in 10%FCS/PBS and aliquoted to produce 11 dilutions. The plate was 
then incubated at 4˚C overnight.  The plates were washed 5x in PBST and 
incubated with the biotinylated detection antibody (50μl per well) at room 
temperature for 1-2 hours.  Plates were then washed 5x and incubated with 50µl 
of streptavidin horseradish peroxidise (HPO) for 45 minutes (Section 4.2.7.3) 
 
 
Table 4.2 Antibody pairs and kits for cytokine ELISAs 
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4.2.7.2 IL-10, IL-12p40, IL-13 (Duo kits from R&D Systems) 
 
Plates were incubated with coating antibody in PBS (50μl per well) and left 
overnight at 4˚C.  Plates were then washed with 400μl of PBST and blocked with 
400μl of 1%BSA PBS for 2hours at room temperature. After blocking, 
recombinant cytokine standards and test samples were added in duplicate (50μl 
per well) and left to incubate at room temperature for 2hours.  Plates were then 
washed 5x in PBST and incubated with biotinylated detection antibody diluted in 
PBST (50μl per well) and incubated for 2hours at room temperature. Finally, 
plates were washed 5x in PBST and incubated with streptavidin HPO for 45 
minutes (Section 4.2.7.3) 
 
4.2.7.3  Addition of final substrate 
 
For both plates after incubation with streptavidin HPO, plates were washed in 
PBST, and 50 μl Sure Blue TMB substrate (KPL Gaithersburg MD, USA) added to 
each well.  The plates were left to develop colour at room temperature and 
readings taken using a MRXII plate reader (Dynex Technologies Ltd, Worthing UK) 
at 650nm every 5-10minutes . 
 
4.2.8 Toluidine Blue staining of pinnae sections 
 
Pinnae sections were prepared as previously (3.2.2) and stained with Toluidine 
Blue (service provided by the Veterinary Pathology Department, University of 
Liverpool, UK.) 
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4.3 Results 
 
4.3.1 1x and 4x pinnae show varying levels of cytokines and chemokines 
 
The cytokine and chemokine balance within the whole pinnae was established 
using array analysis of skin biopsy culture samples from pooled biological 
replicates (n=5) for day 2 only (Figure 4.1A).  
 
4.3.1.1 Cytokines 
 
There were several spots for different cytokines which were saturated in all three 
array blots and therefore comparisons between the 3 groups of mice are 
unreliable. These were the colony stimulating factors M-CSF, GM-CSF and G-CSF, 
and the pro-inflammatory cytokine IL-6.   The concentration of these molecules 
appeared greater in the 1x and 4x than naïve groups, although there was little or 
no difference between the 1x and 4x samples (Figure 4.1B). The pro-
inflammatory cytokines IL-1β and IL-16 were expressed highly in 1x compared to 
naïve mice and increased further in the 4x group. The regulatory cytokine IL-10 
followed a similar pattern of expression.  IL-4 and IL-5 also increased after 
infection and were greater in 4x than 1x samples but both were expressed at 
much lower levels than IL-10. Of the other cytokines, only five were expressed in 
only 1x or 4x groups but not in both.  The supernatant sample from 1x mice had 
much higher levels of IL-17 than the naïve sample, whilst the 4x group expressed 
similar levels to the naive. IL-13, IL-27 and IFNγ were all up regulated only in the 
4x group with no difference between the 1x and naïve. IL-3 also differed in the 4x 
group but was reduced in expression compared to the naïve. 
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4.3.1.2 Chemokines 
 
In contrast to the pattern of cytokine expression, many of the chemokines 
showed no difference in expression between the three groups (Figure 4.1C). Six 
chemokines which did alter in expression were up regulated in both 1x and 4x 
samples compared to naïve, but there was no discernible difference between the 
1x and 4x groups. These chemokines were; CCL1, CXCL9, CXCL13, MIP-1α, MIP-2 
and MCP-5.  Both CXCL9 and CXCL13 were up regulated almost 2-fold compared 
to the naïve value, whilst the difference was not as great with the other four 
chemokines. In contrast, two chemokines, C5a and CCL11, which recruit 
neutrophils and eosinophils respectively, were up regulated after 1x infection 
but further up regulated in 4x infection. Two other chemokines, CXCL10 and MIP-
1β, were up regulated to a greater extent in the 1x group than either the naïve 
or 4x group. CCL5 was detected at similar levels in naive and 1x samples but was 
lower in the 4x group.  
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Figure 4.1 Images and graphical representation of the cytokine and chemokine 
array 
 
A: Proteome Profiler ™ Array blots after 20 seconds of exposure. The plan of 
capture antibodies is shown in panel 1 with the results in panels 2-4. The positive 
controls are in the top corners and bottom left with the negative control in the 
bottom right. The samples were pooled biological replicates of 5 mice from day 2.  
 
B & C: Graphical representation of the densitometry values of cytokine and 
chemokine spots. The intensity of each spot was calculated and the negative 
control deducted for each of the replicates and plotted as a mean of the 2 
replicates ± SD.  
 
A 
 
 
96 
 
  
C
y
to
k
in
e
s

IL
-1

IL
-1
IL
-1
ra
IL
-2
IL
-3
IL
-4
IL
-5
IL
-6
IL
-7
IL
-1
0
IL
-1
3 I
L-
12
p7
0
IL
-1
6
IL
-1
7
IL
-2
3
IL
-2
7
IF
N
g
TN
Fa
G
-C
S
F
G
M
-C
SF
sI
C
A
M
-1
M
-C
S
F
TI
M
P
-1
TR
E
M
0
5
0
0
0
1
0
0
0
0
1
5
0
0
0
2
0
0
0
0
2
5
0
0
0
N
a
iv
e
1
x
4
x
a.u
 
 
97 
 
 
 
 
C
h
e
m
o
k
in
e
s
C
C
L1
C
C
L2
C
C
L5
C
C
L1
7
C
XC
L1
C
XC
L9
C
XC
L1
0 C
XC
L1
1 C
XC
L1
2 C
XC
L1
3
C
5a
E
ot
ax
in

M
IP
-1

M
IP
-1
M
IP
-2
M
C
P
-5
0
5
0
0
0
1
0
0
0
0
1
5
0
0
0
2
0
0
0
0
2
5
0
0
0
N
a
iv
e
1
x
4
x
a.u
 
 
98 
 
 
4.3.2 4x pinnae show significantly elevated levels of Th2 cytokines 
 
Supernatants from skin biopsy cultures of pinnae from naïve mice, and from 1x 
and 4x mice collected on days 1, 2, 4 and 8 after the final infection were tested 
by cytokine specific ELISAs  (Figure 4.2).  
IL-1β was expressed at high levels at the earliest time point (Day 1) in both 
infection groups and rapidly declined over the time course but no significant 
difference between the 1x and 4x groups was detected (Figure 4.2A).  The 
expression of TNFα revealed a different profile showing  a steady increase from 
naïve levels to a peak at day 4 post-infection followed by a decline back to naïve 
level at day 8 (Figure 4.2B). Again there was no significant difference between 
the 1x and 4x groups.   
IL-12 was expressed by both infection groups at significantly higher levels than 
the naïve (Figure 4.2C).  Expression of IL-12 remained steady over the time 
course of infection in 1x mice but in 4x mice levels were significantly elevated on 
day 2 and 4 compared to the 1x time points. In the 1x samples IL-10 was barely 
detectable over naïve levels until day 8 (Figure 4.2D).  In contrast, in 4x mice IL-
10 was expressed at high concentrations, ~1000pg/ml at its peak on day 2 before 
dropping at day 4 .  
Of the Th2-type cytokines, IL-4 and IL-13 were both expressed at significantly 
higher concentrations in 4x compared to 1x pinnae (Figures 4.2E & F). For IL-4, 
the concentration of protein was relatively low compared to the other cytokines 
peaking at only ~60pg/ml at 4x day 4 before rapidly reducing over the time 
course, although levels of IL-4 remained significantly higher in 4x mice compared 
to either the 1x or naïve. In contrast to IL-4, IL-13 peaked at ~1500pg/ml at 4x 
day 2. The expression rapidly decreased by day 4 with 4xday 2 being the only 
significantly increased time point compared to 1x.  
 
 
C 
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A B 
C D 
E F 
Figure 4.2 Cytokine ELISAs performed on skin biopsy supernatants 
 
A: IL-1β B, TNFα, C, IL-12p40, D, IL-10, E, IL-4, F, IL-13.  
N= 5 biological replicates significance is given for 4x samples versus the equivalent 
1x time point. Significance is the 1x versus 4x time points, *p<0.05, **p<0.01 and 
***p<0.001. Dashed line indicates the minimum level of detection. 
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4.3.3 4x pinnae show a significant influx of DEC  
 
After infection, there was a visible influx of cells in the dermis (Figure 3.2) and 
some of these were recovered as DEC. Both 1x and 4x pinnae compared to naïve 
tissues (Figure 4.3).  In the 1x group, the cell number increased from day 1, 
peaked at day 2, and then fluctuated on days 4 and 8. The cell counts in 4x 
pinnae peaked earlier at day 1 and remained elevated on day 2 before declining 
to 1x levels by day 4. There were significantly more cells in the 1x compared to 
naïve at days 2-8 (day2 and 8 p<0.001, day 4 p<0.05). The 4x pinnae also had 
significantly higher numbers of DEC than naïve (p<0.001 for all time points) and 
1x pinnae on days 1 and 2 (p<0.001).   
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Figure 4.3 DEC counts 
 
Total DEC counts from skin biopsies were calculated per 
pinnae and shown as mean + SEM (n = 20 samples from 
three experiments). Significance is shown for 4x values 
compared to the equivalent 1x time point. ***p<0.001. 
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4.3.4 The majority of DEC are CD45+ 
 
To determine what proportion of these migratory cells were leukocytes, DEC 
were labelled with anti-CD45 mAb. Of the DEC recovered, approximately 80-90 % 
were CD45+ in all groups, at all time points (Figure 4.4).  There was no significant 
difference in the percentage of CD45+ cells between time points over the 
infection time course and there were no significant differences between the 1x 
and 4x infection groups.  The percentage of CD45+ cells reaches a maximum on 
day 2.  
 
 
 
 
 
 
 
 
 
4.3.5 Phenotypic characterisation of the DEC 
 
DEC were labelled with a further panel of antibodies against various cell surface 
markers (Table 4.1 ) to distinguish various populations of hematopoietic cells, in 
particular those involved in angiogenesis (1.2.3).   DEC recovered on days 1, 2 
and 4 after infection were analysed to cover the early cell influx, peak and 
eventual reduction in cell number after infection.  Various types of cells were 
identified based on their expression of different surface markers as shown in 
Table 4.3 
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Figure 4.4 CD45+ cells in the DEC 
 
The percentage of live CD45+ cells within the DEC obtained at different 
time points.  Values are means + SEM for 5 DEC samples. There was no 
significant difference in or between infection and naïve groups. 
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Cell Type Markers 
Neutrophils CD11b+, Gr1+, F4/80 -  
Macrophages/Monocytes CD11b +, MHCII+, F4/80+ 
Dendritic Cells CD11c+, MHCIIHi, 
Eosinophils F4/80+/mxd , MHCII -, SiglecF + 
 
 
4.3.5.1 Neutrophils 
 
CD45+ cells were plotted according to their expression of F4/80 and Gr1 which 
revealed four populations (Figure 4.5B).  The majority were F4/80+ and expressed 
varying levels of Gr1, however a separate population was Gr1+ but F4/80- (shown 
as gated population).  These cells were virtually undetectable in naïve pinnae 
(Figure 4.5A).  F4/80-Gr1+ cells were 100% CD11b+ (Figure 4.5C) and thought to 
be neutrophils as confirmed by stained cytospins (Figure 4.5D).  The percentage 
of DEC which were F4/80-Gr1+ and CD11b+ on days 1-4, peaked at day 1 in both 
1x and 4x pinnae with an average of 12% and 14% respectively (Figure 4.5E). The 
percentage of these cells then decreased rapidly from day 1 to 2 and again at day 
4.  
 
4.3.5.2 Dendritic Cells 
 
A scattered population of MHCIIhi and F4/80mixed DEC was observed (Figure 4.6B). 
These were predominantly CD11c+ (80-90% of the MHCII hi cells) and therefore 
thought to be dendritic cells (Figure 4.6C).   These MHCIIhi and F4/80mixed DEC 
were only a small percentage of the total in 4x mice and this percentage 
remained constant over the infection time course days 1-4 (Figure 4.6E).  The 
highest percentage of dendritic cells within the DEC was in 1x mice at day 1 
(~12%) which was significantly greater than in naïve or 4x groups. 
 
Table 4.3 Cell Identification through surface phenotype 
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4.3.5.3 Macrophages and monocytes 
 
Both macrophages and monocytes express the myeloid markers CD11b and 
F4/80 but they express varying levels of MHCII (Figure 4.7). A mid to low MHCII 
expressing DEC population were also F4/80+ and CD11bhi, peaking at ~15%, and 
were assumed to be macrophages. There was no difference in the percentage of 
these cells between the 1x and 4x groups over the time course (Figure4.7E) 
 
4.3.5.4 Eosinophils 
 
A large proportion of the F4/80+cells were MHCII- and SiglecF+ which is a classic 
marker of eosinophils (Figure 4.8 B&C). After 1x infection there was an 
immediate increase in these F4/80+MHCII-SiglecF+ cells (up to ~15% of the DEC) 
but this declined slightly between days 1 and 2 to around 10%.   F4/80+MHCII-
SiglecF+ cells from 4x pinnae were more abundant peaking at ~45% on day 1 post 
infection and remaining elevated over the remaining time course.  At all time 
points the proportion of these cells was significantly greater in infected pinnae 
compared to naïve (1x day 1 & 4 p<0.05, 1x day 2 and 4x days 1&2 p<0.01, 4x day 
4 p<0.001). Additionally all 4x time points were significantly higher than the 1x 
equivalents (statistics shown in figure 4.8E) 
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Figure 4.5 Neutrophils  
 
A representative plot from 5 individual biological replicates is shown for all time points in panels B and C 
A: Naïve and Isotype control. There was no nonspecific staining seen in the Isotype for the population selected. In the Naïve there is a small 
population of cells within the region marked which was selected based upon the infected sample. B: The infected samples from all 3 time 
points for 1x and 4x. The selected population is marked and used to gate on the plots shown in panel C for percentage CD11b+. C: The % of 
CD11b shown as an overlay of selected cells (purple) over Isotype (grey). D: Cytopsins of the selected population showing neutrophil 
morphology. E:  The percentage of neutrophils within the entire DEC population. There is no significant difference between 1x and 4x time 
points however days 1 and 2 for both 1x and 4x are significantly increased compared to the naïve (p<0.001 for all) statistics shown mean 
+SEM 
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Figure 4.6 Dendritic Cells 
 
A representative plot from 5 individual biological replicates is shown for all time points in panels B and C 
A: Naïve and Isotype control. There was no nonspecific staining seen in the Isotype for the population selected. In the Naïve there was a 
reasonable proportion of the cells within the region marked which was selected based upon the infected sample. B: The infected samples 
from all 3 time points for 1x and 4x. The selected population is marked and used to gate on the plots shown in panel C for percentage 
CD11c+. C: The % of CD11c shown as an overlay of selected cells (purple) over Isotype (grey). D: Cytopsins of the selected population showing 
the morphology of the cells. E:  The percentage of dendritic cells within the entire DEC population. There was a significant difference 
between 1x day 1 and 4x day 1 however there are significantly more dendritic cells in all 1x time points and at 4xday 2compared to the naïve 
(for all p<0.05) statistics shown mean +SEM 
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 Figure 4.7 Macrophages 
 
A representative plot from 5 individual biological replicates is shown for all time points in panel B 
A: Naïve and Isotype control. There was only a small amount of nonspecific staining seen in the Isotype for the population selected (<1%). In 
the Naïve there was a reasonable proportion of the cells within the region marked which was selected based upon the infected sample. B: 
The infected samples from all 3 time points for 1x and 4x. The selected population is marked C: Cytopsins of the selected population showing 
the morphology of the cells. D:  The percentage of macrophages within the entire DEC population. There was no significant difference 
between 1x and 4x at any of the time points however all were significantly increased compared to naïve (1x and 4x days 1 and 2 p<0.01, 1x 
day 4 p<0.001 and 4xday 4 p<0.05) statistics shown mean +SEM 
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Figure 4.8 Eosinophils 
 
A representative plot from 5 individual biological replicates is shown for all time points in panels B and C 
A: Naïve and Isotype control. There was no nonspecific staining seen in the Isotype for the population selected. In the Naïve there was a very 
small percentage of cells (<2%) within the region marked which was selected based upon the infected sample. B: The infected samples from 
all 3 time points for 1x and 4x. The selected population is marked C: The % of SiglecF shown as an overlay of selected cells (purple) over 
Isotype (grey). D:  Cytopsins of the selected population showing the morphology of the cells. E:  The percentage of eosinophils within the 
entire DEC population. All 4x time points were significantly increased compared to the 1x (statistics shown mean +SEM). All infected samples 
were significantly increased compared to the naïve (p<0.001) 
D E 
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4.3.6 Phenotypic characterisation of CD45+ cells remaining in the tissue 
 
In order to establish the abundance of haematopoietic cells which did not 
emigrate as DEC, the pieces of skin remaining after overnight culture were 
digested with liberase and the single cell suspension subsequently analysed for 
the presence of CD45+ cells. As a proportion of the total digested skin cell 
population there were very few CD45+ cells remaining in the 1x pinnae, however 
there were significantly more in the 4x pinnae peaking at 30% of the total 
digested skin cells (Figure 4.9). These were subjected to the same analysis as the 
DEC for phenotypic markers of different populations. Gr-1+F4/80- neutrophils 
were found in the remaining split pieces were significantly more in the infected 
groups than the naïve. There were also significantly more in the 4x compared to 
the 1x, perhaps indicating that in the 4x neutrophils are able to migrate further 
into the skin and remain after overnight culture (Figure 4.10).  
Only a small percentage of cells were CD11c+ dendritic cells (2% at peak), and 
there was no significant difference between the naïve and infection groups 
Figure 4.11).  Flow cytometric analysis showed that F4/80 mixed MHCII hi cells 
expressed low levels of CD11c compared to the DEC, suggesting they could be 
skin resident cells e.g. Langerhans cells. Macrophages showed a similar profile to 
the dendritic cells with similar numbers seen in all groups including the naïve 
group; there was no significant difference between the 1x and 4x groups (Figure 
4.12).  As in the DEC, a significant number of SiglecF+ eosinophils were observed 
in the 4x compared to the 1x group which were significantly more abundant than 
in the naïve group which had less than 0.5% eosinophil like cells (Figure 4.13). 
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Figure 4.9 CD45+ cells in the skin  
 
A representative plot from 5 individual biological replicates is shown for all time points in panels B and C 
A: Naïve and Isotype control. There less than 0.5% nonspecific staining in the Isotype for the population selected. In the Naïve there were 
several CD45+ cells within the region marked. B: The infected samples from all 3 time points for 1x and 4x. The selected population is marked 
C: The percentage of CD45+ cells within the entire cell suspension after digest. All 4x time points were significantly increased compared to the 
1x (statistics shown men +SEM). The 4x samples were significantly increased (p<0.001) compared to the naïve as were days 1 and 2 of the 1x 
(p<0.05) ***p<0.001. 
4x 
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Figure 4.10 Neutrophils in the skin  
 
A representative plot from 5 individual biological replicates is shown for all time points in panels B and C 
A: Naïve and Isotype control. There less than 0.5% nonspecific staining in the Isotype for the population selected. In the Naïve there were 
several Gr1+/F4/80- cells within the region marked. B: The infected samples from all 3 time points for 1x and 4x. The selected population is 
marked and analysed for CD11b expression below the plots C: The percentage of Gr1+/F4/80- cells within the entire cell suspension after 
digest. All 4x time points were significantly increased compared to the 1x (statistics shown mean +SEM). The 4x samples were significantly 
increased (p<0.001) compared to the naïve as were days 1 and 2 of the 1x (p<0.05) ***p<0.001 
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Figure 4.11 Dendritic cells in the skin  
 
A representative plot from 5 individual biological replicates is shown for all time points in panels B and C 
A: Naïve and Isotype control. There was no nonspecific staining in the Isotype for the population selected. In the Naïve there was a 
reasonably large percentage of cells within the region marked. B: The infected samples from all 3 time points for 1x and 4x. The selected 
population is marked and analysed for CD11c expression below the plots C: The percentage of F4/80mxd/MHCHi/CD11c+ cells within the entire 
cell suspension after digest. There was no significant difference between any of the groups, shown mean +SEM 
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Figure 4.12 Macrophages in the skin  
 
A representative plot from 5 individual biological replicates is shown for all time points in panels B and C 
A: Naïve and Isotype control. There was no nonspecific staining in the Isotype for the population selected. In the Naïve there was a large 
percentage of cells within the region marked. B: The infected samples from all 3 time points for 1x and 4x. The selected population is marked 
C: The percentage of F4/80+/MHCMid cells within the entire cell suspension after digest. 1x day 2 is significantly reduced compared to the 
other groups (p<0.01), but there was no significant difference between any of the other groups. shown mean +SEM 
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Figure 4.13 Eosinophils in the skin  
 
A representative plot from 5 individual biological replicates is shown for all time points in panels B and C 
A: Naïve and Isotype control. There was no nonspecific staining in the Isotype for the population selected. In the Naïve there were only a few 
cells in the region marked. B: The infected samples from all 3 time points for 1x and 4x. The selected population is marked and analysed for 
SiglecF expression below the plots C: The percentage of F4/80+/MHC-/SiglecF+ cells within the entire cell suspension after digest. There were 
significantly more cells in the 4x compared to the naïve and 1x time points (p<0.001) and 1x day 4 was significantly increased compared to 
the naïve (p<0.01). statistics shown mean +SEM 
A B C 
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4.3.7 More mast cells were presented in the dermis of 4x pinnae compared to 
1x. 
 
Mast cells can be found in connective tissue including the skin but are not 
thought to be present in DEC and can be detected by staining of pinnae sections 
with toluidine Blue (Figure 4.14A). Mast cells were seen in all groups and are 
distributed evenly throughout the skin. In naïve pinnae, 1-2 mast cells per field of 
view were detected whereas in the 1x pinnae a greater number were visible still 
within the dermal layer.  In 4x pinnae the number increased further and were 
located amongst the cellar influxes under the epidermis. The number of cells per 
field of view from several pinnae sections were counted which showed there was 
a negligible increase in the number of mast cells in the 1x compared to the naïve 
group, however the number of mast cells increased significantly in the 4x pinnae 
compared to both 1x and naïve (Figure 4.14B). 
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Figure 4.14 Mast cells in the dermis 
 
A-D: Representative images of mast 
cells in the dermis, pinnae sections 
were stained with Toluidine blue (A-C 
20x, D- 40x magnification) 
E: Graphical representation of mast cell 
counts from day 2 pinnae. **p<0.01 4x 
compared to 1x. 5 pinnae for each 
group were stained and counted. 
E 
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4.3.8 4x DEC show increased expression of alternatively activated macrophage 
markers by PCR 
 
As the majority of haematopoietic cells were found within the DEC, and because 
they were an easier population to handle, the DEC population was examined to 
determine whether alternatively-activated macrophages (implicated in 
angiogenesis) were present in the DEC.  Cells were obtained on day 2 post-
infection, as this is the peak of cell influx into the skin, and is when the highest 
levels of cytokines were produced.  For all three genes identified as being 
markers of alternative activated macrophages; Arginase-1, Ym1 and RELMα, 
expression was most abundant and significantly greater in the 4x than in the 
naïve and 1x groups (p<0.001) (Figure 4.15).   There was a small and significant 
increase in expression of Ym1 in the 1x group compared to the naïve (p<0.05). 
The 1x expressed significantly higher levels of transcript for the classical marker 
iNOS than either the 4x or naïve.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15 Expression by DEC of macrophage markers of activation.  
 
A- Arginase-1  B – Ym1, C – RELMα, D – iNOS. Values are mean + SEM n = 5 
biological replicates of DEC taken from day 2 for the infected samples. 
Expression is given relative to GAPDH **p<0.01, ***p<0.001 
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4.3.9 DEC cell sorting into pure populations of Eosinophils, Macrophages and 
Dendritic Cells 
 
To determine which of the three predominant leukocyte classes identified 
(Figures 4.6-4.9) – macrophages, dendritic cells and eosinophils, contribute to 
the angiogenic environment in the skin, samples of these cells were sorted from 
total DEC from 1x and 4x pinnae according to their expression of MHCII and 
F4/80 (Figure 4.16). Naive samples could not be sorted as not enough cells were 
attainable.  
 
 
 
 
 
 
 
 
 
 
 
Previously, (P.C.Cook, PhD thesis), the sorted cell populations described above 
and denoted R2 (Eosinophils), R3 (Macrophages), and R4 (Dendritic cells) were 
analysed by real time PCR for different markers of alternative activation, and 
cytokine gene expression.  This revealed the R3 population to express high levels 
of Arg-1 and Ym1 indicative of an alternative activated macrophage population 
whilst Relmα, IL-4, and IL-13 were most abundant in the eosinophil population 
(Figure 4.17A taken from Cook 2011). In addition for this study the cells were 
F4/80 
MH
CII 
Figure 4.16 Representative graph of parameters for cell sorting.   
 
Representative flow plot showing the gating strategy of cell sorting (Plot 
shown is 4x day 2) alongside representative images of cells from these 
sorted populations. 
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analysed for their expression of COX2 (Figure  4.17B). COX 2 expression was 
detected in all three cell samples. In the macrophage and eosinophil samples 
expression was increased in the 4x compared to the 1x, significantly so for the 
macrophages (p<0.01). Expression was reduced in the 4x dendritic cells 
compared to the 1x.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17 Analysis of markers of alternative activation and cytokine 
expression  
 
A: Expression in sorted DEC samples. Figure is taken from Cook 2011. 
Sample size is n=3-4 separate experiments of 15 pooled biological 
replicates each. R2 = Eosinophils, R3 = Macrophages and R4 = Dendritic 
cells.  B: COX2 expression analysed by SQ-PCR n=3 for each group. 
**p<0.01 
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4.3.10 DEC cells express transcript for selected growth factors and MMPs 
 
The cDNA samples from the same cell sort were then tested for expression of 
VEGF, Flk-1(VEGF receptor 2), MMP-9, HGF and PlGF by SQ-PCR (Figure 4.18).   
The two soluble isoforms of VEGF (VEGF120 and VEGF164) were identified in all of 
the cell samples but levels did not significantly differ between the 1x and 4x 
groups in either the eosinophil or macrophage samples.   However, the dendritic 
cell sample expressed significantly higher levels of both VEGF120 and VEGF164 
transcript in the 1x compared to the 4x group. The dendritic cell sample in the 1x 
group also contained significantly greater levels of transcript for the VEGF 
receptor, Flk1. Transcript for this receptor was also identified in both the 
macrophage and eosinophil samples of both groups of mice. In both the 
eosinophil and macrophage samples, the transcript was more abundant in the 4x 
group, although the difference was only significant in the macrophage 
population.   
In the transcript analysis of whole pinnae (Section 3.3.12), HGF and PlGF were 
significantly up regulated only in the 4x group following infection.  Here, 
transcript for HGF did not differ between the 1x and 4x groups in either the 
dendritic cell or the macrophage samples.  However, expression was elevated 4-
fold in the eosinophil sample from 4x mice, and was significantly greater than in 
the 1x group.   Conversely, PlGF transcript was most abundant in the 
macrophage sample from 4x compared 1x mice.  PlGF was undetectable in the 
dendritic cell and eosinophil samples from both 1x and 4x mice.  
MMP-9 transcript was un-detected in all of the cell samples from 1x DEC but was 
found in all samples from 4x DEC, particularly the eosinophil sample which was 
significantly higher compared to the dendritic cell and macrophage samples from 
4x mice (p<0.01). 
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Figure 4.18 Analysis of growth factor and MMP9 expression by sorted 
DEC  
 
A: VEGF120, B: VEGF164, C: Flk-1, D: PlGF, E: HGF, F:MMP-9. Transcript 
expression in the sorted DEC samples; 1x and 4x day 2 post infection. n=3 
seperate experiments each consisting of 15 biological replicates pooled 
for 1x and 4x. Statistics are the 4x and 1x groups compared for each cell 
type mean +SEM. *p<0.05, **p<0.01 and ***p<0.001. 
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4.4 Discussion 
 
4.4.1 Overview 
This chapter has shown that there is a difference in the predominant cytokines 
produced in the skin between 1x and 4x infections. The 4x pinnae contain 
elevated levels of IL-4, IL-13 and IL-10 compared to 1x. This coincides with an 
increase in the number of cells in fluxing into the 4x pinnae with the majority of 
these being eosinophils. The macrophages and eosinophils of the 4x produce 
higher levels of transcript for the growth factors identified, although dendritic 
cells down regulated VEGF in the 4x pinnae and appeared less angiogenic.  
As shown in Chapter 3, there were focal influxes of cells into the dermis of the 
pinnae following infection.  Here, it was shown that there was a significant 
increase in the number haematopoietic cells recruited into the 4x compared to 
the 1x pinnae. The majority of these cells were recoverable as DEC, with only a 
few remaining in the skin tissue after overnight culture. The lineage and 
functional phenotype of the cells recruited can determine both the immune and 
angiogenic response to the infection. 
 
4.4.2 Cytokine balance in the skin 
 
Recruitment and persistence of leukocytes in tissue sites is dependent on the 
cytokine and chemokine release. It had already been established, that after 
multiple infections the initial skin response switches to a predominately Th2-type 
environment in the 4x pinnae characterised by high levels of IL-4, IL-10 and IL-13 
(Cook 2011).  The array and subsequent cytokine ELISAs performed in this 
chapter confirm this observation. The up-regulation of IL-4 and IL-13 are 
associated with fibrosis and IL-4 in particular can activate fibroblasts to produce 
collagen (Salmon-Her 2000). It is probable that the IL-4 and IL-13 produced are 
acting not only on the cells of the immune system but also on the cells of the 
skin. The pro-inflammatory cytokines such as IL-12, IL-1β and TNFα were up 
regulated in both the 1x and 4x groups. All three are associated with wounding 
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and are typically produced early in response to damage (Hübner 1996). As there 
was no difference in the expression of either IL-1β or TNFα between the 
infection groups, this suggests that the release of these cytokines is an 
immediate innate response to the damage to the cells of the skin; keratinocytes 
and fibroblasts (Albanesi 2005), and as such not influenced by the repeated 
exposure to the cercariae. One cytokine not analysed here is TGFβ, which is 
expressed almost immediately upon wounding and has significant effects on the 
immune system. TGFβ1 induces re-epithelialisation and stimulates angiogenesis 
(Roberts 1986). Although not shown here a small experiment was done to test 
the levels of bioactive TGFβ1 within the skin 2 days post infection. The results of 
which showed a small increase between naïve and 1x and again between 1x and 
4x although none of the differences were significant as only two samples were 
tested for each group.  
 In addition to the cytokines quantified by ELISA two additional factors were up 
regulated after infection, more in the 4x, CXCL13 and IL-16.  Both of these are 
potent chemoattractants with CXCL13 being specific for B-cells whilst IL-16 
recruits CD4+ cells including eosinophils. The increase of CXCL13 was surprising 
as no B-cells were detected in the skin in either the 1x or 4x. However CXCL13 
has been significantly correlated with active cutaneous vasculitis and correlates 
with blood vessel damage and inflammation in Hepatitis C infected patients 
(Sansoono 2008). Within the schistosome model presented here CXCL13 may be 
acting in a similar way causing dis regulation of the blood vessel growth rather 
than B-cell recruitment. IL-16 can be released by the basal cells of the epidermis 
and throughout the dermis, and like CXCL13 can be up-regulated in inflammatory 
skin diseases (Laberge 1998).  There is evidence that IL-16 can promote IL-4 
release from eosinophils (Bandeira-Melo 2002), which could present an earlier 
driver of the eosinophil recruitment and IL-4 release in the 4x pinnae in this 
model.  
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4.4.3 The neutrophil influx was not altered between 1x and 4x infections. 
 
The initial cell type recruited to wounds is the neutrophil, here it functions to 
provide a first line of defence against micro-organisms entering the wound site 
(Kim 2008). In addition, neutrophils have also been proposed as potential 
initiators of the angiogenic cascade mainly through the release of preformed 
VEGF within their granules (Gaudry 1997), and the release of MMP-9(Ardi 2007). 
Within this infection, the neutrophils were recruited to the same extent in both 
infections with a peak of recruitment at day 1 and declining over the time course. 
This suggests that following both 1x and 4x infection the initial penetration of the 
cercariae is stimulating the same wound healing mechanisms and is unaffected 
by the previous exposure to the cercariae. However the phenotype of the 
neutrophils was not analysed in this study and it was therefore not determined 
whether the neutrophils are a source of VEGF or other growth factors in this 
model. Recruitment and persistence of further leukocytes in tissue sites is 
dependent on the cytokine and chemokine release of which neutrophils are an 
important source. They predominantly release chemokines and cytokines which 
aid in the recruitment of monocytes and macrophages to the tissue site (Scapini 
2000).   CCL2 in particular can be produced by neutrophils in high concentrations. 
This was up-regulated only in the 4x. This could suggest that whilst the number 
of neutrophils does not change between 1x and 4x infections the milieu of 
chemokines they produce might, which could influence the further recruitment 
of the leukocytes.  
 
4.4.4 4x macrophages express Arginase-1 and up-regulate PlGF compared to 1x 
 
The predominance of cytokines within a tissue site can control the phenotypic 
differentiation of the cells recruited (1.3.4.2). As shown IL-4, IL-13 and IL-10 were 
all up-regulated in the 4x pinnae. These high levels of IL-4 and IL-13 would be 
expected to lead to alternative activation of the macrophages within the 4x 
pinnae. The alternative/ classical axis is almost certainly an over simplification of 
the activation of macrophages which as recently discussed (Mosser 2008) are 
more likely to be able to take on a range of intermediate phenotypes which cross 
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these standard boundaries. Early (within hours) after infection it is likely that 
there are mixed populations of macrophages in the skin which are then activated 
to an alternative phenotype by the increasing Th2 cytokines. Indeed the 
macrophages in this study did not express particularly high levels of RELMα 
which is considered to be marker of alternative activation by IL-4/IL-13. The 
macrophages did express Arginase-1 and Ym1 and were phenotypically pro-
angiogenic in the 4x (Figure 4.18). Of the growth factors analysed the 
macrophages were the primary producers of PlGF in the 4x pinnae. PlGF can 
promote the survival of endothelial cells and tumour associated macrophages 
(Adini 2002). It is intrinsically linked with pathological angiogenesis and is 
expressed in inflammatory conditions in the adult body (Seaman 2007). PlGF was 
one of the growth factors significantly up regulated only in the 4x compared to 
the naïve. The data here suggests that this up-regulation could be partially if not 
solely due to the phenotype of the invading macrophages and resulting in 
inflamed and vigorous angiogenesis and perhaps the dysregulated branching 
seen in the 4x pinnae. 
Interestingly, delivery of PlGF into skin causes severe inflammation and oedema 
(Carmeliet 2001). It is possible that PlGF in this model is either causing or 
exacerbating the oedema seen in the 4x pinnae and causing persistent 
inflammation through expression by the recruited macrophages whilst 
additionally activating the PlGF receptor Flt-1 on endothelial cells.  
The macrophages also up regulated expression of the VEGF receptor; Flk-1. 
Whilst there was no difference in the expression of VEGF between the 1x 
macrophages and 4x macrophages the 4x pinnae are likely to be more responsive 
to the VEGF being produced by other cells in the skin. Flk-1 signalling can drive 
MMP production in macrophages and as seen MMP-9 is up regulated in the 
sorted macrophages of the 4x. COX 2, which drives the production of 
prostaglandins from arachadonic acid, is often up-regulated in inflamed tissues 
and is abundant in macrophages found in tumours and inflamed tissues (Nakao 
2005). The macrophages in the 4x express significantly higher levels of COX2 
enzyme consistent with the pro-inflammatory pro-angiogenic phenotype 
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hypothesised from the PlGF levels. Together these results suggest a more 
inflammatory macrophage phenotype expected with the high levels of MMP-9 
and PlGF likely to cause extensive remodelling.  The expression of these growth 
factors and phenotype may be dependent on one of several cytokines expressed 
in the skin. Knockout studies (See chapter 4 for IL-10-/-) of cytokines would allow 
aid in determining the cytokine or combination of cytokines responsible for the 
angiogenic activation of the macrophages in the 4x. Additionally 4x infection in 
macrophage deficient mice would allow the functional consequences of the 
macrophage derived PlGF to be determined.  
 
4.4.5 The majority of the 4x DEC are HGF expressing Eosinophils 
 
Alongside the high levels of monocyte and macrophage chemoattractants there 
was a noticeable increase within the 4x group of the eosinophil 
chemoattractants CCL11 (Eotaxin-1) and C5a. These both drive eosinophil 
recruitment and rolling and C5a in particularly aids attachment and 
transmigration of the eosinophils across endothelial cells (DiScipio 1999). In the 
4x group, eosinophils are the vast majority of the cells recruited to the pinnae 
and comprise ~45% of the DEC. 
The eosinophil has long been associated with helminth infections and varying 
opinions exist on the purpose and requirement of eosinophils for worm 
expulsion.  Whilst it has been shown that eosinophils are responsible for the 
death of the larvae of Onchocerca lienalis (Folkard 1996) ablation of eosinophils 
in other infections have little or no effect on the pathology. 
Indeed ablation of eosinophils does not affect any of the traditional measures of 
schistosomiasis pathology associated with the eggs (including granuloma size and 
worm burden) (Swartz 2006). But these studies did not look at the skin response 
or the effect of eosinophil loss on the levels of cytokines produced.  
The eosinophils have been shown to produce IL-13 (Cook 2011) and, as such, 
may be a vital source of this cytokine in propagating further alternatively 
activated responses. This cytokine production by eosinophils is heavily linked to 
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fibrosis and angiogenesis in asthma. Within this study eosinophils appear to be a 
significant source of both HGF and MMP-9. Eosinophils can directly modulate 
ECM production through their release of MMPs. Expression of MMP-9 has been 
found to aid eosinophil migration through basement membrane proteins and the 
ECM (Okada 1997). Production of this could be beneficial for the eosinophil 
infiltration into the skin but may also have the side effect of releasing ECM 
sequestered growth factors and initiating the MMP cascade in the dermis. This 
could be exacerbating the remodelling and destruction of the ECM of the 4x skin. 
Eosinophils are a significant source of angiogenic growth factors; VEGF, FGF2 and 
PDGF, have all been identified in the granules of the cells (Munitz 2004). They 
have been shown to promote endothelial cell proliferation in vitro and induce 
new vessel formation in chick membrane models. (Puxeddu 2005) Analysis of the 
growth factor expression revealed that the eosinophils produce HGF transcript 
and were the major contributors of HGF amongst the DEC cells. HGF mediates 
invasiveness and branching of the endothelial cells (Rosen 1997) and could be 
produced by the eosinophils to aid their own transit through the skin of the mice 
after 4x infections whilst inducing the angiogenic cascade as a by-product. HGF 
accelerates endothelial cell invasion and induces the cells to accumulate rapidly 
(Grant 1993).  The immature larvae of the intravascular lung worm 
Angiostrongylus cantonensis reside in the vessels of the brain and in humans 
cause eosinophilic meningitis and up-regulation of VEGF, MMP-9 and HGF (Tsai 
2009). All of these were found in this model and in other parasitic infections, 
including Strongylus vulgaris, indicating that induction of HGF and MMPs 
accompanied by eosinophil influxes may be a widespread phenomenon amongst 
vessel interacting parasites. As eosinophils comprise the majority of the cells in 
the 4x DEC the HGF they produce, if bioactive, could be cause of the 
dysregulated fine branching seen throughout the dermis of the 4x pinnae but not 
in the 1x.  
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4.4.6 Dendritic cells from 1x pinnae are more pro-angiogenic than those 
obtained from 4x pinnae. 
 
The other antigen presenting cell identified in the skin was the dendritic cell. This 
is the primary APC and it has been shown that MHCII is down regulated on the 
DCs after multiple infections (Cook 2011). As a percentage of the total DEC there 
was a reduction in the numbers of DCs identified, although this was not 
significantly different to the naïve. Activated dermal DCs will contribute to the 
inflammatory response in the dermis and migrate to the skin draining lymph 
nodes to present antigen (Steinman 2006). Like macrophages, dendritic cells are 
proposed to have alternative activation states (1.3.4.3). Tumour models have 
shown that high levels of VEGF expressed by tumours can down regulate MHCII 
on the surface of DCs effectively halting their maturation as effective APCs and 
increasing the tumour’s chance not to be detected (Gabrilovich 1998). In 
addition HGF also down-regulates MHCII on DCs and is protective in airway 
inflammation models (Rutella 2006). The increased expression of either VEGF or 
HGF or indeed both within the 4x whole pinnae could be down regulating the 
macrophage phenotype and may contribute to the down regulation of MHCII on 
DCs described in this model (Cook 2011). 
The cytokines to which the dendritic cells are exposed can dramatically alter 
their angiogenic potential (Riboldi 2005). In comparison to the eosinophils and 
macrophages, the most pro-angiogenic DCs were found within the 1x DEC. These 
expressed high levels of VEGF and Flk-1 which was down regulated in the DCs 
obtained from 4x pinnae. VEGF expression in dendritic cells is induced by pro 
inflammatory cytokine whilst activation of DCs by IL-10 causes limited up-
regulation of VEGF and up regulation of fibroblast growth factor antagonists 
(Riboldi 2005). The high concentration (~1000pg/ml) of IL-10 observed in the 4x 
pinnae may be causing this down regulation of VEGF expression. Conventional 
myeloid CD11c+ DCs express VEGF in the skin whilst plasmacytoid DCs fail to 
produce VEGF (Fiallo 2002). Within the DCs of the DEC there is a mixed 
population of CD11c+/hi and CD11c-/low these could represent two distinct 
populations in the skin. Further phenotyping of the cells may reveal a switch in 
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the predominance of the DC phenotype between 1x and 4x infections. Both 
growth factors produced by the skin cells and the cytokine balance appear to be 
affecting the activation of the DCs. While this appears unlikely to dramatically 
affect the angiogenesis seen following infection, it could have an impact on 
further downstream immune responses to the parasite something not explored 
in this thesis. 
 
4.4.7 Summary 
 
This chapter has confirmed that following multiple infections the cytokine 
balance in the skin switches to a predominantly Th2 phenotype with the up 
regulation of IL-4, IL-13 and IL-10.  It is concluded that the differences in blood 
vessel growth after 4x infections as shown in chapter 2, are likely due to the Th2-
type cytokine environment affecting the composition and phenotype of cells 
recruited to the infection site, and not a change in the initial intrinsic wound 
healing mechanisms. Pinnae from 4x mice showed a significant increase in 
eosinophils which had a pro angiogenic phenotype compared to pinnae from 1x 
mice. These p4x eosinophils produced higher levels of pro angiogenic growth 
factors and the remodelling protease MMP-9. Macrophages and dendritic cells 
also displayed different phenotypes between the 1x and 4 x infections. All three 
cell types produced the growth factors which differed between the 1x and 4x 
pinnae and as such could contribute to the differences in growth factors seen 
after each infection. In the next chapter, the role of IL-10 in determining 
phenotypic changes to these cells will be examined. There is mounting evidence 
that as well as influencing the levels of IL-4 and IL-13, IL-10 may directly induce a 
‘regulatory’ macrophage phenotype (Mosser 2008) 
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Chapter 5: Examining the influence of IL-10 in 4x 
pinnae 
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5.1 Introduction 
 
The previous chapter characterised the immune cell influx into the pinnae 
following infection, and the growth factors expressed by these cells. It is 
apparent that following multiple infections the phenotype of the cells which 
influx into the skin changes. Particularly the eosinophils, macrophages and 
dendritic cells all showed a change in their growth factor expression (4.3.10).  
Phenotypic changes in leukocytes depend on the cytokines to which they are 
exposed. The now well documented alternative and classical axis of 
macrophages is a prime example of the relatively large change in function the 
exposure to cytokines has on cells (1.3.4.2). 
Between the 1x and 4x infections it is the Th2 associated cytokines IL-13, IL-4 and 
IL-10 which change the most dramatically. IL-4 and IL-13 have close associations 
with alternative activation, particularly of macrophages (Gordon 2003). Whilst 
the function of IL-10 in repressing Th1 and promoting Th2 cytokine release is well 
known, it can also directly activate leukocytes (Dace 2008).   There is mounting 
evidence of a ‘regulatory’ phenotype of macrophage induced by exposure to IL-
10 (Mosser 2008). This phenotype does not produce ECM components but does 
express TGFβ which has a functional role in angiogenesis and wound healing 
(Edwards 2006). IL-10 stimulated macrophages have been implicated in cancer 
progression and express several pro-angiogenic growth factors (Lin 2006). As 
such, within the 4x infection it is possible that the high levels of IL-10 induce the 
pro-angiogenic phenotype in both the macrophages. IL-10 may also influence the 
other major cell types in the DEC. Indeed IL-10 can conversely in dendritic cells 
suppressing expression of VEGF (Riboldi 2005).  
IL-10 also has direct associations with wound healing and angiogenesis (Werner 
2003). It is expressed early after wounding (within 60 minutes), and again several 
days later by keratinocytes and invading monocytes (Ohshima 1998). However 
excess levels of IL-10 can impair wound healing and cause chronic ulcers 
(Lundberg 1998). The balance of IL-10 following wounding is therefore important 
in regulating the response and resolution of wounds. The high levels of IL-10 
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within the 4x pinnae may be responsible for the excessive vessel branching and 
poor state of the skin following infection. As such this chapter will explore the 
role of IL-10 in the 4x infection, in relation to both growth factor expression by 
leukocytes and angiogenesis in the dermis.   
To do this mice genetically deficient for Interleukin 10 (IL-10-/-) will be infected 
either 1x or 4x. The resulting pinnae will be analysed for the same markers of 
angiogenesis identified in Chapter 2. Additionally the DEC in both 1x and 4x will 
be examined for activation status and growth factor expression.   
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5.2 Materials and Methods 
5.2.1 IL-10 knock out mice 
 
IL-10-/- mice were kindly obtained from Dr M. Kullberg. These mice are 
backcrossed for 10 generations onto a C57BL/10 background and originally bred 
by W.Müller (Kühn 1993). Mice weighing approximately 20 grams and aged 7-9 
weeks were infected as previously described (2.1.1). Wild type (WT) C57BL/6 
controls were infected alongside the IL-10-/- mice. Due to limited numbers of 
mice only days 2 and 4 post infection were analysed. 
 
5.2.2 DEC retrieval and flow cytometry 
 
DEC were retrieved from whole pinnae using the in vitro cultured pinnae biopsy 
method (2.1.7). DEC retrieval and staining was carried out as detailed in 4.2.1 
and 4.2.2. In addition to the antibodies listed in table 4.1 the cells were labelled 
with αCD206/Mannose receptor (Alexa flour 647 conjugated # eBioRMUL.2)  
 
5.2.3 Cell sorting 
 
Pinnae were taken from 15 4x WT and 15 4x IL-10-/- mice at day 2 post infection. 
The DEC were extracted and stained for cell sorting as detailed in Chapter 4 
(4.2.1 & 4.2.3). Samples were analysed for cell surface expression of markers and 
by SQ-PCR for pro angiogenic growth factors. 
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5.3 Results 
 
5.3.1 IL-10-/- pinnae become inflamed and vessels more visible after infection 
  
Analysis in this section focuses only on IL-10-/- pinnae, the WT equivalents can be 
found in section 2.3.1. Naïve IL-10-/- mice had clearly visible thin vessels 
throughout their pinnae (Figure 5.1). The large central vessels were visible with 
one or two branch points. In 1x mice two days post infection the large central 
vessels appeared slightly dilated. These vessels were more obvious than in the 
naïve with two or three branch points visible (Figure 5.1). This was accentuated 
at day 4 and some of the vessels appeared convoluted. Vessels were also clearly 
visible on the inner surface of the pinna, whilst these were faint in naïve pinnae. 
In the 4x infected mice the vessels were considerably dilated and bright red 
(Figure 5.1). The surrounding tissue was red and scarred in several places. There 
were more branch points visible compared to the 1x. As with the WT mice 
(Figure 3.2) the 4x IL-10-/- vessels were visible at the terminal edge of the pinnae. 
At day 4 the pinnae were still inflamed and the vessels red and visible. Several 
fine ‘wispy’ vessels were visible and the vessels of the outer surface of the 
pinnae were pronounced. There were several scars and scabbed regions which 
were surrounded by fine networks of vessels. 
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5.3.2 The increases vasculature in 4x IL-10-/- is more organised than in 4x WT 
 
In WT mice the most obvious change to the naïve vasculature of the dermis was 
seen in the 4x mice (3.3.3).  To determine whether the loss of IL-10 would affect 
the number and structure of the vessels, naïve and 4x IL-10-/- pinnae were 
labelled with αCD31. The larger vessels of the pinnae were reasonably similar 
between WT and IL-10-/- , although the trunk vessels of IL-10-/- pinnae did not 
appear to be as wide as the WT (Figure 5.2A). Many of the vessels in 4x WT 
pinnae were distorted in shape, whereas in the 4x IL-10-/- these branches were 
predominantly straight and even (Figure 5.2 A). In the IL-10-/- there were bundles 
of small vessels, as seen in 4x WT (Figure 5.4), however these were not as 
numerous as in the WT (Figure 5.2 B). 
An entire vessel was imaged from the base of the pinna to the fine branches at 
the edge for both 4x IL-10-/- and 4x WT. In these images the irregular branching 
of the 4x WT was clear, with the smaller vessels highly distorted and tangled, 
whilst the 4x IL-10-/-   branches remained mostly regular. (Figure 5.2A). The vessel 
area in the 4x WT and 4x IL-10-/- pinnae was quantified (Figure 5.2C). There was 
no significant difference in the total vessel area in the 4x IL-10-/-  pinnae 
compared to the 4xWT, however there was a significant increase in the vessel 
area in the 4x IL-10-/-  compared to the naïve IL-10-/-  pinnae. 
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Figure 5.2 αCD31 labelled 4x IL-10-/- and 4x WT pinnae 
 
A: Composite images of whole vessels in both IL-10-/-  (top image) and 
WT (Bottom image) 4x pinnae 2 days after infection labelled with 
αCD31. B: Images from the edge (top panel) and mid (bottom panel) of 
4x day 2 WT and IL-10-/- pinnae. C: Analysis of the average area of 
αCD31 labelled vessels in each 920µmx920µm image. Each group is 35 
images taken over 3 pinnae. Mean + SEM, there is no significant 
difference between the WT and IL-10-/-  4x pinnae whilst both infected 
pinnae are significantly increased compared to the naïve (p<0.05). 
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5.3.3 Pinnae from IL-10-/- mice exhibit extensive cell influx and 
distortion after 4x infections 
In this and the following four sections (5.3.4-5.3.7), analyses were performed on 
IL-10-/- mice only, to focus on the responses in 1x compared to 4x infected mice 
sampled at day 2 and day 4 after infection.  Results were viewed in light of data 
acquired for WT mice in chapter 4. 
There was no significant increase in the thickness of the IL-10-/- pinnae at the 1x 
time points compared to the naïve, however the thickness increased significantly 
after 4x infections, at both day 2 and day 4 post infection, compared to both 
naïve and 1x time points (p<0.001). This was consistent with the observations 
made in the WT pinnae (Figure 3.3).  
H&E stained sections showed that naïve IL-10-/- pinnae are morphologically 
identical to WT naïve pinnae (Figure 3.3 B). With a thin epidermis and blood 
vessels spread evenly through an intact dermis. This confirmed that loss of IL-10 
had no effect on the skin morphology before infection.  
Within 1x pinnae there was an increase in the thickness of the dermis, 
particularly under regions where the epidermis was damaged (Figure 5.3C). 
There was a small increase in the thickness of the epidermis but only in patches 
along the pinnae. At day 2 after 1x infection there were clear cell infiltrates 
within the pinnae, these were spread throughout the dermis. There was also 
considerable scabbing on the outer edge of the epidermis. At day 4 these 
granulated areas were severe however the epidermis was already fully formed 
below the scabs visible. 
Within the 4x pinnae, at day 2, there was an excessive influx of cells, which were 
densely packed under the epidermis and caused distortion of the dermis (Figure 
5.3 C lower two panels). The epidermis had thickened across the entirety of the 
pinnae observed.  Many of the blood vessels were visible and enlarged, with 
some signs of haemorrhaging in badly damaged areas of the tissue. At day 4 the 
epidermis appeared mostly repaired, although the cell influx had not reduced 
 
 
137 
 
and the dermis was still swollen and distorted. There were dense layers of 
granular cells packed under the epidermis lying along the basement membrane 
and within the scabs of the 4x pinnae.  
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5.3.4 Pro-angiogenic growth factors were up-regulated after infection in IL-10-/- 
pinnae 
 
The VEGF120 and VEGF164 isoforms of VEGFA were expressed in both the 1x and 4x 
groups although VEGF188 was not detected (Figure 5.4 A&B). Infection induced a 
significant increase in both isoforms at day 4 post 1x and 4x infections compared 
to the naïve (1x d4 p<0.05 and 4x d4 p<0.01 for both VEGF120 and VEGF164). There 
was no significant difference in VEGF expression between the 1x and 4x groups 
and both showed an increase in VEGF between days 2 and 4. 
In comparison to VEGF, HGF did show a difference between 1x and 4x at day 2.  
4x IL-10-/- pinnae 2 days post infection expressed significantly higher levels of 
HGF transcript compared to the equivalent 1x pinnae (p<0.05) (Figure 5.4 C). All 
time points except day 2 of the 1x infection were significantly increased 
compared to the naïve (p<0.01). FIGF was significantly up regulated only at day 4 
post infection in both the 1x and 4x compared to naïve (p<0.01) (Figure 5.4 D). 
There was no significant difference between the two infection groups at either 
day 2 or day 4 post infection.  
MMP-9 showed a steady increase in expression between day 2 and day 4 in the 
1x pinnae, and at day 2 this increase was significant compared to the naïve 
(p<0.001) (Figure 5.4 E). The levels of MMP-9 transcript were further increased in 
the 4x. At day 2 and day 4 post infection expression of MMP-9 was significantly 
increased compared to the naïve (day 2 p<0.05, day 4 p<0.001). In addition the 
expression of MMP-9 in 4x pinnae 4 days post infection was significantly higher 
than in the same 1x time point(p<0.05). 
PlGF was significantly up-regulated compared to the naïve in all four of the 
infection time points (1x day 2 p<0.05 1x day 4, 4x day 2 and 4x day 4 p<0.001) 
(Figure 5.4 F). Between the time points in each infection group there was little 
change in the expression of PlGF. However comparing each 1x and 4x time point 
there was significant up regulation of PlGF in the 4x at day 2 (p<0.05). 
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Figure 5.4 Pro-angiogenic growth factor expression in IL-10-/- pinnae 
cDNA from naïve, 1x day2 and 4 and 4x day 2 and 4 whole pinnae was 
analysed for each of the six growth factors below. The sample size for 
each group is 4 pinnae. Shown is the mean + SEM statistics are the 1x 
versus the 4x for each time point,*p<0.05. A: VEGF120. B: VEGF164 C: HGF 
D: FIGF E: MMP-9 F: PlGF. 
PlGF 
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5.3.5 Infection induces a significant influx of cells into the dermis 
 
In both the 1x and 4x infections there are signficantly more DEC when compared 
to the naïve (1x d2 and 4x d4 p<0.01, 1xd4 and 4xd2 p<0.001). There was no 
signficant difference between the timepoints in either the 1x or 4x groups. This 
differs from the WT which showed a decrease of almost half between the day 2 
and day 4 timepoints of the the 4x infection (4.3.3). There were however 
signficantly more cells in the 4x groups at both timepoints compared to the 1x 
equivalent, consistent with wild type observations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 DEC cell counts from IL-10-/- whole pinnae  
DEC cell numbers were calculated per pinnae from 5 
pinnae per group. Stats shown are the 1x and 4x time 
points compared. Mean +SEM *p<0.05 and **p<0.01 
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5.3.6 4x IL-10-/- DEC contains significantly more eosinophils than 1x 
 
With limited mice available DEC analysis was restricted to the main cell types 
identified in the WT mice; eosinophils, macrophages/monocytes and dendritic 
cells. Similar to the WT (4.3.4) 80-90% of the DECs from the IL-10KO pinnae were 
CD45+ (Figure 5.6 A). There was no significant difference in the percentage of 
CD45+ cells between any of the groups. 
Of these CD45+ cells the majority appeared to be macrophages and eosinophils. 
The percentage of macrophages in the DEC peaked at ~20% day2 after a single 
infection and was a similar percentage at day 4 (Figure 5.6C). This was a 
significant increase compared to the naïve at both day 2 and day 4 (p<0.001). 
The percentage of macrophages in the 4x was also significantly increased 
compared to the naïve but only at day 2 (p<0.01). By day 4 the percentage of 
macrophages had decreased.  
The eosinophils were the majority of the DEC in the WT pinnae and similarly in 
the IL-10-/- pinnae, ~30% of the DEC were eosinophils at day 4 after 4x infection 
(Figure 5.6D). There were significantly more eosinophils in the 4x compared to 
the naïve (day 4 p<0.001, day 2 p<0.01) and 1x (shown on graph Figure 5.6D). 
There were considerably fewer eosinophils in the 1x pinnae at days 2 and 4, 
although day 2 had a significantly higher percentage of eosinophils than the 
naïve (p<0.001).  
The dendritic cells, which made up a much smaller percentage of the wild type 
DEC, were again only a small proportion of the IL-10-/- DEC. Only 1x DEC at day 4 
showed a significant increase in the percentage of dendritic cells compared to 
the naïve (p<0.01).  
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Figure 5.6 – Flow cytometric analysis of DEC 
from IL-10-/- pinnae 
 
A: CD45+ cells, there was no significant 
difference between the infection time points 
however 1x day 2 and both 4x points are 
significantly higher than the naïve (p<0.01 
for all ). B: Representative plots of the cell 
populations identified by F4/80 and MHCII. 
Cells were selected in the three gates as 
shown on the naïve 1 – Dendritic cells, 2- 
Macrophages, 3- Eosinophils and verified 
with further labelling (not shown). C-E: 
Graphical representation of the percentages 
of macrophages, eosinophils and dendritic 
cells in the DEC. 
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5.3.8 Th2 cytokines are reduced in IL-10-/- supernatants 
 
Cytokine levels in the whole pinnae overnight culture supernatants were 
determined by ELISA, to ascertain the Th1/Th2 balance in the skin of IL-10-/- mice 
(5.2.12). In contrast to the WT data in chapter four (4.3.2) several of the 
cytokines analysed here were undetectable in either one or more groups 
(Figure4.7). 
IL-4 expression was restricted to only the 4x samples and was below the level of 
detection in both the naïve and 1x pinnae (Figure 5.7 A). This expression was 
similar to the WT (4.3.2 Figure 4.2E), however some IL-4 was detected in the 1x 
infected WT mice whereas 1x IL-10-/- supernatants contained no detectable IL-4. 
The concentration of IL-4 in the 4x was high at day 2 and decreased by ~50% by 
day 4 
Whilst IL-4 expression was similar to the WT, IL-13 was undetectable in all but 
one of the IL-10-/- groups (Figure 5.7 B). A small amount of IL-13 was detectable 
in the 4x pinnae at day 4, although this is only just above the minimum level of 
detection. In contrast IFNγ, which was undetectable in the WT mice, was 
expressed above the minimum level of detection in 4 of the 5 IL-10-/- groups 
(Figure 5.7C). IFNγ was detected at day 4 in the 1x infection, whilst day 2 was 
below the level of detection. In the 4x however IFNγ was detectable at both day 
2 and day 4 post infection and was significantly increased at day 2 compared to 
the 1x. Both time points were significantly increased compared to the naïve 
(p<0.05).  
IL-12 was detected in the 1x and absent in the 4x supernatants (Figure 5.7D). The 
1x infected showed little difference compared to the naïve at day 2. However at 
day4 the concentration was increased, although this was not quite significant 
compared to the naïve (p=0.061). In comparison TNFα was detected in all 
infected groups and was expressed at significantly higher levels than the naïve 
(1x d2 and 4x d2 p<0.001, 1x d4 p<0.05 and 4xd2 p<0.01) (Figure 5.7E). Between 
the time points in the 1x and 4x groups TNFα dropped slightly. There was 
significantly more TNFα in the 4x at day 2 compared to the 1x (p<0.01). 
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Figure 5.7 Cytokine concentrations in 
IL-10-/- whole pinnae supernatants 
Supernatants from 5 pinnae per group 
graphs show the mean +SEM, statistics 
are the 1x vs 4x for each time point. 
**p<0.01, ***p<0.001. A: IL-4 B: IL-13 C: 
IFNγ D: IL-12 E: TNFα  
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5.3.8 4x IL-10-/- pinnae contain increased levels of HGF and VEGF compared to 
WT 
 
The WT 4x pinnae contained the most IL-10 and it is therefore within this group 
that IL-10 is likely to have the greatest effect. To more accurately determine the 
effect loss of IL-10 has in the pinnae, WT and IL-10-/- pinnae were directly 
compared after 4x infection. Sections 5.3.8 - 5.3.12 contain results comparing 
growth factors and immune cell phenotype between 4x WT and 4x IL-10-/-mice.  
Expression levels of VEGF120 and VEGF164 were significantly increased in the         
IL-10-/- compared to the WT at both day 2 and day 4 after infection (p<0.05) 
(Figure 5.8 A&B). The expression of both VEGF isoforms did not change 
significantly between the time points in either the IL-10-/- or WT pinnae. In 
contrast levels of PlGF did differ between days 2 and 4 (Figure 5.8C). PlGF 
expression decreased significantly (p<0.05) at day 4 compared to day 2 in both 
the WT and IL-10-/-. This trend is consistent with the data previously analysed of 
both the WT and IL-10-/- time courses (3.3.12 & 5.3.4). There was no significant 
difference in expression of PlGF between the WT and IL-10-/-. 
HGF did differ between the IL-10-/- and WT groups, but did not change over the 
time course (Figure 5.8D).  Expression of HGF was significantly increased at both 
day 2 and 4 post infection in the IL-10-/- pinnae compared to the WT (p<0.05). 
Comparison of the time points within the infection showed no change in HGF 
between day 2 and 4.  
HGF and VEGF were also analysed by ELISA to determine protein levels of the 
genes (Figure 5.8 E&F). VEGF protein levels were significantly higher in the WT 
pinnae compared to the IL-10-/- (Figure 5.8E). VEGF levels remained consistent 
between days 2 and 4 in both infection groups. This is in contrast to the 
transcript analysis which showed higher levels of both VEGF isoforms in the        
IL-10-/-, although the difference between WT and IL-10-/-  in VEGF120, the primary 
isoform the ELISA detects, was not as great as for VEGF164 .  
As identified in the transcript, HGF was significantly up regulated in the IL-10-/- 
group compared to the WT. Protein levels peaked at day 2 in both the WT and 
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the IL-10-/- pinnae (Figure 5.8 F). There was significantly more HGF protein at       
IL-10-/- day 2 than WT day 2, however there was no difference between the WT 
and IL-10-/- at day 4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B A 
C D 
E F 
Figure 5.8 Comparison of growth factor expression between 4x WT and 
4x IL-10-/- 
A-D Transcript analysis of four genes  VEGF120, VEGF164,  PlGF and HGF . E-F 
Protein analysis of HGF and VEGF. Sample size is 5 pinnae per group 
statistics shown are 1x vs 4x for each time point. Graphs are mean +SEM 
for both transcript and protein analysis *p<0.05, **p<0.01 and 
***p<0.001. 
 
PlGF 
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5.3.10 IFNγ is up regulated in IL-10-/- pinnae  
 
Interleukins 4 and 13 and IFNγ varied the most between WT and IL-10-/- pinnae 
therefore these three were chosen for direct comparison analysis.  
The concentration of IL-4 in the IL-10-/- and WT supernatants was almost 
identical at both days 2 and 4 (Figure 5.9 A). Both groups showed a peak of 
expression at day 2, which was reduced to approximately a fifth of the 
expression by day 4. Whilst the average concentration of IL-4 in the IL-10-/- was 
slightly higher than the WT at day 4 this was not significant, neither was the 
concentration at day 2. In contrast IFNγ, which was previously shown to be un-
detectable in the WT (4.3.2) was significantly increased in the IL-10-/- (Figure 
5.9B). In the IL-10-/- at both day 2 and day 4 the expression of IFNγ was 
significantly higher than in the WT.  
The reverse was observed for IL-13, which was the predominant Th2 cytokine in 
the 4x wild type (Figure 5.2F). In the 4x IL-10-/- IL-13 is undetectable at day 4 and 
barely detectable at day 2. The average levels are only just above the minimum 
level of detection (Average = 65pg/ml minimum level of detection = 60pg/ml).  
 
 
 
 
 
 
 
 
 
 
Figure 5.9 Comparison of IL-4, IL-13 and 
IFNγ concentrations between WT and        IL-
10-/- 
A: IL-4, B: IFNγ, C: IL-13 Cytokine 
concentration determined by ELISA. Sample 
size is 5 pinnae per group shown is the mean 
+SEM. Statistics are 1x vs 4x for each time 
point  *p<0.05 and ***p<0.001. 
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4.3.11 Macrophages and Eosinophils from IL-10-/- DEC show reduced expression 
of Ym1 and RELMα respectively 
 
In Chapter 3 the DEC was sorted to produce pure populations of macrophages, 
eosinophils and dendritic cells (4.3.9). Here DEC from 4x WT and 4x IL-10-/-  
pinnae was sorted into the three cell populations. Due to limited numbers of 
mice only day 2 DEC was sorted, as after this time point the numbers of WT DEC 
decline (4.3.3). The sorted WT and KO cells were analysed by Q-PCR for 
expression of the three alternately activated macrophage associated markers; 
Ym1, RELMα, Arginase and classical marker iNOS (Figure 5.10) 
In the IL-10-/- macrophages there was a reduction in arginase expression 
compared to the WT by ~25% (Figure 5.10A). Expression remained the same in 
dendritic cells, however IL-10-/- eosinophils showed a small increase in arginase 
expression compared to the WT. iNOS was reduced in the IL-10-/- macrophages 
compared to WT whilst in contrast expression was up-regulated in IL-10-/-  
dendritic cells (Figure 5.10B). 
Ym1 is induced in WT macrophages whilst in the IL-10-/- samples the level of Ym1 
was severely decreased and expression was barely detectable (Figure 5.10C). 
Ym1 was also reduced in the IL-10-/- eosinophils. RELMα, which is expressed by 
the eosinophils in the WT samples and at low levels by macrophages, was almost 
absent in IL-10-/- eosinophils (Figure 5.10D). RELMα expression in IL-10-/- 
macrophages was barely detectable.  
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Figure 5.10 Alternatively activated macrophage markers in sorted IL-
10-/- DEC 
 
Total DEC from 15 mice was pooled to produce enough cells to sort. A: 
Arginase-1, B: iNOS, C: Ym1 and D: RELMα 
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5.3.12 Macrophages and dendritic cells in IL-10-/- DEC expressed more PlGF than 
WT. 
 
To determine whether IL-10 signalling causes growth factor production by DEC, 
transcripts of the sorted cells were analysed for pro-angiogenic growth factors. 
VEGF120 and VEGF 164 were detected in all three cell types, in both the WT and IL-
10-/- groups (Figure 5.11A&B). Expression of either VEGF isoform did not differ 
greatly between the WT and IL-10-/- eosinophils.  However VEGF expression by 
both macrophages and dendritic cells was up regulated in the IL-10-/- compared 
to the WT. Within the IL-10-/- samples the macrophages expressed the highest 
levels of both VEGF120 and VEGF 164.  
Two MMPs were also analysed; MMP-9 and 19 (Figure 5.11 C&D). MMP-9 
expression was increased slightly in IL-10-/- eosinophils and macrophages, 
compared to their WT counterparts, whilst levels did not change in the dendritic 
cells. Macrophages produced much higher levels of MMP-9 transcript than either 
the eosinophils or dendritic cells in both WT and IL-10-/-. MMP-19 expression was 
similar, however unlike MMP-9 there was an increase in MMP-19 in the IL-10-/- 
dendritic cells compared to the WT. In addition MMP-19 was slightly down 
regulated in the IL-10-/- eosinophils compared to WT. 
HGF expression, in contrast, was increased in IL-10-/- eosinophils compared to 
WT. In IL-10-/- macrophages and dendritic cells HGF expression was down 
regulated slightly (Figure 5.11E). PlGF, which was previously detected only in WT 
macrophages, was detected in the IL-10-/- macrophages but also in IL-10-/- 
dendritic cells (Figure 5.11 F). Expression of PlGF increased substantially in the IL-
10-/- macrophages compared to the WT.  
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Figure 5.11 Pro-angiogenic growth factor and MMP expression by sorted KO 
and WT DEC 
  
A: VEGF120 , B: VEGF164, C: MMP-9, D: MMP-19, E: HGF and F: PlGF. Samples 
are from sorted DEC of 15 pooled biological replicates.  SQ-PCR was used to 
determine the expression of the genes. 
PlGF 
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5.4 Discussion 
5.4.1 Overview 
 
In this chapter it was shown that loss of IL-10 leads to the increased production 
of various angiogenic growth factors after a single infection and that after 
multiple infection the pinnae of 4x IL-10-/- mice had significantly enhanced levels 
of both VEGF and HGF. There was also a significant increase in the cell influx into 
the pinnae of 4x IL-10-/- mice which was composed mainly of neutrophils.  It was 
also found that eosinophils and macrophages from these mice expressed 
increased levels of pro-angiogenic growth factors, whilst dendritic cells began 
expressing VEGF and PlGF. 
 
5.4.2 The vasculature in IL-10-/- pinnae was increased, but displayed a more 
organised morphology. 
 
The outward appearance of pinnae in IL-10-/- mice was similar to that of WT mice, 
with no discernible difference between naïve and 1x pinnae. After a single 
infection the vessels were more visible, consistent with observation of 1x WT 
pinnae and the vessels remained organised with no excessive scabbing or 
distortion.  After multiple infections the vessels became more visible and 
appeared thicker, similar to pinnae in 4x WT mice. However unlike the WT skin, 
shown in chapter 2, there was more scarring and scabbing discernible in the IL-
10-/- pinnae.  IL-10 is expressed rapidly in wounds, and transcript for IL-10 is up-
regulated within 60 minutes (Ohshima 1998). IL-10 has been suggested as a 
marker for wound vitality and can be detected as late as 10 days after wounding 
(Sato 1999). Here, loss of IL-10 in the 4x pinnae appears to result in reduced 
maturation and remodelling of the wounds leading to the distinctive scarring 
seen externally.  
Anti CD31 labelling revealed that, as in WT pinnae, there was an increase in the 
area of the vessels in infected IL-10-/- mice compared with naïve cohorts.  
However compared to the WT pinnae, the vessels remained ‘neat’ and not 
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distorted.  In fact, the increase in vasculature in 4x IL-10-/- pinnae was more 
organised and controlled, perhaps indicating that in 4x WT pinnae one of the up 
regulated growth factors, identified in chapter 2, causes excessive growth and 
vessel distortion. One candidate growth factor may be VEGF188 which ordinarily 
controls directional growth of new vessels (Ruhrberg 2002) and which in IL-10-/- 
pinnae is absent. Thus in 4x WT mice, where an abundance of this factor is 
observed, this may be the cause of the tangled excessive growth.  
 
5.4.3 Expression of pro-angiogenic growth factors in whole IL-10-/- pinnae 
 
Analysis of the whole pinna ensures that the entire composite cell population, 
such as keratinocytes and fibroblasts as well as in fluxing haematopoietic 
immune cells, were included during sampling.   The levels of pro angiogenic 
growth factors in the 4x IL-10-/- pinnae peaked later than in 4x WT pinnae and, 
with regards to HGF and VEGF, the transcript was more abundant. To better 
elucidate the dynamics of growth factor expression, a longer time course would 
be essential but not feasible within this project.  In addition, analysis of the 
angiopoietin expression (Ang1, Ang2) and measurement of vascular leakage as 
determined in Chapter 2, would also be essential to determine the speed of 
maturing vasculature. Unfortunately, limited numbers of IL-10-/-  mice made 
performing such assays impossible in this study. 
Infected 1x IL-10-/-  pinnae exhibited a significant increase in the expression of 
several growth factors identified in WT pinnae compared to naïve samples, most 
noticeably HGF which was not up-regulated in 1x WT pinnae.  Since IL-10 was not 
produced in abundance in 1x WT pinnae, its absence in 1x IL-10-/- pinnae was not 
expected to affect the growth factor levels.  However, it would appear that 
either IL-10 directly, or a downstream gene activated by IL-10, restricts growth 
factor expression in WT mice.  Indeed, since keratinocytes produce IL-10 at 
wound edges to promote the resolution and maturation of wounds, loss of this 
function may increase the release of growth factors and induction of 
angiogenesis by the fibroblasts (Sato 1999).  
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Direct comparison between the 4x WT and 4x IL-10-/- tissue samples 
demonstrated that the cytokine deficient mice produced more VEGF and HGF 
transcript but similar levels of PlGF. This suggests that IL-10 does not affect all 
angiogenic pathways activated in the schistosome infected pinnae.  As HGF was 
up-regulated in 4x WT pinnae where IL-10 was abundant, one hypothesis might 
be that loss of IL-10 could reduce HGF expression. However, the opposite 
situation was observed.  
The loss of IL-10 could affect skin resident cell populations. Digest and analysis of 
the epidermal and dermal layers without the DEC would be needed to determine 
the relative contribution of fibroblasts and/or keratinocytes to the change in 
growth factors.  
 
5.4.4 Changes in the cytokine profile of IL-10-/- pinnae 
 
The profile of cytokine production in the absence of IL-10 was similar to that 
detected in WT pinnae apart from with respect to IL-13 and IFN-y.  After 4x 
infections, IL-4 remained elevated, although IL-13 was undetectable and IFNγ 
was detectable. Regulation of IFN-y has been shown to be dependent on IL-10 in 
S.mansoni infections, particularly at the granuloma stage (Gazzinelli 1992). IL-10 
inhibits the expression of IFN-y by T-cells and subsequently prevents it’s 
activation of macrophages. The increased levels of IFN-y could be altering the 
activation status of the macrophages and explain the reduced Ym-1 expression 
seen in the IL-10-/- DEC. Although it is unknown which cell type is now producing 
the IFN-y it could be the small population of CD4+ lymphocytes detected in the 
DEC (not shown). One of the main sources of IL-13 in the WT 4x pinnae is the 
eosinophil (Chapter 4). Loss of IL-10 may have directly affected the eosinophil 
phenotype or the IL-13 expression of skin resident cells including mast cells 
(Gessner 2005). Unfortunately mast cell levels were not determined in this 
chapter due to limited availability of IL-10-/- tissue. Analysis of WT and IL-10-/- skin 
after the removal of DECs would aid to determine the source of these cytokines.    
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5.4.5 Changes in cell recruitment in IL-10-/- pinnae  
 
Cell recruitment to skin sites of inflammation in IL-10-/- mice appears to be 
associated with accelerated wound healing and is characterised by rapid re-
epithelisation and high infiltrates of cells into the skin (Eming 2007).  The pinnae 
of IL-10-/- mice infected with RA cercariae exhibit increased cell influx compared 
to WT mice and elevated levels of IL-12 and IFNγ (Hogg 2003 (b)). The data 
presented here shows that infected IL-10-/- mice  had significantly higher 
numbers of DEC than WT mice, and these persist at a high level to day 4.  
The proportions of different types of leukocytes present in DEC from IL-10-/- mice 
was markedly different from WT mice.   The number of eosinophils and dendritic 
cells were reduced in IL-10-/- mice whilst neutrophils were significantly more 
abundant. The available evidence demonstrating that IL-10 controls cell 
recruitment by IL-10 is conflicting.  For example, using IL-10-/- mice in models of 
asthma, the absence of IL-10 was reported to increase IFNγ expression and 
reduce levels of IL-5 and eosinophilia but without effecting levels of IL-4 (Yang 
2000). In contrast, over expression of IL-10 in a different asthma model, lead to 
reduced eosinophilia and IL-4 (van Scott 1999).  The data shown here is more in 
agreement with the IL-10-/- model of asthma.  
 
Neutrophil numbers were significantly increased in IL-10-/- compared to WT mice. 
Experimental administration of exogenous IL-10 to cutaneous wounds inhibits 
the infiltration of both neutrophils and macrophages to the wound site (Sato 
1999).  Therefore loss of IL-10 in the multiple schistosome infection model may 
release this control allowing excessive neutrophil influx.  However, an increase in 
the numbers of macrophage was not observed in the present study.  
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5.4.6 Phenotypic changes in IL-10-/- DEC  
 
IL-10 directly influences VEGF expression by macrophages, particularly in hypoxic 
conditions (Dace 2008). In ischemia induced angiogenesis in rat corneas there 
was excessive vessel growth which was induced buy VEGF positive macrophages. 
In the absence of IL-10 these macrophages did not promote excessive vessel 
growth and did not up regulate VEGF (Dace 2008). However, according to the 
data shown in this chapter, macrophages worked in the opposite way, with 
higher levels of PlGF and VEGF transcript in 4x IL-10-/- macrophages.  
 
The activation of macrophages is particularly plastic and can be influenced by the 
balance of a number of cytokines (1.3.4.2). Recent reviews have suggested IL-10 
may directly induce a “regulatory” phenotype or up-regulate IL-4/13 which in 
turn induces an alternative phenotype (Mosser 2008). To elucidate which 
cytokines drive the alternative activation phenotype in the 4x WT pinnae the 
three AAmac markers - Arginase, Ym1 and RELMα and also the classical marker 
iNOS were analysed in the sorted DEC populations.   Arginase expression in 
infected IL-10-/- macrophages was only reduced by ~25% compared to WT 
pinnae, although iNOS and Ym1 expression were almost completely ablated. This  
differential patterns of expression of arginase and Ym1, which would 
conventionally be expected to be co-expressed, may suggest that arginase-1 
expression is controlled by IL-4 mediated activation, whilst IL-10 or IL-13 are 
responsible for the stimulation of Ym1 expression.  
 
Macrophages from the pinnae of IL-10-/- mice produced slightly elevated levels of 
growth factors which is contrary to the hypothesis that IL-10 induces a more pro-
angiogenic phenotype. It would appear that the up regulation of IL-4, IL-13 or IL-
10 in the 4x WT mice, induces up regulated levels of transcript for pro-angiogenic 
growth factors in DEC but loss of IL-10 does not completely ablate this 
phenotype. This would suggest that IL-4 is the primary cytokine involved in 
controlling the up-regulation of pro-angiogenic factors in macrophages. Multiple 
infections of IL-4R-/- mice have shown that arginase-1 expression in 4x 
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macrophages is reduced to 1x levels (Cook 2011) and analysis of these cells for 
angiogenic mediators may show more of a reduction in growth factor expression 
than in IL-10-/- mice.  Loss of IL-10 however did affect the levels of PlGF which 
was up-regulated considerably more in the 4x IL-10-/- compared to WT 
macrophages. As PlGF is primarily induced in inflammatory conditions, it is 
possible that loss of IL-10 and the subsequent up regulation of IFNγ or TNFα, 
induces expression of PlGF by macrophages.  
 
 
RELMα which was largely expressed by eosinophils, was also much reduced in 
the IL-10-/- compared to WT mice. The transcript levels in eosinophils of the 
growth factors analysed did not change dramatically with the exception of HGF 
which was increased by 50%. This indicates that eosinophils recruited in the 
presence of IL-10, or a downstream IL-10 effector molecule, can alter the 
phenotype of eosinophils either before or upon entry into the skin. Eosinophils 
cultured in cytokines and chemokines derived from macrophages induced 
growth factor expression and it was shown that IL-10 can up-regulate HGF 
expression in eosinophils (Kobayashi 2009).   
 
Dendritic cells were more pro angiogenic in IL-10-/- than WT mice consistent with 
the hypothesis that IL-10 activation of dendritic cells in the 4x pinnae inhibits 
their maturation and VEGF expression. Dendritic cells from IL-10-/- mice 
expressed slightly higher levels of VEGF and transcript for PlGF. The pro-
angiogenic potential of dendritic cells is conflicting. The exact contribution of 
these PlGF expression dendritic cells was not investigated in this work but 
several studies have implicated them in exacerbating tumour growth and 
becoming part of new blood vessels (Fainaru 2010, Conejo-Garcia 2005).  
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5.4.7 Summary 
 
The results in this chapter highlight the complex nature of cytokine interaction 
and composition of leukocytes in and the skin cell response. Vessel growth was 
affected by the loss of IL-10 but not through a reduction in vessels. Instead the 
number of vessels was increased but appeared more organised and mature than 
in 4x WT pinnae.  The angiogenic phenotypes of all three major constituent cell 
populations comprising DEC were affected by the loss of IL-10.  However, IL-10 
does not appear to be the major stimulator of angiogenic factors in macrophages 
as initially thought,  IL-4 expression was unaffected by the loss of IL-10 indicating 
it is probably produced by a cell of the skin, for example mast cells or 
keratinocytes (Enk 1992),which is unaffected by the presence of  IL-10.    
In addition to cytokine environment of the skin, uptake of the parasite antigens 
may influence the phenotype of constituent cells. In the next chapter, the direct 
effect of larval parasite secretions on leukocytes and vascular endothelial cells 
will be determined, and will be related to the development of an angiogenic 
phenotype and de novo vessel growth. 
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Chapter 6: Investigating the pro angiogenic potential 
of cercarial secretions (0-3hRP) 
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6.1 Introduction 
  
The majority of this thesis has focused on characterising the angiogenic response 
following either a single or multiple infection through examination of both the 
vessels in the skin, and the influx of haematopoietic cells. This final chapter will 
focus on determining whether the cercarial secretions themselves induce 
angiogenesis.  
Upon penetration of the skin, cercariae release the contents of their acetabular 
glands. These are thought to aid the transit of the schistosome larvae through 
the skin, and perhaps its entry into the vasculature (McKerrow 2002).  These 
secretions, within the first 3 hours after transformation, can be collected and are 
termed the 0-3 hour released preparation (0-3hRP). They consist primarily of 
proteases but also several glycans and other protein and carbohydrate 
components (Curwen 2006). This chapter aims to determine if these secretions 
also contain component(s) which induce angiogenesis. 
There is emerging evidence for the involvement of angiogenesis in the survival of 
several parasitic infections, including species which either dwell in, or utilise, the 
skin as a point of entry to the body. The migration of mature O. volvulus from the 
skin is suggested to be aided by the release of secretions by the parasites which 
promote tissue degradation and angiogenesis (Higazi 2003). Current hypotheses 
propose that release of an angiogenic growth factor by various parasites may be 
essential for their transit or development in the host organism (Dennis 2011) 
Angiogenesis induction by schistosome eggs has been long established. The livers 
of infected mice exhibit increased vasculature induced by either host-derived 
growth factors stimulated by the passage of eggs, or an egg-derived factor. 
(Freedman 1988). Indeed, egg secretions and live eggs both induce endothelial 
cell proliferation (Shariati 2011). The schistome eggs secrete a component, which 
induces changes in mature vasculature and appears to induce the process of 
angiogenesis. Many of these studies, also compared responses with sonicated 
cercarial extracts which did not induce angiogenic responses (Kanse 2005, 
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Shariati 2011), but no work to date has examined the effect of cercarial 
secretions in their native state.   As shown with schistosome eggs, cercarial 
secretions may directly induce angiogenic factors, or interact receptors on the 
blood vessels. This chapter will utilise both in vitro and in vivo assays to 
determine the angiogenic potential of cercarial secretions in the form of purified 
0-3hRP. 
Finally, it was shown in chapter 4 that after multiple exposures to schistosome 
larvae, macrophages in the skin displayed a pro angiogenic phenotype (4.3.10).  
Whilst this may be due to changes in cytokine environment, it may also be the 
result of direct uptake of parasite antigen by these cells. Therefore, the 
angiogenic phenotype of phagocytic cells in the skin could be due to both the 
uptake of antigen and the influence of the cytokine environment. This chapter 
will address whether cercarial secretions directly influence phagocytic cells and 
promote the secretion of angiogenic factors. 
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6.2 Materials and Methods 
6.2.1 Collection of 0-3hRP 
 
Cercariae were shed from snails in ‘aged tap water’ placed under a 200 W lamp 
for 2hours. The cercariae were washed by gentle centrifugation in aged tap 
water and placed in serum free RPMI 1640 medium containing 200U/ml of 
penicillin and 100ug/ml streptomycin (Pen-strep RPMI 1640). Cercariae were 
mechanically transformed by vortexing for 3 bursts of 30 seconds to separate 
heads from tails, and were then incubated  in serum free Pen-strep RPMI 1640 at 
37°C and 5% CO2 for 3hours. The supernatant (parasite free) was then collected 
and concentrated in Vivaspin 15 tubes (Sartorius Stedim Ltd, Epsom, UK) with a 
5kDa membrane. (Jenkins 2005).The protein concentration of the final 0-3hRP 
was determined using a Coomassie plus-200 assay (Perbio Science Ltd. UK). 
 
6.2.2 L929 fibroblast culture and production of conditioned media 
 
L929 fibroblasts (from Professor P. Kaye, University of York) were cultured in 
75cm2 flasks on DMEM with 10% FCS, 2mM L-glutamine, 200U ml-1 penicillin and 
100µg ml-1  streptomycin, 50µM 2-mecaptoethanol  at 37°C/5% CO2 for 5-7 days. 
The culture supernatant was then harvested, filter sterilised (0.22µM), and 
frozen at -80°C.  
 
6.2.3 Bone marrow cell extraction and differentiation 
 
The femurs, tibia and fibula of 8 week old C57BL/6 mice were removed and 
cleaned of tissue. Bones were briefly sterilised in 70% ethanol and rinsed twice in 
1% Pen-strep PBS. Bone marrow was removed by flushing the bones with 1% 
Pen-strep PBS. Cells were dissociated with gentle pipetting and spun at 900rpm 
for 7 minutes. Cell pellets were re suspended in ACK buffer for 5 minutes at room 
temperature to lyse red blood cells, before being washed in an excess of 1% Pen-
strep PBS. 
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6.2.3.1 Bone marrow derived macrophages 
 
Bone marrow cells were re-suspended in culture media (DMEM supplemented 
with 10% heat-inactivated low endotoxin foetal bovine serum, 2mM L-glutamine, 
200U ml-1 penicillin and 100µg ml-1 streptomycin, 50µM 2-mercaptoethanol and 
20% L929 cell-conditioned medium (containing M-CSF). Cells were plated at a 
density of 2.5x106 cells per well in 24 well plates and incubated 37°C/5%CO2 for 7 
days.  
6.2.3.2 Bone marrow derived dendritic cells 
 
Bone marrow cells were re suspended in DMEM containing 10% FCS 2mM L-
glutamine, 200U ml-1 penicillin and 100µg ml-1 streptomycin, 50µM 2-
mercaptoethanol and 20ng/ml GM-CSF (Peprotech, London UK), plated at 
2.5x106 cells per well in 24 well plates, and incubated 37°C/5%CO2 for 4 days. 
Fresh culture media containing 40ng/ml of fresh GM-CSF was added on day 4 
and the cells cultured for a further 2 days. 
 
6.2.4 Bone marrow derived cell culture with 0-3hRP 
 
After culture of bone marrow cells to facilitate differentiation into macrophages 
or dendritic cells, the cells were removed using cold shock treatment described 
in 4.2.1.  Cells were counted and re plated at 5.0x104 cells per well, and 
stimulated with fresh culture media containing no stimulant, 0-3hRP (10µg/ml) 
or LPS and cultured for 18hrs.  Cells were removed after culture and a sample 
labelled for flow cytometry to confirm cell identity using the antibodies listed 
below (Table 6.1) (Paveley 2009). 
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Antibody Clone Supplier Isotype Supplier 
F4/80 FITC BM8 eBioscience Rat IgG2a eBioscience 
CD11b APC M1/70 eBioscience Rat IgG2bκ eBioscience 
IA/IE Biotin M5/114.15.2 eBioscience Rat IgG2bκ ebioscience 
CD11c FITC N418 eBioscience Armenian 
Hamster IgG 
ebioscience 
Streptavidin 
Pacific blue 
Goat IgG Invitrogen - - 
 
 
6.2.5 Transcript analysis from bone marrow derived cells 
 
Samples of cells after stimulation were collected and placed in 250µl of TRIZOLTM 
before RNA was extracted and cDNA produced (as described for the DEC 3.2.9). 
SQ-PCR was performed using primers for VEGF, HGF and PlGF (3.2.10 , Primer 
sequences in appendix 1) 
6.2.6 Wound Healing Assay 
 
L929 Fibroblasts were cultured as before (6.2.2) and harvested when confluent. 
After washing in fresh media, cells were plated at 5x104  per well of a 24 well 
plate in ‘Fibroblast media’ (DMEM with 10% FCS, 2mM L-glutamine, 200U ml-1 
penicillin and 100µg ml-1  streptomycin) and allowed to adhere and proliferate 
overnight at 37°C/5%CO2. The cell monolayers were scratched with a P1000 
pipette tip to remove a strip of cells and gently washed to remove debris. 
Growth factors or stimulants were added in fibroblast media to each well; VEGF 
10ng/ml (Peprotech,USA), 0-3hRP 10µg/ml, SEA 10µg/ml or media alone. Cells 
were imaged immediately after addition of stimulants, and again at 24 hours and 
36 hours using a Zeiss inverted microscope under bright light. 
 
Table 6.1  Antibodies used for bone marrow derived cell staining.  
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6.2.7 Culture of Human Umbilical Vein Endothelial Cells (HUVECs) 
 
HUVECs (Promocell, UK) were cultured in endothelial cell growth medium with 
supplement mix containing foetal calf serum, endothelial cell growth 
supplement, epidermal growth factor, basic fibroblast growth factor, heparin and 
hydrocortisone (PromoCell). HUVECs used in this study were no older than 
passage number  five and were grown to confluence in complete HUVEC media 
at 37°C/ 5% CO2.  Cells were recovered following aspiration of culture medium 
and addition of Trypsin/EDTA. Cells were incubated for 2 minutes at 37°C until 
they had rounded up and released into suspension.  PBS was then added to 
quench the trypsin. The cell suspensions were centrifuged at 900rpm for 7 
minutes, and then re suspended in fresh medium and then plated out at the 
required density. 
 
6.2.8 HUVEC proliferation Assay 
 
HUVECs were cultured as described in section 6.2.7.  At a concentration of 
2.5x104 per well of a 96-well plate in 100ul of complete endothelial cell media. 
Aliquots of 100µl of soluble egg antigen (5, 10 or 50µg/ml) 0-3hRP (5, 10 or 
50µg/ml), VEGF (5, 10 or 50ng/ml) (Peprotech, USA), or media alone were added 
at the desired final concentration.  HUVECs were incubated at 37°C/5%CO2 
overnight, prior to removal of 120µl of culture media, and replacement of 20μl 
fresh medium containing 18.5kBq of radioactive thymidine (methyl- 3H) (GE 
Healthcare Life Sciences, UK). Cells were incubated for a further 18hrs before 
harvesting using Filter-Mate Harvester onto UniFilter-96 GF/C plates.  After the 
filter had completely dried, 20ul of Microscint-20 was added to each well and 
sealed with film. The plates were analysed using a TopCount scintillation counter 
(PerkinElmer Beconsfield UK) 
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6.2.9 Proliferation assay with protease inhibition 
 
Cells were cultured and plated as described (6.2.8) but to 50ug/ml 0-3hRP a 
protease inhibitor cocktail (Halt Protease Inhibitor Cocktail Kit #78410, Pierce)   
was added in decreasing concentrations. To control for cell death due to the 
inhibitor, cells in media alone plus inhibitor were used as a control. As above, 
cells plates were incubated overnight at 37°C/5%CO2 prior to assay for 
proliferation activity (6.2.8). 
 
6.2.10 Branching Assay 
 
The wells of a 24 well culture plate were coated with 300µl of BD Growth factor 
reduced Matrigel (BD Biosciences) which was allowed to set for 30mins at room 
temperature. BD Matrigel is a mix of proteins used as an ECM substitute in cell 
culture. It is liquid between 4°C and 10°C at which point test stimulants can be 
mixed in. Above 10°C the Matrigel sets into a solid plug.   HUVECs (5.0x104) were 
plated on top of Matrigel in 500µl of endothelial cell growth media containing 
either SEA, 0-3hRP (both 10ug/ml), VEGF (10ng/ml; Peprotech, USA) or media 
alone. The plate was then incubated overnight at 37°C/5%CO2. After incubation 
the plates were imaged under transmitted light.  
 
6.2.11 Staining of HUVECs with phalloidin and DAPI 
 
HUVECs were cutured (6.2.7) and plated at a density of 5x104 per well onto 
coverslips in a 24 well plate,. The plate was then incubated overnight at 
37°C/5%CO2. Test substances were then added at a final concentration of; SEA, 
0-3hRP (both 10ug/ml) VEGF (10ng/ml) prior to incubation for a further 24hrs. 
Coverslips were removed from the wells, and adherent cells fixed in BD Fix/Perm 
(BD Biosciences) for 15mins at 4°C.  After rinsing in PBS, 50µl of Perm/Wash 
buffer (BD Biosciences) containing 10% normal rabbit serum (NRS) was added for 
20minutes at room temperature. Phalloidin (AF488 conjugated, Invitrogen) and 
DAPI (Invitrogen) were diluted in Perm/Wash buffer containing 10%NRS and 
added to the coverslips for 30minutes at room temperature. Slides were rinsed 
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in PBS before being mounted in Vecta shield (Vector Laboratories UK) on a 
microscope slide. Slides were imaged using a Zeiss LSM 510 meta (Carl Zeiss Ltd).  
 
6.2.12 Matrigel Plug assay 
 
BD Matrigel was thawed on ice and mixed with the test reagents, SEA (50µg/ml), 
0-3hRP (50µg/ml), VEGF (400ng/ml), or PBS. Solutions were mixed in a ratio of 
100µl of test substance to 400µl of Matrigel to keep the protein concentration of 
the Matrigel high enough to set.   Aliquots of 500µl were injected into the ventral 
side of the groin area close to the dorsal midline of anaesthetised mice using 
chilled needles.  The mice were sacrificed at day 4 post injection and the plugs 
excised. The plugs were imaged using a stereomicroscope at 18x magnification 
(Carl Zeiss) 
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6.3 Results 
6.3.1 PlGF expression is induced in bone marrow derived macrophages and 
dendritic cells after culture with 0-3hRP 
 
6.3.1.1 Bone marrow-derived macrophages  
 
For the three predominant growth factors identified in the previous chapters, 
VEGF120, PlGF and HGF there was no significant difference between the transcript 
expression profile between blank (medium only) and LPS stimulated cells (Figure 
6.1). For VEGF120 and HGF, there was also no difference between the blank and 
0-3hRP stimulated cells. However, 0-3hRP induced a significant increase in PlGF 
transcript compared to cells cultured in medium only and those stimulated with 
LPS.  
 
 
 
 
 
 
 
 
 
Figure 6.1 Growth factor expression by 
bone marrow derived macrophages. 
 
Transcript from 3 biological replicate 
cultures was analysed for A: HGF, B: 
VEGF120 and C: PlGF expression.  Graphs 
are mean +SEM. Statistics shown are for 0-
3hRP vs Blank *p<0.05 
A B 
C 
PlGF 
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6.3.1.2 Bone marrow-derived dendritic cells  
 
Dendritic cells stimulated with LPS or 0-3hRP expressed significantly less HGF 
than the un-stimulated cultures (p<0.05 for both) and there was no significant 
difference in the expression of HGF between the LPS and 0-3hRP stimulated cells 
(Fig 6.2). In contrast, VEGF120 expression did not differ between any of the three 
groups of cells, although the relative levels of VEGF120 were much lower in 
dendritic cells than macrophages. In contrast, there was a small increase in 
transcript levels for PlGF cells stimulated with 0-3hRP compared to medium and 
LPS, although this was not statistically significant. 
 
 
 
 
 
 
 
* 
* 
Figure 6.2 Growth factor expression by 
bone marrow derived dendritic cells. 
 
Transcript from 3 biological replicate 
cultures was analysed for A: HGF, B: VEGF 
and C: PlGF expression.  Graphs are mean 
+SEM. Statistics shown are for 0-3hRP and 
LPS vs Blank *p<0.05 
A B 
C PlGF 
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6.3.2 Parasite antigens induce fibroblast migration  
 
One of the main components of the dermis are fibroblasts (Smith 1982). They are 
important in the remodelling and release of angiogenic factors in the skin and 
the recruitment of leukocytes (Smith 1997). To determine whether 0-3hRP can 
directly activate fibroblasts and enhance their migration, an in vitro wound assay 
was performed (6.2.6). This assay is commonly used to indicate the wound 
healing potential of a substance but is only a suggestive in vitro model. 
VEGF is not reported to enhance fibroblast migration and as such serves as a 
further negative control, along with media alone, in this assay. The fibroblasts at 
the leading edges of the 0-3hRP and SEA treated wounds became elongated and 
moved to cover the scratch in the plate (Figure 6.3A). Fibroblasts along the 
leading edges of the VEGF and media alone wells (blank) were slower to elongate 
and more remained rounded early after scratching. At 24hrs, the fibroblasts in 
the 0-3hRP treated wounds almost covered the scratch, although sparsely 
distributed, whereas relatively large cell free are discernible in the VEGF and 
Blank cultures.  
The width of the wound was measured at the start and 24hrs after culture and 
the distance the leading edge of fibroblasts had moved expressed as a 
percentage of wound closure (Figure 6.3B). There was no significant difference 
between VEGF-treated and un-treated wells. However, there was a significant 
increase in wound closure in response to SEA and 0-3hRP compared to medium 
(SEA p<0.01, 0-3hRP p<0.05). 
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Figure 6.3 Fibroblast 
migration in the 
presence of parasite 
antigens 
 
A: Representative 
images from three 
wells for each 
condition. The same 
area of plate is shown 
for each time point 
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6.3.3 0-3hRP induces endothelial cell proliferation 
 
In order to form new vessels, the endothelial cells of existing vessels must 
proliferate (Carmeliet 2000). Therefore one of the more commonly used in vitro 
models for angiogenic potential is the ability of the test substance to induce 
increased endothelial cell proliferation. It has been shown previously that SEA 
will induce endothelial proliferation (Loeffler2002) and SEA was used as a 
positive control alongside VEGF.  
HUVECs cultured in media alone proliferated and incorporated H3-thymidine into 
their DNA (Figure 6.4).  However, VEGF induced significantly greater levels of 
proliferation compared to the blank (p<0.01). This appeared to be a dose-
dependent trend, although there was no significant difference between the 
different concentrations.  Addition of SEA induced also significantly increased 
levels of proliferation; however unlike VEGF this was not dose-dependent, and 
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Figure 6.3B Fibroblast migration in the presence of parasite antigens 
 
B: Fibroblast migration shown as a percentage of the initial scratch now 
covered. Data is 12 measurements over the three wells for each condition. 
Mean +SEM. Statistics are for 0-3hRP and SEA vs Blank *p<0.05 and **p<0.01 
B 
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there was no significant difference in the level of proliferation between the 
different doses. Proliferation induced by SEA was only slightly lower than that 
induced by VEGF and not significantly different. 0-3hRP induced significant 
proliferation compared to the blank at 5µg/ml, but at greater concentrations the 
level of proliferation induced by 0-3hRP showed an inverse relationship, and 
proliferation appeared to be inhibited at 50µg/ml. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B
la
n
k
V
E
G
F
 5
V
E
G
F
 1
0
V
E
G
F
 5
0
S
E
A
 5
S
E
A
 1
0
S
E
A
 5
0
0
-3
 5
0
-3
 1
0
0
-3
 5
0
0
500
1000
1500
2000
2500
3000
3500
4000
4500
Blank 5    10   50 5   10   50 5    10   50
VEGF SEA 0-3hrRP
**
**
**
**
** ** *
(ng) (g) (g)
c
p
m
Figure 6.4 HUVEC proliferation following 24hrs culture 
Data is from 3 replicate wells for each condition. Cells were cultured with either 
media alone (blank) or increasing concentrations of VEGF (ng), SEA (µg) or 0-3hrRP 
(µg). Cells were cultured with radioactive thymidine (methyl- 3H) and the counts 
analysed. Statistics shown are test substances compared to blank; Mean cpm + SEM 
*p<0.05 and **p<0.01. 
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6.3.4 Protease inhibition restores 0-3hRP induced proliferation 
 
At high concentrations of 0-3hRP (50µg/ml) proliferation appeared to be 
inhibited (Figure 6.4) and as 0-3hRP contains high levels of proteases it was 
hypothesised that they may inhibit the proliferation of the cells HUVECs, or 
decrease cell viability as the concentration of 0-3hRP increased.  
Culture of HUVECs in media alone induced proliferation, whilst addition of 
5µg/ml of 0-3hRP induced significant up regulation of proliferation (Figure 6.5). 
Cell cultures containing 50µg/ml of 0-3hRP again inhibited proliferation as 
previously shown (Figure 6.4). At the highest concentrations of protease inhibitor 
(1:400) proliferation increased but was not significantly higher than cells cultured 
with media alone, and was significantly lower than cells in 5µg/ml of 0-3hRP. 
However, as the concentration of inhibitor decreased, cell proliferation was 
restored to levels higher than the blank (p<0.01 and p<0.001), and were similar 
to levels induced by 5µg/ml 0-3hRP. 
 
 
 
 
 
 Blank 5ug 0 1:400 1:800 1:16001:32001:6400
0
5000
10000
15000
20000
25000
30000
35000
**
***** ***
0     1:400  1:800  1:1600  1:3200  1:6400
  50g
0-3hrRP
0
  5g
0-3hrRP
Media
c
p
m
Figure 6.5 HUVEC proliferation in the presence of a protease inhibitor 
 
Data is from 3 replicate wells for each condition. Cells were cultured with either 
media alone (blank) or 0-3hRP in the presence of increasing concentrations of 
protease inhibitor.  Significance shown is each sample containing protease inhibitor 
compared to the 50µg/ml of 0-3hRP without inhibitor. Mean +SEM **p<0.01 and 
***p<0.001. 
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6.3.5 HUVECS form primitive branch-like structures in response to 0-3hRP 
 
After proliferation, endothelial cells ordinarily migrate into primitive tubes 
(Carmeliet 2000). In order to determine whether this occurs in response to 0-
3hRP, HUVECs were grown on Matrigel coated plates in the presence of 0-3hRP, 
VEGF, SEA or media alone for 24hours.  HUVECs cultured in media alone survived 
and remained evenly distributed across the plate with no cell to cell interactions 
observed (Figure 6.6D).  Culture with VEGF induced the cells to form branch 
structures across the plate with multiple branching points from the cells and 
webs of branches apparent (Figure 6.6A).  SEA induced similar branch patterns 
with webs of primitive tubes (Figure 6.6C), however it additionally induced high 
levels of proliferation of the HUVECs with a large ‘pool’ of endothelial cells 
feeding into the branching network. Finally, cells stimulated with 0-3hRP 
exhibited primitive branching with 2-3 junctions (Figure 6.6B). Cells did not form 
webbed networks but were spaced across the plate in small groups of branches. 
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6.3.6 HUVECs extend filopodia and align after culture with 0-3hRP 
 
To determine the morphological changes to the HUVECs, cells were stained with 
phalloidin and DAPI after culture and imaged (Figure 6.7). Cells grown in only 
basal endothelial cell media, without any additional growth factors, grew in neat 
sheets of cells which were grouped together sporadically over the plate (Figure 
6.7A). The cells were predominately round with a cobblestone morphology and 
fit closely together. Closer examination of the cells showed organised actin and a 
small cytoplasm.  
Addition of VEGF to the culture media dramatically altered the morphology of 
the HUVECs (Figure 6.7B).  Examination of single cells revealed that they had a 
much larger cytoplasm than the cells cultured in media alone. Several had long 
actin filaments reaching out to contact other cells in the surrounding area. Over 
the entire surface of the plate, the cells were elongated with actin filaments 
stretched across the length of the cells.  The cells had an oblong morphology and 
lined up into strings of cells. In several regions, these tubes of cells were 
stretched thin and aligned into circles of interacting cells.  
HUVECs cultured with SEA showed a similar morphology to the VEGF stimulated 
cells, with cells grouping and stretching across the plate in a web formation 
(Figure 6.7C). Many of the cells were stretched thinner than the VEGF cultured 
cells with long reaching filopodia contacting between cells. Like VEGF treated 
cells, those cultured with SEA had a larger cytoplasm than the cells in only media.  
0-3hRP treated HUVECs had a similar morphology to the VEGF and SEA cells. 
However unlike cells in these conditions, they 0-3hRP HUVECs were spread out 
thinly across the plate with large gaps between the strings of cells. They did not 
produce the dense circles of 3 or 4 cells as seen in the VEGF and SEA treatments, 
and there did not appear to be as much proliferation.  As with the other 
stimulants, 0-3hRP-stimulated HUVECs had a large cytoplasm and several 
extensions of the cytoplasm making contacts between the cells. They also 
elongated and formed into primitive vessel like cords of endothelial cells.  
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Figure 6.7 Actin filament staining of HUVECs after 24hr culture 
 
Representative images from 3 replicate wells of cells. HUVECs were cultured in 
24 well plates on coverslips for 24hrs before being removed and stained with 
DAPI (blue) and Phalloidin (Green).  A: Blank, B: VEGF, C:SEA and D: 0-3hRP. 
1st panel is taken under 20x magnification the 2nd and 3rd panels are 10x 
magnification under invert confocal.  
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6.3.7 0-3hRP induces blood vessel growth into Matrigel plugs in vivo 
 
0-3hRP was integrated into the synthetic extracellular matrix – Matrigel, to 
determine whether it induces blood vessel growth in vivo. Matrigel combined 
with different stimulants was injected subcutaneously into the lower abdomen 
of mice to produce a solid plug (6.2.12), which were excised 4 days post 
implantation. Matrigel was removed in tact with no signs of absorption into the 
body.  
Matrigel containing only PBS, showed no vessel growth into, or within the plugs 
(Figure 6.8; top). Vessels within the peritoneum and dermis adjacent to the plug 
also showed no dilation or branching.  Plugs incorporating VEGF, exhibited 
vessels growing into the plug from both the peritoneal and dermal sides (Figure 
6.8; second top).  Vessels were present in the centre of the plug and the larger 
vessels showed one or two branches. Existing vessels of the body adjacent to the 
plug were dilated and branched from the surrounding tissue into the plug. Areas 
of vessels appeared burst with blood extravasated into the surrounding tissue.  
Plugs incorporating SEA showed a similar level of blood vessel growth to VEGF 
plugs but without the dilation of the surrounding vessels (Figure 5.8; second 
from base). Vessels were long and they penetrated from the dermal and 
peritoneal sides into the entire plug with several showing small branches (Figure 
6.8 third panel ).  Plugs with 0-3hRP also exhibited many branching vessels 
(Figure 6.8; base *). The majority of these appeared to be growing from the 
dermal side over and into the plug (Figure 6.8 base ). The mature surrounding 
vessels of the body branched into the plug but again did not exhibit vessel 
dilation and blood extravasation as seen with VEGF plugs. 
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Figure 6.8 Matrigel plugs 4 days after implantation 
Representative images of plugs excised 4 days after implantation. There 
were a total of 4 plugs for each test substance. Left panel shows the plugs 
in situ with the edges marked in white where not clear. The mid and right 
panels show part and fully excised plugs A: PBS B: VEGF C: SEA D: 0-3hRP 
Vessels grew into the plug (arrowed) and were seen clearly throughout the 
plug. * indicates a small network of fine vessels within the plug.  
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6.4 Discussion 
 
6.4.1 Overview 
 
This chapter revealed that angiogenic responses were induced directly by 
cercarial secretions. Bone marrow-derived dendritic cells and macrophages 
stimulated with 0-3hRP resulted in up regulation of PlGF expression without 
additional cytokine stimulus. The cercarial secretions appear to contain a pro-
angiogenic growth factor which is not a protease and can induce both 
endothelial cell proliferation and organisation into new vessels.  
 
6.4.2 0-3hRP induced PlGF expression in bone marrow derived macrophages  
 
The three growth factors up regulated in the DEC; VEGF, HGF and PlGF were all 
analysed in directly stimulated macrophages and dendritic cells.  However, the 
only factor to be enhanced by 0-3hRP was PlGF.  This indicates that differences in 
HGF and VEGF expression detected in samples collected ex vivo after infection, 
are likely to be due to the cytokine environment in the whole pinnae not direct 
antigen recognition.  However, the increase in PlGF in dendritic cells was not 
significant, and PlGF expression was only detected in ex vivo dendritic cells from 
the DEC of 4x IL-10-/- mice (4.3.12) whilst it was absent in the WT group (3.3.10).  
In the presence of IL-10, MHCII expression on dendritic cells can be down-
regulated (Laxmanan 2005), so perhaps the high levels of IL-10 in 4x WT mice, 
also prevents the recognition of 0-3hRP by dendritic cells and inhibiting 
expression of PlGF. The macrophages significantly increased expression of PlGF. 
Further analysis of receptors on the macrophages and dendritic cells which could 
be inducing PlGF may elucidate a pathway by which cercariae are directly 
inducing the leukocytes to produce inflammatory angiogenic genes.  
It was planned to use bone marrow-derived cells (stimulated with 0-3hRP) in co-
culture experiments with murine endothelial cells to determine whether they 
directly interact with and stimulate the endothelial cells. Several attempts were 
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made to extract vascular endothelial cells ex vivo from mouse pinnae by adapting 
several methods employing various enzymes (trypsin, liberase, dispase and 
collagenase) in combination with differential centrifugation, or fluorescent cell 
sorting (van Beijnum 2008, Tae Cha 2005, Marelli-Berg 2000, Normand 1995). 
Unfortunately, no endothelial cells were gained using differential centrifugation, 
and only a small number of cells (31% purity) were extracted using anti CD31 cell 
sorting, which did not survive to culture. More work is needed to refine the 
techniques. Therefore, for the remainder of the cell experiments with 0-3hRP, 
HUVECs were used as a substitute as they are robust and easy to culture.  
 
6.4.3 0-3hRP stimulates fibroblast migration  
 
 
As discussed the cercariae will cause considerable damage to the structure of the 
skin (1.1.2). The dermis of 4x pinnae thickens and there is up-regulation of MMPs 
and growth factors (Chapter 3), to restore the pinnae structure the damage must 
be healed. An essential step in wound healing is the deposition of ECM by 
fibroblasts (Eckes 2000). It has been shown that T-cells cultured with SEA can 
induce fibroblast migration and proliferation. This is due to the release of a 
fibroblast activating protein by the stimulated T-cells (Lammie 1986). 
To determine whether 0-3hRP can directly induce fibroblast activation an in vitro 
wound assay was utilised.  Although this is only a basic in vitro model of wound 
healing it is a useful tool in first assessing the potential of a test substance 
(Rodriguez 2005). Addition of 0-3hRP to scratched fibroblast monolayers caused 
the cells to proliferate and migrate across the wound quicker than in media 
alone. This suggests that 0-3hRP may contain a factor which directly stimulates 
the fibroblasts, inducing either proliferation alone or proliferation and migration.  
Transcript analysis of 0-3hRP stimulated fibroblasts could be undertaken to 
determine whether they up-regulate the expression of growth factors or 
cytokines, which may contribute to the environment seen in the skin following 
infection. An additional further experiment would be to determine if 0-3hRP 
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could affect the speed of wound healing in vivo by the addition of 0-3hRP to 
incisional wounds in mice. These experiments were planned but due to 
availability and time restraints were unable to be performed within this project 
and the in vitro assay serves only as a basic model hypothesising some fibroblast 
simulation by the 0-3hRP. 
 
6.4.4 0-3hRP induces cell endothelial proliferation and branching 
 
 
Angiogenesis requires mature vessels to become permeable and for the 
endothelial cells to proliferate and form into new tubes which eventually 
develop a lumen and mature (Carmeliet 2000). Co culture of HUVECs and 0-3hRP 
was undertaken to determine if 0-3hRP could induce endothelial cell 
proliferation or branching. Both branching and proliferation assays are 
commonly used as in vitro markers of angiogenic processes although they do not 
conclusively prove a substance can induce angiogenesis in vivo (Auerbach 2000). 
Culture with both SEA and 0-3hRP induced cell proliferation, although at higher 
concentrations of 0-3hRP proliferation was inhibited. As 0-3hRP contains a high 
level of proteases it was hypothesised that at higher concentrations the 
proteases may be damaging the cells. This appeared to be true as proliferation 
was restored by including a protease inhibitor in the culture.  
This appears to be in contrast to research on the pro-angiogenic abilities of egg 
secretions. In previous studies, SEA induced proliferation was ablated after the 
antigen was pre boiled or incubated with proteinase K (El-Awady 2001), 
suggesting it to be a protein. A later study however identified a factor which was 
heat and protease resistant and produced by live eggs in culture stimulating 
vessel proliferation (Kanse 2005). The results here suggest that 0-3hRP induces 
proliferation of endothelial cells using a different mechanism than the eggs and 
is likely to be a growth factor homolog as opposed to a protease.  Caenorhabditis 
elegans produces a PDGF/VEGF like ligand which is biologically active (Tarsitano 
2006).  In addition to growth factor homologs Onchocerca venom like antigens 
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induce an angiogenic response when injected into the cornea of mice. (Tawe 
2000). Within the cercarial secretions are a series of venom allergen like genes 
which may be the factors promoting the endothelial cell proliferation (Chalmers 
2008, Curwen 2006). 
HUVECs were also cultured in plates coated with Matrigel to determine whether 
0-3hRP can induce vessel branching. Endothelial cells respond to guidance cues 
to direct them to line up into tubes of cells connected to each other with 
vascular adhesion molecules including PECAM1 and VE-cadherin (Carmeliet 
2000). Culture of the HUVECs with 0-3hRP induced small branches to form over 
the plate as seen with VEGF and SEA stimulated cells. Directional growth and the 
assembly of endothelial cells into vessels could potentially benefit the cercariae 
by increasing their chances of finding a vessel to extravasate through. 
Several parasites require blood vessel growth, during the life cycle of Trichinella 
spiralis the larvae transform into a nurse cell-parasite complex contained in a 
collagenous capsule, which requires a continuous supply of nutrients in order to 
survive (Baruch 1991). Vessels are stimulated to grow into and surround the 
capsule through the secretion of an angiogenic factor by the nurse cell and 
stimulates the release of angiogenic factors from macrophages (Shariati 2009). 
Schistosome eggs induce vessel growth through up-regulation of endothelial cell 
produced VEGF (Loeffler 2002). Granulomas were considered to be avascular 
however many early granulomas are vascularised with the vessels regressing 
during maturation (Baptista 2005).  
Closer examination of the endothelial cells after culture revealed structural 
changes in the cytoskeleton of the cells, and close association between individual 
cells. In cells cultured in media alone remained rounded with a small cytoplasm. 
After culture with stimulants the size of the endothelial cells increased and the 
cytoplasm swelled. This is characteristic of activated endothelial cells which have 
been stimulated by either a growth factor or cytokine (Cheville 1994). In 
addition, cells cultured with SEA and 0-3hRP developed long filopodia extensions. 
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These are a hallmark of activation and serve to contact endothelial cells to each 
other and follow guidance cues (De Smet 2009).  
Vascular endothelium develops with a leading tip cell, these up-regulate 
expression of Notch1 and direct migration in response to VEGF and other growth 
factors (Hellström 2007). Additional labelling of the HUVEC cultures with 
antibodies to adhesion molecules would reveal whether the parasite secretions 
are inducing a tip cell morphology, as well as activating an angiogenic pathway. 
The cells in the stimulated cultures became long and thin increasing their contact 
surface area to each other and potentially developing cell to cell tight junctions, 
close electron microscopy would help to confirm this. The general morphology 
and change in the shape of the cells after culture with 0-3hRP is indicative of 
endothelial cell activation and branching, showing that cercarial secretions can 
induce blood vessel organisation into branches and strongly implies that the 
secretions can induce new vessel growth by direct interaction with the 
endothelial cells of the blood vessel.  
 
6.4.5 0-3hRP induces blood vessel growth in vivo 
 
 
The proliferation and branching assays are both in vitro models. To determine 
whether cercarial secretions can induce vessel growth within a mammal host, 
the Matrigel plug assay was used. This gelatinous protein mix is analogous to 
ECM, but can be kept liquid to allow growth factors to be integrated into it 
before setting into a solid plug. It has been widely used in tumour models and to 
test the angiogenic potential of known and hypothesised growth factors (Akhtar 
2002, Cattaneo 2009, Murayama 2002). 
Plugs containing just PBS showed no vessel growth, and did not affect the vessels 
of the body surrounding the plugs. As the plugs were introduced by injection 
there was minimal damage to the skin and no disturbance noticeable to the 
vessels of the skin or peritoneum. VEGF induced considerable growth into the 
Matrigel and also caused noticeable haemorrhaging around the plug. As VEGF 
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induces vessel permeability (Weis 2005) this is likely due to the continuous 
presence of VEGF from the plug next to the mature vessels of the skin and 
peritoneum. Both the SEA and 0-3hRP plugs also induced vessel growth into the 
plugs but without the noticeable vessel dilation seen in VEGF plugs. This suggests 
that the growth factor produced by the parasite is likely to not induce excessive 
vascular permeability and does not work in the same pathway as VEGF. 0-3hRP 
induced deep vessel growth into the plug confirming the hypothesis that the 
factor in the cercarial secretions could be acting as a guidance cue for the vessel 
growth.  
Vessel growth in the plugs was rapid (plugs were excides at day 4 and day 7) 
indicating that the parasite secretions are acting quickly on the vessels. To 
determine whether the secretions could act in the time frame that the cercariae 
are within the skin further time points would need to be analysed. Additionally 
different concentrations of the cercarial 0-3hRP should be tested to determine if 
vessel growth can occur at lower concentrations or if the growth is an artefact of 
the concentration used in this assay.  
 
The aim of the cercariae is to penetrate and progress out through into a blood 
vessel as quickly as possible. Whilst the cercariae could rely entirely on physical 
movement the production of a growth factor, and the proteases within the 
secretions, may aid the parasites passage through the skin and increase its 
chances of exit and survival into the blood stream. Release of proteases in the 0-
3hRP is likely to degrade the ECM and release sequestered growth factors. But as 
the HUVEC cultures were completed without an ECM or additional growth 
factors than those found in the media, this data shows that the cercariae also 
produce a growth factor like molecule. This may activate the endothelial cells of 
the blood vessels prior to the cercariae reaching them aiding their transition into 
the vessel.  
Endothelial cells can express Protease activated receptors (PARs) which are 
activated by extracellular proteases (Brass 1997). These may be activated by the 
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cercarial proteases and stimulate the endothelial cells.  Further to this work PAR 
reporter cell lines could be tested with 0-3hRP to determine if it activates the 
receptor, perhaps revealing an additional method of endothelial cell activation.  
 
6.4.6 Summary 
 
This chapter has shown that macrophages and dendritic cells primed with 0-3hRP 
up regulate some angiogenic growth factors. Additional experiments using 
murine endothelial cells and 0-3hRP primed macrophages will determine 
whether the immune cells, after exposure to parasite antigen, can directly 
interact with and induce angiogenic processes in the endothelial cells. In 
addition, the work here has shown that the cercariae directly induce endothelial 
cell activation and new vessel growth in vitro and in vivo. This appears to be 
through the production of a growth factor and not solely due to the proteases in 
the 0-3hRP.  Early studies with schistosome eggs have proposed a mechanism by 
which the eggs interact with the endothelial cells causing proliferation and 
migration of the cells over the surface of the egg, subsequently aiding in egg 
progression through the vessel wall (File 1995). It has also been observed that 
the vessels in which eggs are residing become dilated and torturous in chronic 
infections, due to continual stimulation and remodelling of the vessels (Nagy 
1981, Freedman 1988). These morphological changes were also seen in the 
pinnae of mice in this study (Chapter  3) and the endothelial cell proliferation and 
migration data, although only a superficially model, presented in this chapter 
appears to suggest a similar mechanism.  
Very little parasite and blood vessel interaction work has been done in recent 
years, as S.mansoni is a vessel dwelling parasite better understanding of its entry 
and exit from vessels would be beneficial to identifying life cycle stage targets for 
therapy. If cercariae and eggs are utilising similar methods to enter and exit 
vessels this provides a potential mechanism to target which could affect more 
than one stage during infection. In addition the lung stage somules are in close 
association with vasculature while they progress through the lung capillaries. 
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This is a tight space for the somules to navigate and whilst the presiding theory 
has been that the parasite pushes through using mechanical means they may 
produce a vessel-dilating factor or induce the expression of growth factors and 
cytokines in the lungs. Indeed it has been shown that induction of IL-13 by the 
lung somules increased fibrosis and lung vessel remodelling (Graham 2010). 
More work is needed to determine the exact mechanisms and the component of 
the 0-3hRP responsible for the vessel growth and comparisons between gene 
expression during different life cycle stages may identify a common factor or 
family of factors responsible for vessel interactions.   
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Chapter 7: General Discussion 
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7.1 General Discussion 
 
7.1.1 Overview 
 
This study has shown visually and quantifiably that after infection with cercariae 
there is an up regulation of pro-angiogenic growth factors in skin.  After multiple 
infections, growth factor levels were elevated and the predominant factors 
changed (Figure 7.1). Three growth factors were up regulated predominantly in 
the multiply infected skin; HGF, VEGF and PlGF. These are all angiogenic factors 
with wide ranging roles, HGF and PlGF are particularly associated with 
pathological angiogenesis (Seamen 2007, Bussolino 1992). The difference in 
growth factors appeared to be mainly due to the changes in the phenotype of 
leukocytes infiltrating into the dermis. Macrophages were a rich source of PlGF 
and eosinophils, the primary cell type in the 4x, expressed HGF (Figure 7.1).  The 
appearance and structure of the blood vessels following 4x infection closely 
resembled that of tumour vasculature. Many of the vessels were dilated and 
twisted as is commonly seen with new vessels around tumours. As these vessels 
are continuously exposed to high levels of vasodilators and growth factors the 
tumour vasculature never fully matures and remains leaky (Carmeliet 2000). The 
morphology of the 4x vessels appears to be remarkably similar to that of tumour 
vasculature The increased levels of growth factors, persisting to day 8 after 
infection, may present a similar situation in the 4x infected pinnae as that 
observed around tumours. To determine this, imaging with markers for pericytes 
and smooth muscle actin would help to determine the maturity state of the 
vessels.   
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Figure 7.1: Overview of experimental model 
Cercariae attach to the skin and penetrate into the epidermis, at this point the tail 
detaches. The somule migrates throughout the epidermis and release the contents of 
its acetabular glands. Early upon entry to the dermis neutrophils respond releasing 
pro-inflammatory cytokines. As the somule migrates macrophages and dendritic cells 
are recruited as well as eosinophils in the 4x pinnae. These cells express 
predominantly Th2 cytokines in the 4x and high levels of PlGF and HGF. The dermis of 
the 4x pinnae has increased dermal vasculature which is positive for the remodelling 
marker CD105. 
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Loss of IL-10 in the pinnae affected the structure of the 4x vessels unlike in the 
WT, vessels in the knock out were more organised and less distorted.  There was 
also reduced eosinophil recruitment but up regulated the expression of HGF and 
PlGF, consistent with observations that these growth factors are up regulated in 
a pro inflammatory environment. In addition, it was shown that cercarial 
secretions can induce angiogenic phenotypes in the phagocytic leukocytes, 
macrophages and dendritic cells, through up regulation of PlGF. Finally, it was 
shown that the 0-3hRP can directly activate endothelial cells. In vitro it was 
observed that 0-3hRP induces endothelial cell proliferation and migration into 
tubes. In vivo new vessels grew into completely a vascular Matrigel plugs 
containing 0-3hRP. 
 
7.1.2 Pro-angiogenic growth factors in the skin following S.mansoni infection 
 
Previous to this research, angiogenesis had only been associated with the egg 
stage of infection (Loeffler 2002, Freedman 1988). Indeed, previous studies using 
sonicated cercariae had shown little or no angiogenic potential (Kanse 2005). 
Combined with more recent data from this lab showing that cytokines associated 
with wound healing and angiogenesis were up regulated in the skin, particularly 
after 4x infection, it was hypothesised that angiogenesis could be occurring in 
response to the cercariae. The data presented within chapter 3 has confirmed 
this hypothesis and shown that pro-angiogenic genes are up-regulated in the skin 
following infection and in addition the vasculature of the pinnae visibly increases.  
This increase and the levels of growth factors were exacerbated after multiple 
infections.  
Utilising imaging techniques widely used in cancer angiogenesis (Levashova 
2010, Seshadri 2007) the vasculature was successfully labelled with a CD31mAb 
and imaged (Figure 3.4).  This revealed an increase in the diameter and area of 
the vessels in the pinnae which was not due to increased vascular pressure. 
Increased vessel diameter could aid the schistosome egress from the skin. As 
schistosomula are approximately 50µm in diameter they can only exit via larger 
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vessels (Crabtree 1982). If vessel dilation and diameter increase are induced by 
the parasite antigens this could represent a way in which the schistosomes aid 
their own exit from the dermis into the blood vessel. This could be true for other 
stages in the life cycle, in particular maturation in the lung capillaries. Within the 
lungs the capillaries are difficult for the schistosomes to pass through. They 
reside here for a number of days and during this time may activate endothelial 
cells and induce vessel dilation to aid their passage. If this is true the parasitic 
factor which interacts with the vessels in the skin may be conserved across the 
life cycle stages. 
Whilst images of the dermal vasculature were clear and relatively easier to 
produce, no images of the parasite and the vessels were successfully taken. 
Antibody labelling of the parasite was accomplished (Figure 7.2) but no clear 
picture was obtained with the confocal techniques available.  A better technique 
using would be Optical projection tomography producing a 3D reconstruction of 
the entire vasculature of the pinnae (Oldham 2006).  
 
 
 
 
 
 
 
 
 
Figure 7.2 Parasite and Blood vessel imaging 
 
Pinnae were labelled with αCD31-APC (Red) and  serum antibodies to 
cercariae and a secondary antibody conjugated to AF488 (Green). 
Images were taken using a confocal microscope using the same 
method for αCD31 labelling (Chapter 2).  
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Reconstruction of entire pinnae, with both vessels and parasites labelled, may 
help to determine which vessels the parasite interacts with and whether the 
small fine bundles of vessels are surrounding a parasite in the skin. Trapped 
parasites may release secretions to encourage vessels growth towards their 
position in the skin in a similar way to Onchocerca volvulus whose larvae are 
deposited in the skin where they undergo developmental stages and actively 
encourage new vessels growth towards the developing larvae to help provide the 
nutrients for development (Higazi 2003).  
Angiogenesis is influenced by a wide array of growth factors with several families 
showing overlapping functions. To narrow down the gene families activated after 
infection a Q-PCR based gene array was utilised. Whilst several of the results 
were unreliable, the array did give a general impression that pro-angiogenic 
growth factors were induced following infection with many of these peaking 
earlier in the 4x pinnae when compare to 1x pinnae. PlGF and HGF were up-
regulated significantly in only the 4x pinnae and both are strongly associated 
with pathological angiogenesis and inflammation (Seaman 2007, Xin 2001). They 
are often up regulated in fibrotic conditions, e.g. asthma and may be the driving 
factors in the considerable thickness seen in the skin. They are likely to influence 
the considerable scarring and damage to the external layers of the skin observed 
in whole pinnae imaging. HGF in particular promotes the growth of scar tissue 
and can be found in Keloid scars (Mukhopadhyay 2010).  
This increase in scarring and thickness was one of the most noticeable 
differences between the 1x and 4x pinnae. The thickness could also be from 
excessive collagen deposition as MMP-9 persisted at an increased level 
compared to the naïve until day 8. This suggests continual remodelling of the 
collagen. Pinnae sections were analysed following trichrome staining (which 
marks collagen in blue), unfortunately as the skin is very collagen dense it was 
hard to discern any differences.  
The increase in the number and width of the dermal vessels could aid the 
parasites escape from the skin. To determine the functional effect of 
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angiogenesis following infection, manipulation of the angiogenic pathways would 
be necessary. Attempts to inhibit angiogenesis in the skin during infection were 
made using endostatin (data not shown). Unfortunately, insufficient endostatin 
could be purchased for a full scale experiment within the constraints of this 
project and delivery into the skin was difficult. Specific antibody blocking of VEGF 
receptors and Met (the HGF receptor) would help to determine the phenotypic 
changes each of these growth factors is responsible for in the 4x pinnae. Blocking 
of angiogenesis, and in particular the vascular leakage, could affect the migration 
of the schistosome larvae through the host. Infection in Ang1 overexpressing 
mice which have leakage resistant vasculature (Thurston 1999) may result in 
significant numbers of the cercariae being trapped in the skin. 
 
7.1.3 Pro-angiogenic leukocyte influx 
 
The differences in the growth factor expression between 1x and 4x were at least 
partly due to changes in the DEC phenotype. As previously described after 
multiple infections with RA cercariae and the bird schistosome T.regenti there 
was an increase in Th2 cytokines (Il-4, IL-13 and IL-10) in 4x pinnae. This was 
accompanied by a significant increase in dermal leukocytes, containing 
predominately eosinophils (Chapter 4), these were the main source of the HGF. 
The combination of cytokines and eosinophils gives the 4x pinnae an asthma 
type phenotype.  Asthma is a condition characterised by excessive tissue damage 
and exaggerated repair in the lungs during which there is an increase in the 
number and size of bronchial blood vessels. Lung tissue contains high levels of IL-
4, IL-13, MMPs and VEGF alongside significant eosinophil influx. The 4x skin 
shows a very similar profile of cells and cytokines.  The eosinophil influx may be 
the cause of much of the excessive damage to the skin and the persistence of 
both HGF and MMPs. 4x infection in an eosinophil knockout would be an ideal 
method to test how much of the angiogenesis in 4x pinnae is due to the 
eosinophil influx. As the eosinophils are the main producers of the HGF and IL-13 
it would be predicted that the tissue damage and remodelling would be 
decreased.  
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The 4x macrophages are the source of PlGF in the DEC. Infections in IL-10-/- mice 
showed a loss of Ym1 and a significant increase in PlGF. This could indicate that 
the IL-10 in the multiple infection is regulating the expression of PlGF by the 
macrophages reducing their inflammatory ability. The loss of IL-10 did not affect 
IL-4 levels but did result in the complete loss of IL-13. This indicates that the Ym1 
expression in the macrophages was not IL-4 dependant but instead could be IL-
10 or IL-13 induced. IL-4 itself is widely regarded as anti angiogenic but does 
induce angiogenic phenotypes in several cells (Mantovani 2002). The 1x/4x 
infection model was tested in IL-4Rα-/- mice whilst this research was on going 
(Cook 2011). The pinnae of IL-4Rα-/- mice had reduced eosinophilia and 
significantly reduced expression of alternatively activated macrophage markers, 
Arginase-1 and Ym-1. As the IL-4Rα-/- mice will be unable to respond to both IL-
13 and IL-4 these studies did not conclude whether Ym-1 expression is IL-4 or IL-
13 controlled. In the future IL-4-/- and/or IL-4Rα-/- mice could be subjected to the 
multiple infection model and the growth factor levels analysed within the whole 
pinnae and DEC. Loss of IL-4 may reduce the expression of pro-angiogenic genes 
from the DEC, in particular the macrophages (Gordon 2003).  
One cytokine not analysed within this study was TGFβ, as it is only active after a 
series of cleavage steps, PCR is not an accurate way to measure levels. A TGFβ 
reporter cell line was utilised to measure bioactive levels of the cytokine 
however only a small number of supernatants were tested (data not shown). This 
revealed a slight increase between naïve and 1x and 1x and 4x, although due to 
the small sample size this was not significant. A more thorough study of TGFβ 
would be prudent in the future as it has significant angiogenic abilities (Pepper 
1997, Viñals 2001, Wakefield 2002) and could also compensate for the loss of IL-
10 in the 4x resulting in the less sever phenotype seen than expected.  
One cell type not thoroughly explored in this study was the neutrophil. Although 
not as well associated with angiogenesis as macrophages or eosinophils, 
neutrophils are an emerging cell type in the initiation and control of angiogenesis 
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(Gaudry 1997, Ardi 2007, Piccard 2011).  Like macrophages, neutrophils have 
recently been proposed to have several alternative activation states – N1 and N2 
in addition to tumour associated neutrophils (TAN). TGFβ is proposed to induce a 
pro-tumoral phenotype in neutrophils by up-regulating Arginase, VEGF and 
MMP-9 whilst down regulating TNF-α expression; N2 neutrophils. In contrast 
neutrophils activated with Interferon beta (IFNβ) express TNF-α and no pro-
angiogenic growth factors (Piccard 2011). This is currently a simplified 
explanation of neutrophil polarisation and IL-10 has also been instigated as a 
mediator of this phenotypic switch (Moore 2001). Neutrophils are recruited early 
after cercarial penetration and infiltrate into both the dermis and epidermis 
(Icani 1984, Hogg 2003). The angiogenic phenotype of these cells may be 
different between 1x and 4x pinnae and could either directly induce early vessel 
branching and/or activate further angiogenic pathways up-regulating 
angiogenesis. Analysis of cDNA from sorted neutrophils could be used to 
determine the pro-angiogenic phenotype and any differences between the 1x 
and 4x pinnae.  
 
7.1.4  0-3hRP induced angiogenesis  
 
Coinciding with the culmination of this research, several reviews on angiogenesis 
in parasite infections have hypothesised that parasites may induce this 
neovascularisation for their own benefit (Dennis 2011).  
Chapter 6 tested the angiogenic potential of 0-3hrRP in several well described 
angiogenic assays (Akhtar 2002, Poulaki 2011). Endothelial cells cultured with 0-
3hRP became activated, both proliferating and migrating into vessel structures.  
The working hypothesis for this chapter was that the increase in pro-angiogenic 
growth factors in the skin was due to 0-3hRP degradation of the ECM releasing 
bound growth factors. This is likely to be one mechanism by which the growth 
factor levels are increased in vivo after schistosome penetration. The physical 
movement of the parasite may also induce activation of the MMP pathways. 
However, the assays used in this chapter indicated that the secretions alone 
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without the presence of ECM could induce angiogenesis. Endothelial cell 
proliferation assays in the presence of the inhibitor revealed that   0-3hRP 
contains a factor other than a protease which can activate the endothelial cells.  
To determine whether 0-3hRP has homology to a known growth factor, and 
signals through known receptors, the growth factor pathways activated in the 
endothelial cells must be identified. Unfortunately these experiments could not 
be completed with murine dermal endothelial cells as extraction of the cells from 
the pinnae was relatively unsuccessful. Only a 30% pure population was achieved 
through cell sorting and these did not survive subsequent cells culture. 
Endothelial cells can vary widely in their phenotype between tissue sites (Jackson 
1997, Chi 2003). As such HUVECs may have a different panel of receptors 
expressed compared to murine dermal endothelial cells (mdECs). Therefore, 
some of the features seen after HUVEC culture with 0-3hRP may not be induced 
in mdECs, conversely mdECs may be more responsive to 0-3hRP than HUVECs.  
Administration of 0-3hRP directly into the skin of mice would show whether the 
secretions alone can induce all or some of the pro-angiogenic factors detected in 
the dermis following infection. However the method of administration would 
have to be simple and cause as little wounding as possible, as growth factors 
would be released upon damage to the skin and may cloud any observations. A 
less invasive technique could be the use of micro needles (Prausnitz 2004, Henry 
2000, Gill 2006 ). Needles coated in 0-3hRP would deliver the secretion 
thoroughly through the skin and cause limited damage. A negative control, e.g. 
PBS, would have to be administered to a second set of mice to control for any 
damage following the infection.  
Within this study however an alternative method was used to determine 
whether 0-3hrRP induces de novo vessel growth although this was not within the 
skin. Matrigel plugs containing 0-3hrRP were implanted into mice using a single 
fine needle and no surgery thereby limiting the damage caused. These showed 
vessel growth into the plugs which was absent in the PBS only plugs. VEGF and 
SEA plugs also induced vessel growth. This in vivo experiment was strong 
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evidence of a molecule within the 0-3hRP and SEA which can induce directional 
growth of new vessels into an avascular region.   
The up-regulation of growth factors and matrix metalloproteinases alongside 
direct induction of endothelial cells suggests that 0-3hRP could be useful in 
inducing wound healing mechanisms. 0-3hRP was added to fibroblasts after the 
monolayer had been scratched. This increased the migration of the fibroblasts 
and closed the wound in the monolayer more rapidly than those cultured in 
media alone. To determine more accurately whether 0-3hRP can induce wound 
healing it would be applied to incisional wounds in murine skin. The speed of 
wound closure and histological analysis of the wounds would reveal whether 0-
3hRP was accelerating the process. If it does increase fibroblast activation it or 
the component which induces this within the secretions could have potentially 
used as a therapeutic to aid in non healing wounds.  
 
 
7.1.5 Summary 
 
In conclusion, work in the thesis has shown that the passage of the cercariae 
through the skin does induce new vessel growth. This could be by one or more of 
three potentially overlapping mechanisms: Wound healing, innate immunity 
induction or direct endothelial activation by parasite secretions. The hypothesis 
prior to the beginning of this work was that the cercariae would cause 
considerable damage during penetration of the skin and with this induce wound 
healing responses. This appears to be true, but additionally after multiple 
infections, it was shown that the angiogenic response in the skin changed. This 
was because of an increase in a different profile of growth factors which seems 
to be due in part by a change in the immune cells recruited to the dermis. The 
final part of this thesis showed that the cercariae themselves can induce new 
vessel growth. More work is needed to determine what the factor within the 0-
3hRP is which induces the growth and if possible to purify a sample to test in 
further assays. Overall, multiple infections with cercariae provide an interesting 
model to study angiogenesis induction following parasite infection. Interestingly, 
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0-3hRP may present a novel substrate which could induce angiogenesis and 
wound healing. If the precise component of the 0-3hrRP which induces 
angiogenesis and fibroblast proliferation could be isolated it may present a 
possible therapeutic in the treatment of slow and non-healing wounds and could 
have clinical applications.  
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Appendix 
 
Section 1 - Primer Pairs, cycle numbers and annealing temperatures 
 
Gene Forward Sequence Reverse Sequence 
Ang 1 GATCTTACACGGTGCCGATT TTAGATTGGAAGGGCCACAG 
Ang 2 CTTAAGCCTGCACCGCTAAC CTGAACTCCCACGGAACATT 
CD105 GCTGAAGACACTGACGACCA CCATGTCGATGCACTGTACC 
ECGF1 CCTTCGCTGAACTTGTCCTC CCCTAGAGCCAGTAGCATCG 
Flk-1   
Figf CTGAACAACAGATCCGAGCA TGCTGAGCGTGAGTCCATAC 
FGF 1 TTCATTCATGAGGCCTTTCC ATGCAGTACCCCTGGAGTTG 
FGF 2 AGCGGCTCTACTGCAAGAAC TATGAAGGAAGATGGACGGC 
FGF 6 GGCCCTGTGCATAAGAAAAA CAATCCTGCTGACTCGACAA 
HGF TTCCCAGCTGGTCTATGGTC TGGTGCTGACTGCATTTCTC 
MMP-2 ACACTGGGACCTGTCACTCC TGTCACTGTCCGCCAAATAA 
MMP-9 CCCAGAGGTAACCCACGTCA CACACGCCAGAAGAATTTGC 
MMP-19 TGAGGAGGAAGAGACCGAGA CCAAAGGGCAGATATTTGGA 
PlGF TGCTGGTCATGAAGCTGTTC ACCCCACACTTCGTTGAAAG 
Tie 2 AAGCATGCCCATCTGGTTAC GTAGGTAGTGGCCACCCAGA 
VEGF CAGGCTGCTGTAACGATGAA CTTGGCGATTTAGCAGCAGA 
COX2 AGAAGGAAATGGCTGCAGAA CCCCAAAGATAGCATCTGGA 
Arginase-1 TCACCTGAGCTTTGATGTCG CTGAAAGGAGCCCTGTCTTG 
 Probe TTCTGGGAGGCCTATCTTACAGAGAAGGTCTCTAC 
RELMα TGCTGGGATGACTGCTACTG CTGGGTTCTCCACCTCTTCA 
 Probe CAAGATCCACAGGCAAAGCCACAA 
Ym1 CTCAATATACACAGTGCAAGTTG TGGGATTCAATTTAGGAAAGTTCA 
 Probe TCCACAGTGCATTCTGCATCATGCT 
iNOS CTGCATGGACCAGTATAAGG CTAAGCATGAACAGAGATTTCTTC 
 Probe AGTCTGCCCATTGCTG 
GAPDH CCATGTTTGTGATGGGTGTG CCTTCCACAATGCCAAAGTT 
 Probe CATCCTGCACCACCAACTGCTTAGC 
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Gene 
 
Cycle number 
Annealing 
Temperature 
°C 
Ang 1 32 60 
Ang 2 32 60 
CD105 30 60 
ECGF1 30 60 
Flk-1 32 63 
Figf 30 60 
FGF 1 30 60 
FGF 2 30 60 
FGF 6 30 60 
HGF 30 60 
MMP-2 30 60 
MMP-9 28 60 
MMP-19 30 60 
PlGF 30 61 
Tie 2 30 60 
VEGF 29 60 
COX2 30 60 
Arginase-1 50 60 
RELMα 50 60 
Ym1 50 60 
iNOS 50 60 
GAPDH 26(SQ-PCR)/50 
(Q-PCR) 
60 
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Section 2 - Raw data from array analysis 
 
The numbers shown are the relative quantification compared to naïve (Naïve 
was set to 1) 
 
Gene d1 d2 d4 d1 d2 d4 
Alanyl (membrane) aminopeptidase  4.31 1.39 2.49 1.02 2.17 0.40 
Angiopoietin 1 1.43 0.89 0.67 2.59 1.81 1.20 
Angiopoietin 2  2.01 0.70 0.57 2.65 1.57 1.37 
Brain specific angiogenesis inhibitor 1  2.70 0.62 2.59 5.86 1.84 8.28 
Cadherin 5  3.13 0.99 2.40 5.49 3.08 1.82 
CCL11 X 14.05 10.71 19.26 1.00 0.85 
CCL2 1.86 1.10 1.27 1.95 1.15 0.73 
C-fos induced growth factor 1.20 1.07 1.24 1.07 0.99 0.63 
Coagulation factor 2 0.11 0.67 0.47 0.99 1.21 0.25 
Colony stimulating factor 3 0.05 1.37 0.14 0.10 3.21 0.01 
Connective tissue growth factor 0.02 0.82 0.12 0.07 0.68 0.00 
CXCL1 0.69 25.40 0.30 0.32 13.27 0.07 
CXCL2 1.26 56.72 1.43 6.44 134.29 0.13 
CXCL5  0.03 9.08 0.50 3.42 43.67 0.01 
Endoglin 0.13 1.28 0.90 3.56 3.67 1.00 
Endothelial cell growth factor 1 0.01 0.96 0.09 0.03 0.82 0.01 
Endothelial differentiation gene 1 2.15 0.71 1.21 1.34 0.47 1.71 
Endothelial PAS domain protein 1 0.06 1.10 0.00 0.14 0.62 0.01 
Eph receptor B4 3.33 0.96 2.49 4.66 1.34 5.01 
Ephrin A1  1.15 1.11 0.86 2.71 1.40 0.47 
Ephrin B2 0.80 0.69 0.32 0.87 0.46 0.21 
Epidermal Growth factor 0.04 0.80 0.01 0.06 0.73 0.00 
Epiregulin 0.01 1.03 0.00 0.03 0.62 0.00 
Fibroblast growth factor 1  1.75 0.97 1.74 5.96 2.47 5.70 
Fibroblast growth factor 2 4.27 1.06 1.46 1.33 1.14 0.97 
Fibroblast growth factor 6  1.45 0.98 0.90 0.67 0.64 0.44 
Firboblast growth factor receptor 3 0.58 1.43 0.49 1.01 3.54 0.47 
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Fizzled homolog 5 1.60 0.83 0.83 0.47 0.35 0.27 
FMS-like tyrosine kinase 1  0.14 0.85 0.16 0.12 2.26 0.02 
Guanine nucleotide binding protein 
α13 
0.10 1.04 0.19 0.09 1.47 0.03 
Heart and neural crest derivatives  
expressed transcript 2  
0.17 1.09 1.00 0.37 1.26 0.12 
Hepatocyte growth factor 0.27 1.18 0.35 0.21 1.30 0.05 
Hypoxia inducible factor 1α  0.63 0.85 1.56 1.39 2.76 1.92 
Insulin-like growth factor 1 0.03 1.30 0.18 0.23 4.54 0.04 
Integrin alpha V  0.00 1.51 0.02 0.00 2.16 0.00 
Integrin beta 3 1.61 2.29 2.07 5.80 5.40 5.30 
Interferon gamma 0.75 0.69 1.34 0.73 1.06 0.67 
Interleukin 1 beta 1.82 22.60 1.55 7.86 66.03 0.80 
Interleukin 6  0.03 1.89 0.19 0.12 8.80 0.02 
Jagged 1 1.43 0.68 1.41 1.11 0.43 0.82 
Kinase insert domain receptor 1.80 0.87 2.44 5.94 1.48 3.40 
Laminin alpha 5 0.17 0.75 0.50 0.37 0.49 0.19 
Leptin 0.16 0.87 0.99 0.89 0.97 0.21 
Leukocyte cell derived chemotaxin 1 0.21 0.78 0.34 0.25 0.96 0.21 
MAD homolog 5 0.05 0.82 0.23 0.05 0.40 0.01 
Matrix metalloproteinase 19 0.01 0.59 0.14 0.04 0.28 0.01 
Matrix metalloproteinase 2 1.07 0.77 1.79 1.92 0.68 1.26 
Matrix metalloproteinase 9  0.87 1.01 1.71 1.32 1.19 0.72 
Midkine  0.62 1.68 0.64 4.88 3.80 2.08 
Mitogen activated protein kinase 14  0.03 0.84 0.05 0.04 0.94 0.05 
Natriuretic peptide receptor 1  0.61 2.50 0.18 1.04 10.28 0.96 
Neuropilin 1 0.94 0.83 1.22 2.16 0.92 1.48 
Neuropilin 2  0.43 0.74 0.47 0.76 1.22 0.68 
Placental Growth factor  0.01 1.08 0.02 0.03 1.73 0.01 
Plasminogen  2.19 0.73 1.65 1.68 0.54 2.09 
Plasminogen activator urokinase  0.02 2.14 0.05 0.07 7.56 0.02 
Platelet/ Endothelial cell adhesion 
molecule 1  
1.08 0.66 1.06 3.11 1.66 2.34 
Platlet derived growth factor alpha  X 1.35 0.00 0.00 2.20 0.00 
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Plexin domain containing 1 X 1.04 0.02 0.03 3.33 0.08 
Pro collagen type IV alpha 3 1.12 0.82 1.20 1.28 0.60 1.99 
Pro-collagen type XVIII alpha 1  0.11 0.83 0.24 0.12 0.45 0.01 
Prostoglandin - endoperoxide 
synthase 1 
0.00 0.27 0.00 0.00 0.96 0.00 
Serine (or cysteine) peptidase 
inhibitor,  
Clade F, member 1 
0.03 1.14 0.13 0.13 0.96 0.09 
Sphingosine kinase 1 0.00 0.79 0.02 0.00 0.47 0.00 
Stabilin 1  0.53 1.08 0.48 0.70 11.62 0.03 
T-box 1 0.00 0.98 0.00 0.00 1.21 0.00 
T-box 4 0.00 1.47 0.00 0.01 2.54 0.00 
Thrombospondin 1 2.07 0.78 1.33 1.38 0.60 1.66 
Thrombospondin 2 0.00 1.07 0.04 0.02 3.41 0.04 
Tissue inhibitor of metalloproteinase 
1 
0.13 0.57 0.19 0.09 0.35 0.16 
Tissue inhibitor of metalloproteinase 
2  
0.32 0.57 0.58 0.29 0.31 0.37 
Transforming growth factor alpha  0.53 0.67 0.66 0.50 0.78 0.92 
Transforming growth factor β1  0.00 0.86 0.00 0.00 0.55 0.01 
Transforming growth factor β2 0.05 0.72 0.01 0.07 1.29 0.45 
Transforming growth factor β3 1.47 1.09 1.64 3.66 1.71 3.90 
Transforming growth factorβr1 0.25 0.89 0.60 1.00 1.81 1.40 
Trans-membrane serine protease 6 1.91 1.52 1.35 2.82 2.31 3.23 
Tumour necrosis factor (ligand)  
superfamily member 12 
1.08 1.11 1.10 2.10 1.49 2.40 
Tumour necrosis factor α 0.01 0.70 0.04 0.02 0.63 0.26 
Tumour necrosis factor α- induced 
protein 2 
1.33 0.83 0.91 1.42 1.43 2.05 
Tyrosine-protein kinase receptor 0.01 0.90 0.01 0.01 0.85 0.00 
Vascular growth factor A  0.07 0.71 0.08 0.02 0.83 0.56 
Vascular growth factor B 0.00 1.00 0.02 0.01 1.42 0.12 
Vascular growth factor C 0.06 0.88 0.20 0.10 1.75 0.22 
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Abbreviations 
 
0-3hRP 0-3 hour released preparation 
AAMφ Alternatively activated macrophage 
Ang1 Angiopoetin 1 
Ang2 Angiopoetin 2 
APC Allophycocyanin 
Arg-1 Arginase-1 
BSA Bovine serum albumin 
CCL Chemokine (C-C) motif ligand  
COX2 cyclooxygenase isoenzyme 
CXCL Chemokine (C-X-C) motif ligand  
DEC Dermal exudate cell 
DEPC Diethylpyrocarbonate 
DMEM Dulbecco’s modiﬁed Eagle's medium 
DNA deoxyribonucleic acid 
EC Endothelial cell 
ECM Extraceullar Matrix 
ELISA Enzyme linked immunosorbent assay 
FGF Fibroblast growth factor 
FIGF c-fos inducible growth factor 
FITC Fluorescein isothiocyanate 
Flk-1 Foetal liver kinase 1 
Flt-1 fms-related tyrosine kinase 1 
Flt-4 fms-related tyrosine kinase 4 
GM-CSF Granulocyte-macrophage colony-stimulating factor 
H&E hematoxylin and eosin 
Hand2 Heart and neural crest derivatives 
HGF Hepatocyte growth factor  
HIF-1 Hypoxia inducible factor 1 
HRP Horseradish peroxidase 
HUVEC Human umbilical vein endothelial cells 
IFNγ Interferon gamma 
IgG1 Immunoglobulin G1 
IL-10-/- Interleukin 10 deficient mice 
IL-X Interleukin- X 
iNOS inducible nitric oxide synthase 
L-Glut L-Glutamine 
LPS Lipopolysaccharide 
MIP1α Macrophage inflammatory protein 1 alpha 
MMP-X Matrix Metalloproteinase -X 
MR Mannose receptor 
PAF Platelet-activating factor 
PBMC Peripheral blood mononuclear cells 
PBS Phosphate buffered saline 
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PBST Phosphate buffered saline + TWEEN20 
PCR Polymerase chain reaction 
PDGF Platelet derived growth factor 
PE Phycoerythrin 
PECAM-1 Platelet endothelial cell adhesion molecule -1 
Pen/Strep Penicillin/Streptomycin 
PlGF Placental growth factor 
Q-PCR Quantitative polymerase chain reaction 
RA Radiation attenuated 
RELMα Resistin like molecule alpha 
RNA Ribonucleic acid 
RPMI Roswell Park Memorial Institute medium 
SEA Soluble egg antigen 
SMC Smooth muscle cell 
SQ-PCR Semi quantitative polymerase chain reaction 
TGFβ Transforming growth factor beta 
Th T helper cell type 
Tie2 Tyrosine-protein kinase receptor 2 
TLR Toll like receptor 
TMB 3,3’,5,5’-Tetramethylbenzidine 
TNF-α Tumour necrosis factor - α 
VE-Cadherin Vascular endothelial cadherin 1 
VECAM-1 Vascular endothelial cell adhesion protein 1 
VEGF Vascular endothelial growth factor 
WT Wild Type 
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